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1.1 Gut-brain axis 
The term “gut-brain axis” (GBA) indicates the communication between the gut and the brain. 
This communication is guaranteed by neural messages (through vagal and spinal afferent 
neurons), immune messages (through cytokines) and endocrine messages, through gut 
hormones (Holzer et al., 2012). 
The regulation of energy homeostasis is located in the hypothalamus involved in the control of 
food intake by humoral and neural signals.  
Feeding behavior and body weight are controlled by peripheral signals that can be short- and 
long-term signals. The short-term signals are generated by pancreas, liver, skeletal muscle or 
gastrointestinal tract (GIT) as either afferent sensory relays, nutrients or hormones that reach 
the central nervous system (CNS) through the blood–brain barrier. Long-term signals provide 
information to the brain about the energy stores and induce responses to maintain energy 
homeostasis (Havel, 2001).  
A finely orchestrated cooperation of short- and long-term signals allows humans to integrate 
energy intake and expenditure and to maintain the energy balance. Homeostatic regulation of 
energy balance is also influenced by hedonic and emotional neural signals. Indeed, eating 
behavior is physiologically regulated over three main phases: a preparatory phase, an eating 
phase and a post-eating phase (Berthoud et al., 2011). 
The GBA influences the mechanisms implicated in the processes of satiety and satiation. 
Satiety is the mechanism that inhibits further eating from the post-prandial time until the next 
meal and determines the intermeal interval. Satiation is the mechanism that determines the end 
of eating during a meal thus influencing the meal size (Berthoud et al., 2011). The mechanisms 
underlying GBA communication involve immune-neuro-endocrine mediators. This 
communication includes the CNS, the autonomic nervous system (ANS), the enteric nervous 
system (ENS) and the hypothalamic pituitary adrenal (HPA) axis (Holzer et al., 2012). 
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A role of the gut microbiota in both intestinal physiology and in CNS has been demonstrated 
thus leading to the individuation of a “microbiota-gut-brain-axis” (Duca & Lam, 2014). 
The microbiota is the microbial community of several different environments of the body. The 
intestinal tract has the most abundant population with 1000 different bacterial species which 
make up the majority of the all 100 trillion micro-organisms inhabiting the gut (Turnbaugh et 
al., 2007). 
Different studies on germ-free animals showed that the bacterial colonization of gut is 
important to the development and the maturation of both ENS and CNS. The absence of 
microbiota is linked with the alterations of gut-sensory motor functions involved in delayed 
gastric emptying and intestinal tract (Carabotti et al., 2015). 
Figure 1 shows the mechanism involved in “microbiota-gut-brain-axis”. 
 
 
Figure 1.1. Mechanisms of the bidirectional brain-gut microbiota axis (Carabotti et al., 
2015). 
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1.2 Intestinal nutrient sensing 
Gustatory system in the oral cavity involves the activity of taste receptors that transmit signals 
via sensory vagal afferents to the brain informing about the composition of the meal. However, 
a fine net of taste receptors is also present in the GIT thus constituting a sensory system in the 
gut. This system allows the GIT to detect the ingested nutrients and inform the CNS by both 
neural and humoral mechanisms. Indeed, the sensing of nutrients present into the lumen by the 
taste receptors located on enteroendocrine cells (EECs) induces the secretion of peptides acting 
as hormones. The GIT endocrine system produces over 20 hormones that influence food intake, 
insulin release and gut motility (Mace et al., 2015). The action of the hormones is also mediated 
by vagal afferent fibres which are located in the lamina propria of the intestinal villi where the 
gut peptides are released (Duca & Lam, 2014). 
EECs in the stomach secrete ghrelin (A cells), somatostatin (D-cells), gastrin (G-cells), 
histamine (L-cells) and leptin (P cells) whereas those in the small intestine and in the colon 
secrete cholecystokinin (CCK) (I-cells), glucagon like peptide-1 (GLP-1) (L-cells), peptide YY 
(PYY) (L-cells) and gastric inhibitory peptide (GIP) (K-cells) (Steensels & Depoortere, 2017). 
Enterochromaffin cells  are a type of EECs present in the GIT epithelia and specialized in the 
secretion of 5-hydroxytryptamine (5-HT3, serotonin) regulating secretory and peristaltic 
reflexes, and activating vagal afferents through receptors signalling to the CNS (Mace et al., 
2015). 
The nutrients are detected by a large number of proteins such as nutrient transporters and G-
protein-coupled receptors (GPRs). The delivery of dietary nutrient such as carbohydrates, 
proteins, and fat activates the secretion of hormones by EECs. 
The sweet receptors derive from the heterodimerization of TAS1R2 and TAS1R3, including the 
family C of  GPRs. The sweet receptors are not only expressed on the lingual epithelium, but 
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they also act as a carbohydrate sensor in the intestine on L-cells and K-cell secreting GLP-1 
and GIP respectively (Spreckley & Murphy, 2015). 
The glucose-induced GLP-1 secretion is mediated by sweet taste receptor TAS1R2-TAS1R3, 
the glucose transporter SGLT1 and ATP-sensitive potassium (KATP) channels (Steensels & 
Depoortere, 2017). 
The products of breakdown of proteins such as peptides are sensed via lysophosphatidic acid 
receptor 5 (LPA5R, also known as GPR92/93). The GPR93 is expressed by cells of duodenal 
mucosa, including L-cells, but it is also present in G-cells and D-cells of stomach. The 
activation of GPR93 releases CCK and GLP1 (Spreckley & Murphy, 2015; Janssen & 
Depoortere, 2013). 
The aromatic and basic amino acids are sensed by the calcium sensing receptor (CaSR), a 
receptor expressed in G-cells, I-cells and D-cells promoting the secretion of GLP-1 and PYY. 
Furthermore, basic amino acids are sensed by GPRC6A, present in gastric antral D-cells and 
G-cells. 
The L-glutamate is an umami tasting stimulus that is sensed by the taste receptor heterodimer 
TAS1R1-TAS1R3 expressed in brush cells and endocrine L and X/A cells of gut and also the 
metabotropic glutamate receptor (Janssen & Depoortere, 2013; Spreckley & Murphy, 2015). 
The free fatty acids (FFAs) are delivered from lipid droplets in the small intestine and they are 
transported to the surface of enterocytes. The transport of FFAs in the intestine occurs via the 
cluster of differentiation 36 (CD36) and fatty acid transport protein 4 (FATP4) (Steensels & 
Depoortere, 2017). 
The FFAs are sensed by different free fatty acids receptors, depending on their chain length. 
Medium chain fatty acids (MCFA) and long chain fatty acids (LCFA) are sensed by GPR40 
and GPR120 on EECs. 
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GPR40 is expressed in the pancreatic β-cells influencing the insulin release. This receptor is 
present also in the cells of GIT expressing GLP-1 and GIP, while GPR120 is expressed in 
colonic L-cells and in the δ cells of pancreas and promotes the release of GLP-1 (Janssen and 
Depoortere, 2013; Steensels & Depoortere, 2017). 
Short-chain fatty acids (SCFA) are sensed by GPR43 and GPR41. These receptors are located 
in the human colon and ileum. GPR43 and GPR41 are expressed by enteroendocrine L-cells 
that secrete PYY. Anyway, GPR41 is more present in L-cells of the small intestine, while 
GPR43 is expressed in the human colon (Spreckley & Murphy, 2015). 
GPR119 detects the fatty acid ethanolamides, such as N-oleoylethanolamine (OEA). This 
receptor is present in both pancreatic β-cells and intestinal L-cells. The activation in the 
pancreas of GPR119 mediates the insulin secretion in the presence of glucose. In the gut, the 
activation of this receptor releases GLP-1 and insulin in a glucose dependent manner 
(Spreckley & Murphy, 2015; De Luca, 2018). 
Table 1.1 summarises the chemosensors present on enteroendocrine cells along GIT. 
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Table 1.1. Chemosensors in the GIT (Steensels & Depoortere, 2017; Mace et al., 2015). 
 Enteroendocrine cells 
 X/A cells P cells G-cells D-cells I-cells L-cells 
Gut hormone Ghrelin Leptin Gastrin Somatostatin CCK GLP-1, PYY 
Function Hunger, 
Adipogenesis, 
Growth, Hormone 
release 
Influence 
satiety 
Acid 
secretion 
Inhibition of 
gastrin release 
Inhibition of food 
intake and gastric 
emptying, 
stimulation of 
pancreatic 
enzyme secretion 
Stimulation of 
insulin release. 
Inhibition of 
food intake and 
transit 
Anatomic 
localization 
Stomach Stomach Stomach Stomach, 
small intestine 
Small intestine Small intestine, 
colon 
Nutrient sensor 
Carbohydrates 
and sweeteners 
TAS1R3 
SGLT1 
KATP channels 
 NR NR NR TAS1R2, 
TAS1R3, 
SGLT1, 
KATP channels 
Proteins CaSR, 
GPRC6A, 
TAS1R1-TAS1R3 
 CaSR, 
GPRC6A, 
LPA5R 
   
Lipids GPR43, GPR120  GPR41 GPR120 GPR40, GPR41, 
GPR120, CD36 
GPR40, GPR43, 
GPR41, 
GPR120 
GPR119, 
FATP4 
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1.3 Peptides involved in food intake 
The enterocytes are absorptive cells that on their apical side contain the microvilli used to 
enlarge the contact surface of lumen and to express different transporters that regulate the 
uptake of sugars, amino acids (aa) and fatty acids (FA). 
The EECs are considered the most important endocrine organ in the body. These cells secrete 
a wide range of peptides that influence the regulation of food intake and gastrointestinal 
motility. 
Ghrelin (hunger hormone) is secreted by P/D1-cells (X/A-cells in rodents) from the stomach. 
The concentration of this hormone increases before the meal and decreases in the post-prandial 
phase. Ghrelin influences the hunger on a short-term basis, but it also influences the fat storage, 
resulting in an increased body weight in the long term (Janssen & Depoortere, 2013; Steensels 
& Depoortere, 2017). 
GLP-1 belongs to the family of glucagon peptide. It is secreted after a meal and it induces 
satiety through the delay of gastric emptying and potentiation of the glucose-induced insulin 
secretion.  GLP-1 is released from intestinal L-cells in the distal gut, it is degraded by 
dipeptidylpeptidase-IV (DPPIV) (Steensels & Depoortere, 2017). 
PYY is a pancreatic polypeptide involved in the mechanisms that control the transit of a meal 
through the gut to optimise nutrient digestion and absorption. It is released, in the distal gut, 
from the enteroendocrine L cells in response to a meal and it is degraded by DPPIV (Steensels 
& Depoortere, 2017). 
CKK is a hormone secreted from enteroendocrine I cells of the upper small intestine in response 
to ingestion of fat and protein. This hormone causes the release of digestive enzyme and bile 
from pancreas. Furthermore, CCK is also a satiety signal that decreases meal size and delays 
gastric emptying (Janssen & Depoortere, 2013; Steensels & Depoortere, 2017). 
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1.4 N-acylphosphatidylethanolamines (NAPEs), N-acylethanolamines (NAEs) and 
Endocannabinoids (ECs) 
N-acylphosphatidylethanolamines (NAPEs), N-acylethanolamines (NAEs) and 
endocannabinoids (ECs) belong to the class of lipid messengers, present both in prokaryotic 
and eukaryotic cells (Coulon et al., 2012). 
NAEs and 2-monoacylglycerols (2-MAGs) comprise lipids containing a fatty acid, which is 
linked to either ethanolamine or glycerol, respectively. They belong to a vast group of fatty 
acid-containing bioactive lipids that can exert a number of physiological functions in the human 
body through the activation of specific membrane receptors and nuclear receptors.  
Biosynthesis of NAPEs 
 
In animals, the synthesis of NAPEs occurs through the enzyme N-acytransferase (NAT). This 
enzyme has two different activities: NAT Ca2+ dependent and NAT Ca2+ independent. The 
enzyme Ca2+ is a membrane-bound protein, it is ATP independent and utilizes 
phosphatidylethanolamine (PE) as acyl acceptor. The formation of NAPEs involves the transfer 
of an acyl chain from sn-1 position of the phospholipid to the amine of PE.  
In plants, the synthesis of NAPEs is possible by NAPE synthase activity that promotes the N-
acylation of PE by FFAs (Coulon et al., 2012). 
Catabolism of NAPEs 
In animals, a specific membrane-bound phospholipase D, N-acyl phosphatidylethanolamine 
phospholipase D (NAPE-PLD), catalyses NAPEs hydrolysis. NAPE-PLD belongs to the 
metallo-β-lactamase family and it is tightly bound to membranes (Ueda et al., 2013). The 
enzyme is structurally and catalytically different from other PLD family members and it has a 
specificity for NAPEs among the glycerophospholipids, with similar selectivity for N-acyl 
species of NAPEs (Blancafort et al., 2014). 
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Three different alternative ways are note to produce NAEs. The first, after NAPE hydrolysis, 
is mediated by phospholipase A2, meanwhile lyso-NAPEs are degraded by a PLD-like activity. 
The second way is mediated by phospholipase C (PLC) hydrolysis that leads to diacylglycerol 
and phospho-NAEs that are degraded into NAEs by phosphatase activity.  
The thrird biosynthetic way involves the α/β-hydrolase-4 (Abh4) serine hydrolase deacylates 
NAPEs. The glycerophospho-NAEs (GP-NAEs) thus generated could be hydrolysed by a 
glycerophosphodiesterase-1 (GDE1) (Hansen & Diep, 2009; Coulon et al., 2012). 
In plants, multiple isoforms of PLD are expressed such as PLDβ and PLDγ, that are able to 
hydrolyse glycerophospholipids, including NAPEs (Coulon et al., 2012; Ueda et al., 2016). 
NAEs are hydrolysed in FFAs and ethanolamine by fatty acid amide hydrolase (FAAH) or N-
acyethanolamine-hydrolyzing acid amidase (NAAA) (Coulon et al., 2012). 
FAAH is a serine hydrolase belonging to the amidase signature family, it is composed of 579 
aa. An isozyme of FAAH with ~ 20% sequence identity at the aa level is expressed in humans. 
The optimal pH for the FAAH activity is 8.5-10 (Ueda et al., 2010). 
NAAA is a cysteine hydrolase belonging to the N-terminal nucleophile hydrolase superfamily. 
The primary structure of NAAA is composed by 359 aa in humans.  
The catalytic activity occurs at the optimal pH 4.5-5 (Ueda et al., 2010). 
NAEs and ECs receptors 
The most well-known NAEs and 2-MAG are the two ECs, anandamide (AEA) and 2-
arachidonoylglycerol (2-AG) that bind and activate cannabinoids receptors (CB1 and CB2). 
The CB receptors are distributed in the GIT and in ENS.  
The CB1 receptor is expressed in CNS, in neurons that regulate food intake, energy expenditure 
and reward responses, as well as in liver, pancreas, muscle and adipose tissue. 
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The CB1 receptor participates in brain areas to the regulation of energy balance such as the 
hypothalamus, the corticolimbic circuits, including the nucleus accumbens (NAc) and the 
ventral tegmental area, and the brainstem (Gatta-Cherifi & Cota, 2015). 
The activation of CB1 by ECs increases the consumption of foods. In hypothalamus, the 
homeostatic appetite regulator, leptin, suppresses the food consumption. This hormone 
negatively regulates the hypothalamic levels of ECs (Di Marzo et al., 2001). 
NAEs and 2-MAGs also have a number of physiological roles targeting others aside the 
cannabinoid receptors (Hansen & Vana, 2018; Di Patrizio et al, 2011; Hillard, 2018).  
NAEs activate the vanilloid receptor (TRPV1) which can be also activated by heat, low pH, 
and capsaicin. This receptor is expressed in the GIT on the terminals afferent fibers and in some 
immune cells, its activation influences the pain system (Hansen & Diep, 2009). 
NAEs link peroxisome proliferator-activated receptor-α (PPAR-α) that is a nuclear receptor 
involved in fat metabolism. PPAR-α is expressed in the enterocytes in the small intestine and 
in enteric neurons of myenteric and submucosal plexuses throughout the GIT, but it was also 
found in vagal afferent fibres in GIT. In rats it was found in all regions of gut including the 
colon (Izzo & Sharkey, 2010). 
All NAEs, particularly OEA, activate PPAR-α. OEA activates this receptor with a half maximal 
concentration EC50 of 120 nM, in vitro (Fu et al., 2003). 
Moreoveor the NAEs, linoleoylethanolamide (LEA), palmitoylethanolamide (PEA) and OEA 
link GPR119 and GPR55 that can be also involved in the food intake modulation either by 
acting in the brain or by signaling from the gastrointestinal system.  
In animal studies GPR119 was shown to be expressed in pancreatic islet and in β-cells, on L-
cells regulating the release of GLP-1, in duodenum, colon, ileum and CNS (Izzo & Sharkey, 
2010; Hansen & Diep, 2009).  
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In vitro studies, showed that NAEs have agonist activity on GPR119, with an EC50 that was 
found between 3.2 µM and 0.2 µM for OEA, 0.56 µM for LEA and 0.84 µM for PEA (Hansen 
et al., 2011; Overton et al., 2006).  
Table 1.2 reports the localization and function of all NAEs and ECs receptors. 
 
Table 1.2.  NAEs and ECs receptors 
Receptor Localization Function Compound Reference 
CB1 and CB2 Brain, heart, uterus, leukocytes, spleen, extented 
muscle, testis, liver, small intestine, pancreas,  
immune cells 
Regulation of energy 
balance and 
metabolism, regulation 
of immune and 
inflammatory responses 
AEA, 2-AG D’Addario et al., 
2014; Gatta-
Cherifi & Cota, 
2015 
TRPV1 Peripheral sensory fibres, immune cells Regulation of pain 
system 
AEA, OEA, 
PEA 
D’Addario et al., 
2014; Hansen & 
Diep, 2009 
GPR119 Pancreas, liver, duodenum, colon, ileum, CNS Release of GLP-1 and 
insulin secretion 
OEA, LEA, 
PEA, 2-OG 
Hansen et al., 
2011; Izzo & 
Sharkey, 2010; 
Hansen & Diep, 
2009 
PPAR-α Small intestine, vagal afferent fibres  Lipid metabolism OEA, PEA Izzo & Sharkey, 
2010 
 
1.5 NAEs, ECs and food intake 
ECs have several effects including analgesia, relaxation and appetite stimulation. For this 
reason, these compounds have been studied to treat various pathologies. Many studies focused 
on the orexigenic properties of ECs. The oral treatment with a solution of AEA (20 μg/g body 
weight in soy oil) during lactation in mice increased food intake, body weight and epididymal 
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fat during adulthood (Aguirre et al., 2012). Furthermore, adult mice daily treated for 150 days 
with a single oral dose of AEA increased food consumption more than control mice (Aguirre 
et al., 2017). 
NAEs do not activate cannabinoid receptors. They can regulate food intake via activation of 
PPAR-α, GPR119 (Overton et al., 2006), GPR55 and TRPV1 (Muccioli et al., 2010). 
Among NAEs, OEA was shown to prolong the inter-meal time thus decreasing daily food 
intake (Gaetani et al., 2003). The administration of OEA at an oral dose of 10 mg/kg reduced 
food intake in rats (Nielsen et al., 2004). The same effect was demonstrated by using OEA (50 
mg/kg) in pH-sensitive-enteric coating. That preparation increased the concentration of OEA 
in small intestine, plasma, liver and adipose tissues, but not in the brain and muscles thus 
suggesting that the anorectic effect of OEA does not involve the brain (Oveisi et al., 2004). 
Similarly, a 5 weeks study demonstrated that the oral OEA 100 mg/kg reduced the body weight 
gain and decreased daily food intake in mice (Thabius et al., 2011). 
In humans, we have recently shown that the higher is the content of oleic acid in the meal the 
higher is the post-prandial response of OEA and the lower is the energy intake at the subsequent 
meal (Mennella et al., 2015).  
Animal studies showed that the intra-peritoneal injection of OEA (10 mg/kg bw) reduced food 
intake mainly by meal latency and that this effect was stronger in rats fed a 60% high-fat diet 
(HFD) than in control chow-fed rats (Azari et al., 2014). 
Fu & coworkers (2005) suggested that OEA has an important role in the regulation of lipid 
metabolism. They showed that the intra-peritoneal injection of OEA (5 mg/kg) for two weeks 
increased the expression of PPAR-α, FAT/CD36, liver fatty-acid binding protein (L-FABP), 
and uncoupling protein-2 (UCP-2), while decreased the serum cholesterol and triglyceride 
levels in Zucker rats. 
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Beside their ability to regulate the food intake and lipid metabolism, NAEs showed also anti-
inflammatory effect. In particular, studies focused on PEA showing anti-inflammatory and pain 
reducing effects via activation of PPAR-α (Petrosino & Di Marzo 2017). Esposito et al. (2014) 
demonstrated that PEA improved macroscopic disease signs as well as decreased neutrophil 
infiltration and the expression and release of inflammatory cytokines in a mouse model of 
colitis. On the other hand, in a model of colon cancer the treatment with PEA reduced the 
angiogenesis via activation of PPAR-α in vitro (Sarnelli et al., 2016). 
Furthermore, Borrelli et al. (2014) showed in a mouse model of colitis that 1 mg/kg b.w. of 
PEA reduced the inflammation and intestinal permeability, reduced the weight loss of mice, 
counteracted DNBS-induced GPR55 and TRPV1 down-regulation and regulated CB1 receptor. 
The latter study demonstrated that oral PEA could ameliorate intestinal inflammation 
pharmacological doses. 
1.6 NAPEs, NAEs and ECs in foods 
About the presence of NAPEs, NAEs and ECs in food matrices very little is known. The 
concentration of NAPEs in plants is very low except for oat where these compounds represent 
10-12% of total phospholipids content. 
Table 1.3 shows the concentration of NAPEs and NAEs in different food sources. 
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Table 1.3. NAPEs and NAEs concentration in dietary sources. 
NAPEs 
Source Concentration Reference 
Wheat flour 0.20-0.25 mg/g dry weight Kotel’nikova, 2011 
Wheat flour 0.78 mg/g dry weight Schaffarczyk et al., 2014 
Kidney bean  cultivar Shchedraya seed 0.35 mg/g dry weight Kotel’nikova, 2011 
Soybean  seeds 0.05 mg/g dry weight Kotel’nikova, 2011 
Rye flour  0.20 mg/g dry weight Kotel’nikova, 2011 
Bran 0.15 mg/g dry weight Kotel’nikova, 2011 
Barley seeds 0.27 mg/g dry weight Kotel’nikova, 2011 
Oat seeds 0.22 mg/g dry weight Kotel’nikova, 2011 
NAEs 
Source Concentration Reference 
Pisum sativum cultivar Early Alaska seed 3.44 µg/g of fresh weight Venables et al., 2015 
Pisum sativum cultivar Taos seeds 0.58 µg/g of fresh weight Venables et al., 2015 
Glycine max seeds 31.8 µg/g of fresh weight Venables et al., 2015 
Phaseolus vulgaris cultivar Amarillo del 
Norte seeds 
0.17 µg/g of fresh weight Venables et al., 2015 
Pea seeds 0.45 µg/g fresh weight Chapman et al., 1999 
Glycine max cultivar Dare seeds 1.2 µg/g fresh weight Chapman et al., 1999 
Peanut seeds 1 µg/g fresh weight Chapman et al., 1999 
Tomato seeds 0.7 µg/g of fresh weight Chapman et al., 1999 
Corn seeds 1.2 µg/g of fresh weight Chapman et al., 1999 
Toasted sesam oil 443471 ng/mL Bradshaw & Leishman 2016 
Olive oil 6178 ng/mL 
 
Bradshaw & Leishman 2016 
Walnut oil 250973 ng/mL Bradshaw & Leishman 2016 
Canola oil 5018 ng/mL Bradshaw & Leishman 2016 
Peanut oil  39581 ng/mL Bradshaw & Leishman 2016 
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Sesame oil 2106 ng/mL Bradshaw & Leishman 2016 
Grape seed oil 47578 ng/mL Bradshaw & Leishman 2016 
Safflower oil 2016 ng/mL Bradshaw & Leishman 2016 
Cocoa derived samples 0.01-5.8 µg/g Di Marzo et al., 1998 
Mytilus galloprovincialis 36 ng/g wet tissue weight Sepe et al., 1997 
 
The NAPEs concentration ranged from 0.25 mg/g dw to 0.78 mg/g dw in wheat flour 
(Kotel’nikova, 2011; Schaffarczyk et al., 2014), while in the legumes the concentration ranged 
from 0.35 mg/g dw in Kidney bean cultivar Shchedraya to 0.05 mg/g of dw in soybean 
(Kotel’nikova, 2011). 
NAPEs are present in the Solanum tuberosum L. cultivar Bintje cells with the content that 
increased up to 13-folds in anoxia–stressed cells (Rawyler & Braendle, 2001). 
The NAEs concentration in legumes ranged from 3.44 µg/g of fresh weight to 31.8 µg/g of 
fresh weight in Glycine max (Venables et al., 2005). 
On the other hand Chapman and coworkers (1999) showed that the highest concentration of 
these compounds was found in Glycine max cultivar Dare and corn seeds (1.2 µg/g fresh weight), 
whereas the lowest concentration was found in pea (0.45 µg/g fresh weight). 
Bradshaw & Leishman (2016) showed the presence of NAEs in different cooking oils such as 
olive, walnut, canola, peanut, safflower, sesame and grape seed oil. The highest concentration 
of NAEs was in toasted sesam oil (443471 ng/mL), whereas the lowest concentration was in 
safflower oil (2016 ng/mL). 
NAEs were detected also in cocoa at very low concentrations ranging from 0.01 to 5.8 µg/g, 
OEA being between 0.17 and 6 µg/g and AEA resulting absent together with 2-AG (Di Marzo 
et al., 1998). 
Finally, NAEs were found also in Mytilus galloprovincialis, with a concentration of 41 ng/g 
wet tissue weight.  
17 
 
1.7 NAEs, ECs and diet 
Many studies showed that the NAEs concentration and the function of endocannabinoid system 
was influenced by the diet controlling different physiological processes (Di Marzo, 2008).  
Studies in humans and in animals showed that the concentration of ECs and NAEs can be 
influenced by diet and, in particular, by its composition in fatty acids.  
Pintus et al. (2012) showed that the intake of sheep cheese (90g/day) enriched with α-linoleic 
acid (ALA), conjugated linoleic acid (CLA) and vaccenic acid (VA) modified the plasma lipid 
and endocannabinoid profile in mildly hypercholesterolemic humans after 3 weeks of 
treatment.  
In particular, the consumption of enriched cheese increased the plasma concentration of CLA, 
VA, ALA and EPA, whereas a reduction of the endocannabinoid AEA (40%) was shown. The 
concentration of 2-AG decreased.  
In mice, Hansen & coworkers (2009) showed that the ketogenic diet, a low carbohydrate diet, 
administrated for 4 weeks reduced the levels of NAEs and OEA in the hippocampus, while no 
significant reduction was observed for AEA and PEA, suggesting that the ketogenic diet can 
influence the expression of enzymes involved in the biosynthetic and catabolic ways of NAEs. 
Banni et al. (2011) studied the influence of intake of 2g/day of either krill oil (KO) or menhaden 
oil (MO) or olive oil (OO) (control) on the plasmatic levels of ECs in over weight (OW) and 
obese (OB) subjects for 4 weeks. The intake of KO, but not MO or OO, decreased the level of 
2-AG. The decrease of 2-AG is linked to the plasma n-6/n-3 phospholipids long chain and 
polyunsaturated fatty acid (LCPUFA) ratio. The AEA concentration did not change between 
diets.  
Artmann et al. (2008) showed that the composition of diet could influence the NAEs levels in 
the brain and intestine and modulate the physiopathological function. They administrated 5 
different diets to rats for 1 week. The diets were composed with 5 different fats: palm oil (PO), 
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olive oil (OO), safflower oil (SO), fish oil (FO) and arachidonic acid (AA) containing diet. 
They showed that the SO diet increased the levels of LEA in the jejunum, liver and in the brain, 
the OO increased OEA in the liver and it increased the brain concentration of AEA and OEA. 
The 5 diets reduced the levels of OEA in the jejunum without changes in AEA. Furthermore, 
the levels of AEA and 2-AG increased in the jejunum, without any changes in the liver.  
Meanwhile Joosten et al. (2010) showed that in humans the plasmatic levels of NAEs are 
correlated to both the concentration of serum total FFAs and their specific fatty acid precursors. 
In rats that had been fed with high fats diet (20-45% of total energy) the intestinal levels of 
NAEs were reduced but in rats fed with olive oil rich diet as oleic acid caused an increase in 
the level of OEA (Diep et al.,2011). 
The oleic acid present in a meal increased the plasmatic concentration of OEA influencing the 
sensation of appetite and the energy intake at subsequent meals, in humans (Mennella et al., 
2015). 
1.8 Diet and microbiota  
The human body, especially the GIT is colonized about over 1000 different bacterial species. 
In particular, the highest concentration of bacteria was found in the large intestine (Duca et al., 
2014). The most abundant  bacterial species that are present in the human intestinal tract belong 
to the phyla Firmicutes and Bacteroidetes, while Proteobacteria, Actinobacteria and 
Verrucomicrobia are less abundant (Mulders et al., 2018; Jeffery & O’Toole, 2013).  
The intestinal microbiota is influenced by the age, health, diet and geographical location of the 
individual, gastrointestinal infections, inflammatory, neurological, immunological, 
cardiovascular and metabolic disease (Cani et al., 2016). 
The gut microbiota participates in gut-brain communication influencing the physiology and 
metabolism in host. The bacteria can modify the phenotype of the individual through the 
production of metabolites. 
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Recently, it was demonstrated that diet may influence the microbiota composition (Jeffery & 
O’Toole, 2013), in fact the consumption of a high fat diet induced changes in the microbiota 
and increased the obesity (Mulders et al., 2018). 
Dietary fats can influence the composition of gut microbiota. Prieto et al. (2018) showed that 
mice fed with diets enriched with different fats had a different profile of gut microbiota that 
was correlated with many physiological and biochemical parameters. 
Blood pressure, insulin, body weight and ghrelin were correlated with bacterial taxa and they 
increased in mice fed with enriched butter (BT) diet and decreased (except for ghrelin) in mice 
fed with enriched extravirgin olive oil (EVOO) diet. BT diet increased the values of blood 
pressure correlating positively with Desulfovibrio in faeces. EVOO diet determined lower 
values of insulin and leptin that were inversely correlated with Desulfovibrio and with 
Sutterellaceae, Marispirillum and Mucilaginibacter dageonensis, respectively. 
De Filippo et al. (2010) demonstrated that the microbiota of Italian children is different to the 
one found in children of Burkina Faso. This difference depended by diets of the individuals. 
The microbiota composition was related with long term diet and Wu & coworkers (2011) 
showed that Bacteirodes genus was associated with a diet rich in animal products, while genus 
of Prevotella was correlated with a diet rich in plant foods in humans. 
The Mediterranean diet (MD) is a dietary pattern characterised by a high daily intake of fruits, 
vegetables, legumes, nuts and low intake of processed cereals, moderate intake of fish and low 
intake of saturated fat, meat and dairy products (Martinenz-Gonzalez et al., 2009, Widmer et 
al., 2015). 
On the other hand, the Western diet (WD) is characterised by high intakes of processed meat, 
butter, fried food, potatoes and high-sugar drinks; it was shown to change the microbiota 
towards a composition that was associated with several diseases (Myles, 2014; Albenberg & 
Wu, 2014). 
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De Filippis & coworkers (2015) showed the existence of a correlation between MD, gut 
microbiota and metabolites produced by microbiota. MD was associated with an increase of 
SCFA that were associated with Bacteroidetes and Firmicutes, while a lower adherence to MD 
was associated with a high level of urinary trimethylamine oxide (TMAO), a potential factor 
for cardiovascular disease. 
1.9 Microbiota and ECs 
In obese humans and rodents the tone of EC system is higher than in normal weight individuals 
(Bluher et al., 2006; Engeli et al., 2005; Cote et al., 2007; Izzo et al., 2009). 
Different compounds that derive from gut microbiota can influence the development of insulin 
resistance, type 2-diabetes and inflammation. The lipopolysaccharide (LPS) produced by 
Gram-negative bacteria are the factors that increase the development of metabolic disease 
(Cani, 2012). The alteration of gut microbiota is linked with the development of obesity and in 
these mechanisms a role for the ECs system was proposed.  
The existence of a link between LPS and EC system, as LPS can influence the production of 
ECs by immune cells (Liu et al., 2003). 
In obese animals and humans the gut microbiota influences the ECs system activity in the colon 
and in adipose tissues. In obese mice, the ECs system is over-activated in the intestine and in 
the adipose tissue (Geurts et al., 2011; Muccioli et al., 2010). 
The gut microbiota influences the expression of FAAH and MGL in the colon of obese mice 
(Muccioli et al., 2010). 
In the adipose tissue the mRna levels of NAPE-PLD were higher in obese than in lean mice, 
while the mRna levels of FAAH were higher in lean than in obese mice (Geurts et al., 2011). 
Figure 1.2 summarises the interaction between gut microbiota, metabolite and enteroendocrine 
cell functions. 
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Figure 1.2.  Interaction between gut microbiota, metabolites, enteroendocrine L cells 
functions and specific organs (Cani et al., 2013). 
 
GLP-1 is involved in the control of energy balance and glucose homeostasis via the gut 
microbial fermentation of dietary fibres and/or non-digestibile carbohydrates. SCFA produced 
by fermentation promote the release of GLP-1 and PYY by activation of the GPR41 and GPR43 
(Delzenne et al., 2011). 
The secretion of GLP-1 is stimulated also by the activation of GPR119 by OEA. The activation 
of GPR119 influences the secretion of GLP-2, a hormone associated with an improvement of 
mucosal barrier function, improved tight junctions and decrease of the plasmatic concentration 
of LPS. The production of GLP-2 is regulated by nutritional status of host (Cani et al., 2009; 
Cani et al., 2013). 
NAEs are modulated by gut microbiota and the interaction with GLP-1 can be involved in the 
cross-talk between the gut microbiota and regulation of host glucose metabolism (Everard & 
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Cani, 2014). Therefore, ECs system or NAEs controlled by gut microbiota could contribute to 
control the glucose, lipid and energy homeostasis. 
Anyway, in humans a relationship between modified gut microbiota and ECs system tone is 
not yet demonstrated. 
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1.10 Abbreviations 
GBA: gut-brain axis; GIT: gastrointestinal tract; CNS: central nervous system; EECs: 
enteroendocrine cells; ANS: autonomic nervous system; ENS:enteric nervous system; HPA: 
hypothalamic pituitary adrenal; CCK: cholecystokinin; GLP-1: glucagon like peptide-1; PYY: 
peptide YY; GPRs: G-protein-coupled receptors; FFAs: free fatty acids; CD36: cluster of 
differentiation 36; FATP4: fatty acid transport protein 4; MCFA: medium chain fatty acids; 
LCFA: long chain fatty acids; SCFA: Short-chain fatty acids;  aa: amino acids; FA: fatty acids; 
OEA: N-oleoylethanolamine; DPPIV: dipeptidylpeptidase-IV; NAPEs: N-
acylphosphatidylethanolamines; NAEs: N-acylethanolamines; ECs: endocannabinoids; 2-
MAGs: 2-monoacylglycerols; NAT: N-acytransferase; PE:phosphatidylethanolamine;  
NAPE-PLD: N-acyl phosphatidylethanolamine phospholipase D; PLC: phospholipase C; 
Abh4: α/β-hydrolase-4; GP-NAEs: glycerophospho-NAEs; GDE1:glycerophosphodiesterase-
1; FAAH: fatty acid amide hydrolase; NAAA: N-acyethanolamine-hydrolyzing acid amidase 
AEA: anandamide; 2-AG: 2-arachidonoylglycerol; CB: cannabinoids receptors; PPAR-α: 
peroxisome proliferator-activated receptor-α; L-FABP: liver fatty-acid binding protein; UCP-
2: uncoupling protein-2; LEA: linoleoylethanolamide; PEA: palmitoylethanolamide; ALA:α-
linoleic acid; EVOO: extravirgin olive oil; CLA: conjugated linoleic acid; VA:vaccenic acid 
KO: krill oil; MO: menhaden oil; OO:olive oil; OW:over weight; OB:obese; LCPUFA: long 
chian polyunsaturated fatty acid; PO: palm oil (PO); OO: olive oil; SO: safflower oil; FO:fish 
oil; AA: arachidonic acid; MD: Mediterranean diet;  WD: Western diet; SCFA: short chain 
fatty acids; TMAO: trimethylamine oxide; LPS: lipopolysaccharide. 
 
 
 
 
 
24 
 
References 
 
1) Aguirre, C. A., Castillo, V. A., & Llanos, M. N. (2012). Excess of the endocannabinoid 
anandamide during lactation induces overweight, fat accumulation and insulin resistance 
in adult mice. Diabetology & metabolic syndrome, 4(1), 35. 
2) Aguirre, C., Castillo, V., & Llanos, M. (2017). Oral Administration of the Endocannabinoid 
Anandamide during Lactation: Effects on Hypothalamic Cannabinoid Type 1 Receptor and 
Food Intake in Adult Mice. Journal of nutrition and metabolism, 2017. 
3) Albenberg, L. G., & Wu, G. D. (2014). Diet and the intestinal microbiome: associations, 
functions, and implications for health and disease. Gastroenterology, 146(6), 1564-1572. 
4) Artmann, A., Petersen, G., Hellgren, L. I., Boberg, J., Skonberg, C., Nellemann, C., ... & 
Hansen, H. S. (2008). Influence of dietary fatty acids on endocannabinoid and N-
acylethanolamine levels in rat brain, liver and small intestine. Biochimica et Biophysica 
Acta (BBA)-Molecular and Cell Biology of Lipids, 1781(4), 200-212. 
5) Azari, E. K., Ramachandran, D., Weibel, S., Arnold, M., Romano, A., Gaetani, S., ... & 
Mansouri, A. (2014). Vagal afferents are not necessary for the satiety effect of the gut lipid 
messenger oleoylethanolamide (OEA). American Journal of Physiology-Regulatory, 
Integrative and Comparative Physiology, ajpregu-00067. 
6) Banni, S., Carta, G., Murru, E., Cordeddu, L., Giordano, E., Sirigu, A. R., ... & Griinari, 
M. (2011). Krill oil significantly decreases 2-arachidonoylglycerol plasma levels in obese 
subjects. Nutrition & metabolism, 8(1), 7. 
7) Blancaflor, E. B., Kilaru, A., Keereetaweep, J., Khan, B. R., Faure, L., & Chapman, K. D. 
(2014). N‐Acylethanolamines: lipid metabolites with functions in plant growth and 
development. The Plant Journal, 79(4), 568-583. 
25 
 
8) Berthoud, H. R., Lenard, N. R., & Shin, A. C. (2011). Food reward, hyperphagia, and 
obesity. American Journal of Physiology-Regulatory, Integrative and Comparative 
Physiology, 300(6), R1266-R1277. 
9) Blüher, M., Engeli, S., Klöting, N., Berndt, J., Fasshauer, M., Bátkai, S., ... & Stumvoll, M. 
(2006). Dysregulation of the peripheral and adipose tissue endocannabinoid system in 
human abdominal obesity. Diabetes, 55(11), 3053-3060. 
10) Borrelli, F., Romano, B., Petrosino, S., Pagano, E., Capasso, R., Coppola, D., ... & Izzo, A. 
A. (2015). Palmitoylethanolamide, a naturally occurring lipid, is an orally effective 
intestinal anti‐inflammatory agent. British journal of pharmacology, 172(1), 142-158. 
11) Bradshaw, H. B., & Leishman, E. (2016). Levels of bioactive lipids in cooking oils: olive 
oil is the richest source of oleoyl serine. Journal of basic and clinical physiology and 
pharmacology, 27(3), 247-252. 
12) Cani, P. D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., ... & 
Muccioli, G. G. (2009). Changes in gut microbiota control inflammation in obese mice 
through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 
13) Cani, P. D. (2012). Crosstalk between the gut microbiota and the endocannabinoid system: 
impact on the gut barrier function and the adipose tissue. Clinical Microbiology and 
Infection, 18, 50-53. 
14) Cani, P. D., Everard, A., & Duparc, T. (2013). Gut microbiota, enteroendocrine functions 
and metabolism. Current opinion in pharmacology, 13(6), 935-940. 
15) Cani, P. D., Plovier, H., Van Hul, M., Geurts, L., Delzenne, N. M., Druart, C., & Everard, 
A. (2016). Endocannabinoids—at the crossroads between the gut microbiota and host 
metabolism. Nature Reviews Endocrinology, 12(3), 133. 
16) Carabotti, M., Scirocco, A., Maselli, M. A., & Severi, C. (2015). The gut-brain axis: 
interactions between enteric microbiota, central and enteric nervous systems. Annals of 
26 
 
gastroenterology: quarterly publication of the Hellenic Society of Gastroenterology, 28(2), 
203. 
17) Chapman, K. D., Venables, B., Markovic, R., Blair, R. W., & Bettinger, C. (1999). N-
Acylethanolamines in seeds. Quantification of molecular species and their degradation 
upon imbibition. Plant physiology, 120(4), 1157-1164. 
18) Cote, M., Matias, I., Lemieux, I., Petrosino, S., Almeras, N., Despres, J. P., & Di Marzo, 
V. (2007). Circulating endocannabinoid levels, abdominal adiposity and related 
cardiometabolic risk factors in obese men. International journal of obesity, 31(4), 692. 
19) Coulon, D., Faure, L., Salmon, M., Wattelet, V., & Bessoule, J. J. (2012). Occurrence, 
biosynthesis and functions of N-acylphosphatidylethanolamines (NAPE): not just 
precursors of N-acylethanolamines (NAE). Biochimie, 94(1), 75-85. 
20) D’Addario, C., Di Bonaventura, M. M., Pucci, M., Romano, A., Gaetani, S., Ciccocioppo, 
R., ... & Maccarrone, M. (2014). Endocannabinoid signaling and food 
addiction. Neuroscience & Biobehavioral Reviews, 47, 203-224. 
21) De Filippis, F., Pellegrini, N., Vannini, L., Jeffery, I. B., La Storia, A., Laghi, L., ... & 
Turroni, S. (2015). High-level adherence to a Mediterranean diet beneficially impacts the 
gut microbiota and associated metabolome. Gut, gutjnl-2015. 
22) De Filippo, C., Cavalieri, D., Di Paola, M., Ramazzotti, M., Poullet, J. B., Massart, S., ... 
& Lionetti, P. (2010). Impact of diet in shaping gut microbiota revealed by a comparative 
study in children from Europe and rural Africa. Proceedings of the National Academy of 
Sciences, 107(33), 14691-14696. 
23) De Luca, L. (2018). Fats: Nutritional and Physiological Importance. Reference Module in 
Food Science. ISBN: 978-0-08-100596-5,https://doi.org/10.1016/B978-0-08-100596-
5.22143-4. 
27 
 
24) Delzenne, N. M., Neyrinck, A. M., Bäckhed, F., & Cani, P. D. (2011). Targeting gut 
microbiota in obesity: effects of prebiotics and probiotics. Nature Reviews 
Endocrinology, 7(11), 639. 
25) Diep, T. A., Madsen, A. N., Holst, B., Kristiansen, M. M., Wellner, N., Hansen, S. H., & 
Hansen, H. S. (2011). Dietary fat decreases intestinal levels of the anorectic lipids through 
a fat sensor. The FASEB Journal, 25(2), 765-774. 
26) Di Marzo, V., Sepe, N., De Petrocellis, L., Berger, A., Crozier, G., Fride, E., & Mechoulam, 
R. (1998). Trick or treat from food endocannabinoids?. Nature, 396(6712), 636-636. 
27) Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Bátkai, S., Járai, Z., ... & Kunos, G. 
(2001). Leptin-regulated endocannabinoids are involved in maintaining food 
intake. Nature, 410(6830), 822. 
28) Di Marzo, V. (2008). The endocannabinoid system in obesity and type 2 
diabetes. Diabetologia, 51(8), 1356. 
29) Di Patrizio, N. V., Astarita, G., Schwartz, G., Li, X., & Piomelli, D. (2011). 
Endocannabinoid signal in the gut controls dietary fat intake. Proceedings of the National 
Academy of Sciences, 108(31), 12904-12908. 
30) Duca, F. A., & Lam, T. K. T. (2014). Gut microbiota, nutrient sensing and energy 
balance. Diabetes, Obesity and Metabolism, 16(S1), 68-76. 
31) Engeli, S., Böhnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Bátkai, S., ... & Jordan, 
J. (2005). Activation of the peripheral endocannabinoid system in human 
obesity. Diabetes, 54(10), 2838-2843. 
32) Everard, A., & Cani, P. D. (2014). Gut microbiota and GLP-1. Reviews in Endocrine and 
Metabolic Disorders, 15(3), 189-196. 
28 
 
33) Fu, J., Gaetani, S., Oveisi, F., Verme, J. L., Serrano, A., de Fonseca, F. R., ... & Piomelli, 
D. (2003). Oleylethanolamide regulates feeding and body weight through activation of the 
nuclear receptor PPAR-α. Nature, 425(6953), 90. 
34) Fu, J., Oveisi, F., Gaetani, S., Lin, E., & Piomelli, D. (2005). Oleoylethanolamide, an 
endogenous PPAR-α agonist, lowers body weight and hyperlipidemia in obese 
rats. Neuropharmacology, 48(8), 1147-1153. 
35) Gaetani, S., Oveisi, F., & Piomelli, D. (2003). Modulation of meal pattern in the rat by the 
anorexic lipid mediator oleoylethanolamide. Neuropsychopharmacology, 28(7), 1311. 
36) Gatta-Cherifi, B., & Cota, D. (2016). New insights on the role of the endocannabinoid 
system in the regulation of energy balance. International journal of obesity, 40(2). 
37) Geurts, L., Lazarevic, V., Derrien, M., Everard, A., Van Roye, M., Knauf, C., ... & de Vos, 
W. M. (2011). Altered gut microbiota and endocannabinoid system tone in obese and 
diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Frontiers in 
microbiology, 2, 149. 
38) Hansen, H. S., & Diep, T. A. (2009). N-acylethanolamines, anandamide and food 
intake. Biochemical pharmacology, 78(6), 553-560. 
39) Hansen, H. S., & Vana, V. (2018). Non‐endocannabinoid N‐acylethanolamines and 2‐
monoacylglycerols in the intestine. British journal of pharmacology. 
40) Hansen, K. B., Rosenkilde, M. M., Knop, F. K., Wellner, N., Diep, T. A., Rehfeld, J. F., ... 
& Hansen, H. S. (2011). 2-Oleoyl glycerol is a GPR119 agonist and signals GLP-1 release 
in humans. The Journal of Clinical Endocrinology & Metabolism, 96(9), E1409-E1417. 
41) Hansen, S. L., Nielsen, A. H., Knudsen, K. E., Artmann, A., Petersen, G., Kristiansen, U., 
... & Hansen, H. S. (2009). Ketogenic diet is antiepileptogenic in pentylenetetrazole kindled 
mice and decrease levels of N-acylethanolamines in hippocampus. Neurochemistry 
international, 54(3-4), 199-204. 
29 
 
42) Havel, P. J. (2001). Peripheral signals conveying metabolic information to the brain: short-
term and long-term regulation of food intake and energy homeostasis. Experimental 
Biology and Medicine, 226(11), 963-977. 
43) Hillard, C. J. (2018). Circulating Endocannabinoids: From Whence Do They Come and 
Where are They Going?. Neuropsychopharmacology, 43(1), 155. 
44) Holzer, P., Reichmann, F., & Farzi, A. (2012). Neuropeptide Y, peptide YY and pancreatic 
polypeptide in the gut–brain axis. Neuropeptides, 46(6), 261-274. 
45) Izzo, A. A., Piscitelli, F., Capasso, R., Aviello, G., Romano, B., Borrelli, F., ... & Di Marzo, 
V. (2009). Peripheral endocannabinoid dysregulation in obesity: relation to intestinal 
motility and energy processing induced by food deprivation and re‐feeding. British journal 
of pharmacology, 158(2), 451-461. 
46) Izzo, A. A., & Sharkey, K. A. (2010). Cannabinoids and the gut: new developments and 
emerging concepts. Pharmacology & therapeutics, 126(1), 21-38. 
47) Janssen, S., & Depoortere, I. (2013). Nutrient sensing in the gut: new roads to 
therapeutics?. Trends in Endocrinology & Metabolism, 24(2), 92-100. 
48) Jeffery, I. B., & O'Toole, P. W. (2013). Diet-microbiota interactions and their implications 
for healthy living. Nutrients, 5(1), 234-252. 
49) Joosten, M. M., Balvers, M. G., Verhoeckx, K. C., Hendriks, H. F., & Witkamp, R. F. 
(2010). Plasma anandamide and other N-acylethanolamines are correlated with their 
corresponding free fatty acid levels under both fasting and non-fasting conditions in 
women. Nutrition & Metabolism, 7(1), 49. 
50) Kola, B., Farkas, I., Christ-Crain, M., Wittmann, G., Lolli, F., Amin, F., ... & Fekete, C. 
(2008). The orexigenic effect of ghrelin is mediated through central activation of the 
endogenous cannabinoid system. PLoS One, 3(3), e1797. 
30 
 
51) Kotel’nikova, I. M. (2011). The content of N-acylphosphatidylethanolamines in the seeds 
of cultivated plants and grain products. Russian Journal of Plant Physiology, 58(2), 364-
369. 
52) Liu, J., Bátkai, S., Pacher, P., Harvey-White, J., Wagner, J. A., Cravatt, B. F., ... & Kunos, 
G. (2003). Lipopolysaccharide induces anandamide synthesis in macrophages via 
CD14/MAPK/phosphoinositide 3-kinase/NF-κB independently of platelet-activating 
factor. Journal of Biological Chemistry, 278(45), 45034-45039. 
53) Mace, O. J., Tehan, B., & Marshall, F. (2015). Pharmacology and physiology of 
gastrointestinal enteroendocrine cells. Pharmacology research & perspectives, 3(4) 
54) Martinez-Gonzalez, M. A., Bes-Rastrollo, M., Serra-Majem, L., Lairon, D., Estruch, R., & 
Trichopoulou, A. (2009). Mediterranean food pattern and the primary prevention of chronic 
disease: recent developments. Nutrition reviews, 67(suppl_1), S111-S116. 
55) Myles, I. A. (2014). Fast food fever: reviewing the impacts of the Western diet on 
immunity. Nutrition journal, 13(1), 61. 
56) Mennella, I., Savarese, M., Ferracane, R., Sacchi, R., & Vitaglione, P. (2015). Oleic acid 
content of a meal promotes oleoylethanolamide response and reduces subsequent energy 
intake in humans. Food & function, 6(1), 203-209. 
57) Muccioli, G. G., Naslain, D., Bäckhed, F., Reigstad, C. S., Lambert, D. M., Delzenne, N. 
M., & Cani, P. D. (2010). The endocannabinoid system links gut microbiota to 
adipogenesis. Molecular systems biology, 6(1), 392. 
58) Mulders, R. J., de Git, K. C. G., Schéle, E., Dickson, S. L., Sanz, Y., & Adan, R. A. H. 
(2018). Microbiota in obesity: interactions with enteroendocrine, immune and central 
nervous systems. Obesity Reviews, 19(4), 435-451. 
59) Nielsen, M. J., Petersen, G., Astrup, A., & Hansen, H. S. (2004). Food intake is inhibited 
by oral oleoylethanolamide. Journal of lipid research, 45(6), 1027-1029. 
31 
 
60) Oveisi, F., Gaetani, S., Eng, K. T. P., & Piomelli, D. (2004). Oleoylethanolamide inhibits 
food intake in free-feeding rats after oral administration. Pharmacological research, 49(5), 
461-466. 
61) Overton, H. A., Babbs, A. J., Doel, S. M., Fyfe, M. C., Gardner, L. S., Griffin, G., ... & 
Widdowson, P. S. (2006). Deorphanization of a G protein-coupled receptor for 
oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents. Cell 
metabolism, 3(3), 167-175. 
62) Paterniti, I., Di Paola, R., Campolo, M., Siracusa, R., Cordaro, M., Bruschetta, G., ... & 
Zerbini, G. (2015). Palmitoylethanolamide treatment reduces retinal inflammation in 
streptozotocin-induced diabetic rats. European journal of pharmacology, 769, 313-323. 
63) Petrosino, S., & Di Marzo, V. (2017). The pharmacology of palmitoylethanolamide and 
first data on the therapeutic efficacy of some of its new formulations. British Journal of 
Pharmacology, 174(11), 1349-1365. 
64) Pintus, S., Murru, E., Carta, G., Cordeddu, L., Batetta, B., Accossu, S., ... & Secchiari, P. 
(2013). Sheep cheese naturally enriched in α-linolenic, conjugated linoleic and vaccenic 
acids improves the lipid profile and reduces anandamide in the plasma of 
hypercholesterolaemic subjects. British Journal of Nutrition, 109(8), 1453-1462. 
65) Prieto, I., Hidalgo, M., Segarra, A. B., Martínez-Rodríguez, A. M., Cobo, A., Ramírez, M., 
... & Martínez-Cañamero, M. (2018). Influence of a diet enriched with virgin olive oil or 
butter on mouse gut microbiota and its correlation to physiological and biochemical 
parameters related to metabolic syndrome. PloS one, 13(1), e0190368. 
66) Rawyler, A. J., & Braendle, R. A. (2001). N-Acylphosphatidylethanolamine accumulation 
in potato cells upon energy shortage caused by anoxia or respiratory inhibitors. Plant 
physiology, 127(1), 240-251.  
32 
 
67) Schaffarczyk, M., Østdal, H., & Koehler, P. (2014). Lipases in wheat breadmaking: 
analysis and functional effects of lipid reaction products. Journal of agricultural and food 
chemistry, 62(32), 8229-8237. 
68) Sepe, N., De Petrocellis, L., Montanaro, F., Cimino, G., & Di Marzo, V. (1998). Bioactive 
long chain N-acylethanolamines in five species of edible bivalve molluscs: possible 
implications for mollusc physiology and sea food industry. Biochimica et Biophysica Acta 
(BBA)-Lipids and Lipid Metabolism, 1389(2), 101-111. 
69) Spreckley, E., & Murphy, K. G. (2015). The L-cell in nutritional sensing and the regulation 
of appetite. Frontiers in nutrition, 2, 23. 
70) Steensels, S., & Depoortere, I. (2017). Chemoreceptors in the Gut. Annual review of 
physiology, (0). 
71) Thabuis, C., Destaillats, F., Lambert, D. M., Muccioli, G. G., Maillot, M., Harach, T., ... & 
Martin, J. C. (2011). Lipid transport function is the main target of oral oleoylethanolamide 
to reduce adiposity in high-fat-fed mice. Journal of lipid research, 52(7), 1373-1382. 
72) Turnbaugh, P. J., Ley, R. E., Hamady, M., Fraser-Liggett, C. M., Knight, R., & Gordon, J. 
I. (2007). The human microbiome project. Nature, 449(7164), 804. 
73) Ueda, N., Tsuboi, K., & Uyama, T. (2010). N-acylethanolamine metabolism with special 
reference to N-acylethanolamine-hydrolyzing acid amidase (NAAA). Progress in lipid 
research, 49(4), 299-315. 
74) Ueda, N., Tsuboi, K., & Uyama, T. (2013). Metabolism of endocannabinoids and related 
N‐acylethanolamines: Canonical and alternative pathways. The FEBS journal, 280(9), 
1874-1894. 
75) Venables, B. J., Waggoner, C. A., & Chapman, K. D. (2005). N-acylethanolamines in seeds 
of selected legumes. Phytochemistry, 66(16), 1913-1918. 
33 
 
76) Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K., Chen, Y. Y., Keilbaugh, S. A., ... & Sinha, 
R. (2011). Linking long-term dietary patterns with gut microbial 
enterotypes. Science, 334(6052), 105-108. 
77) Yang, Y., Chen, M., Georgeson, K. E., & Harmon, C. M. (2007). Mechanism of 
oleoylethanolamide on fatty acid uptake in small intestine after food intake and body weight 
reduction. American Journal of Physiology-Regulatory, Integrative and Comparative 
Physiology, 292(1), R235-R241. 
78) Yu, H. L., Sun, L. P., Li, M. M., & Quan, Z. S. (2015). Involvement of norepinephrine and 
serotonin system in antidepressant-like effects of oleoylethanolamide in the mice models 
of behavior despair. Neuroscience letters, 593, 24-28. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
34 
 
 
 
 
 
 
 
 
 
Chapter 2. N-acylphosphatidylethanolamines, N-
acylethanolamines and endocannabinoids food 
database and daily intake upon a Western, a 
Mediterranean and a Vegetarian dietary pattern 
 
 
 
 
 
 
 
 
 
 
 
Lucia De Luca, Rosalia Ferracane and Paola Vitaglione 
Food chemistry (Submitted paper) 
Department of Agricultural Sciences, University of Naples “Federico II”, 80055 Portici, Italy 
35 
 
Abstract  
This study aimed to create a food database of N-acylphosphatidylethanolamines (NAPEs), N-
acylethanolamines (NAEs) and endocannabinoids (ECs) and to assess their daily intakes on 
consumption of Mediterranean (MD), Vegetarian (VD) and Western (WD) diet.  
Data obtained from 43 foods showed that NAPEs and NAEs were more abundant in vegetal 
than in animal food products, NAPEs were in the ranges of 0-4032 vs 4-398 µg/g dw and NAEs 
were in the ranges 0-35 vs 0.1-0.7 µg/g dw, respectively; conversely, ECs were in the ranges 
of 0-0.1 vs 0-34 µg/g dw.  
NAPEs and NAEs daily intakes were higher in MD (263 mg/day and 0.25 mg/day) and VD 
(242 mg/day and 0.28 mg/day) than in WD (163 mg/day and 0.08 mg/day); conversely, ECs 
intake was higher in WD and MD (0.17 mg/day) than in VD (0.01 mg/day).  
Food contents and daily intakes suggested a potential physiological relevance of dietary 
NAPEs, NAEs and ECs. 
 
Keywords 
Food bioactive compounds; nutrient sensing; gastro-intestinal receptors; food database; 
phospholipids; lipid mediators. 
 
Chemical compounds studied in this article 
Oleoylethanolamide (PubChem CID: 5283454); Palmitoylethanolamide (PubChemCID: 
4671); Linoleylethanolamide (PubChem CID: 5283446);  Anandamide (PubChem CID: 
5281969); 2-Arachidonylglycerol (Pubchem CID: 5282280).  
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2.1  Introduction 
N-acylphosphatidylethanolamines (NAPEs), N-acylethanolamines (NAEs), and the 
endocannabinoids (ECs) (Figure 2.1) are lipids present in animals, plants, bacteria and yeasts. 
 
 
Figure 2.1.  Structures of a typical NAPE (16:0/18:1(9Z)/20:4(5Z,8Z,11Z,14Z) (A) and of 
arachidonoylethanolamide (AEA) (B), 2-arachidonoylglycerol (2-AG) (C), 
Linoleoylethanolamide (LEA) (D), Palmitoylethanolamide (PEA) (E) and 
Oleoylethanolamide (OEA) (F). 
 
NAPEs are the precursors of NAEs. In animal tissues, formation of NAEs is catalysed by the 
NAPE-specific phospholipase D (NAPE-PLD) whereas in plant tissues NAEs can derive from 
phospholipase-β (PLD-β). In animals NAEs can be hydrolysed in free fatty acids and 
ethanolamine by fatty acids amide hydrolase (FAAH) or NAE-hydrolyzing acid amidase 
(NAAA), whereas, in plant tissues, only FAAH is present. In both animal and plant tissues 
NAEs can be oxygenated by different pathways (Coulon, Faure, Salmon, Wattelet & Bessoule, 
2012). 
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The role of NAPEs in plants, bacteria and yeasts is to protect and stabilize membranes, indeed 
their content may vary during the biological phases and physical processing (Coulon et al., 
2012; Sandoval, Huang, Garrett, Cage & Champan, 1995).  
In animals, mounting evidence shows that the concentration of NAEs and ECs in the tissues 
may be associated with the types of diet consumed. Hansen et al. (2009) showed that a 4-week-
administration of a ketogenic diet reduced the concentration of NAEs and ECs in the 
hippocampus of mice. Similarly, NAEs concentration within intestinal cells decreased after 
feeding rats with a high fat diet for periods lasting from 1 week to 14 weeks (Aviello et al., 
2008; Di Marzo et al., 2008; Diep et al., 2011). Interestingly, that effect was evidenced sooner 
with diets providing the highest content of fats and was accompanied by the down-regulation 
of mRNA levels of NAPE-PLD and unchanged expression of FAAH (Diep et al., 2011).  
These findings supported the theory that dietary fats are implicated in NAEs biosynthesis 
within the cells with a certain specialization (Joosten, Balvers, Verhoeckx, Hendriks & 
Witkamp, 2010). An olive oil-rich diet providing oleic acid as the predominant fat increased 
the levels of  oleoylethanolamide (OEA) in liver whereas a fish oil-enriched diet decreased the 
levels of all the NAEs, except for docosahexaenoylethanolamide (DHEA) which remained 
unchanged (Artmann et al., 2008). Similarly, Mennella, Savarese, Ferracane, Sacchi & 
Vitaglione (2015) showed in humans that a meal providing higher amounts of oleic acid 
increased post-prandial plasma concentration of OEA which might be responsible of the 
reduced energy intake at subsequent meal.  
In vitro and animal studies showed that NAEs/ ECs are involved in several biological pathways 
by working as agonists of receptors such as: cannabinoid receptor-1 (CB1) and cannabinoid 
receptor-2 (CB2) that are present in the enteric nervous system (ENS), in liver and in cardiac, 
vascular and adipose tissues (Duncan, Davison & Sharkey, 2005); transient receptor potential 
ion channel of the vanilloid type 1 (TRPV1) that is expressed in the gastro-intestinal tract (GIT) 
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on the terminals of extrinsic primary afferent fibres and in some immune cells in the mucosa 
(Izzo & Sharkey, 2010); the peroxisome proliferator-activated receptor-α (PPAR-α) that is 
highly expressed in kidneys, liver, heart, brown adipose tissue and intestine (Witkamp, 2018). 
Moreover, NAEs are also able to link G-protein coupled receptor 119 (GPR119) which is 
expressed on cells in the small intestine, colon and stomach (Hansen & Diep, 2009). Those 
receptors are involved in food intake and in blood glucose control by regulating the secretion 
of glucagone-like peptide 1 (GLP-1) from the GIT (Izzo & Sharkey, 2010; Overton, Fyfe & 
Reynet, 2008). 
OEA may also exert its effects on food intake control, visceral pain and intestinal permeability 
in vitro through TRPV1 whereas PEA modulated intestinal permeability via PPAR-α (Karwad 
et al., 2017).  
Interestingly, OEA was suggested to regulate body weight also by modulating the peripheral 
lipid metabolism because the application of OEA to the enterocytes in vitro increased fatty 
acids uptake by increasing FAT/CD36 mRNA expression (Yang, Chen, Georgeson & Harmon, 
2007). 
On the other hand, the elegant study by Gillum and co-workers (2008) demonstrated that also 
NAPEs can influence food intake by signalling the central nervous system after injections in 
the duodenum, in the peritoneum and in the brain (Gillum et al., 2008). 
Although NAPEs, NAEs and ECs are recognised as bioactive compounds and are present in 
nature, very little is known about their concentration in the food matrices. Only few and sparse 
studies reported their content in some foods (Chapman, Venables, Markovic, Blair, Bettinger 
& 1999; Di Marzo et al., 1998; Venables, Waggoner & Chapman, 2005).  
This study aimed at creating a database of NAPEs, NAEs and ECs in common foods and at 
estimating individual daily dietary intake. To this purpose a LC-HRMS analytical method was 
set up and 43 food products, of which 31 were of vegetal and 12 of animal origin, were 
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analysed. The database was used to assess the daily dietary intake of those compounds in three 
dietary plans that were built on the basis of the principles of the Western diet (WD), 
Mediterranean diet (MD) and Vegetarian diet (VD). 
2.2 Materials and methods 
2.2.1 Foods  
The 43 food products analysed in this study were purchased from a local market and included: 
beans, lentils and chickpeas (Agria SPA; S. Giuseppe Vesuviano, Italy), brown pasta (Di 
Martino, Gragnano, Italy), pasta (Antonio Amato, Salerno, Italy), whole wheat flour (Barilla 
SPA, Parma, Italy), flour (Divella, Rutignano, Italy), parboiled rice (Colussi, SPA, Milano, 
Italy), whole wheat bread and refined wheat bread (Italy), breakfast whole cereals (Nestlè Italia 
SPA, Assago, Italy), Gorgonzola cheese (Si Invernizzi Srl,  Trecate, Italy), parmigiano cheese 
(Parmareggio SPA, Modena, Italy), eggs (Maddaloni, Ercolano, Italy), lettuce (Fresco 
dall’Orto Berna, Battipaglia, Italy), whole milk (Parmalat SPA, Milano, Italy), red wine 
(Tavernello, Faenza, Italy), codfish (Findus, Roma, Italy), coffee powder (Kimbo SPA, Melito 
di Napoli, Italy), coffee (Kimbo SPA, Melito di Napoli, Italy), natural tuna (Rio Mare, Bolton 
Group Srl, Milano, Italy), cocoa (Nestlè Italia SPA, Assago, Italy), salami (Di.A SRL, Caserta, 
Italy), extravirgin olive oil (Monini Gran Fruttato, Perugia, Italy), butter (Prealpi, Varese, 
Italy), coconut oil (Food For All snc, Pescantina, Italy), hemp oil (Italy) and palm oil (Italy).  
The red meat, potatoes, orange, tomato, apples, anchovies, chicken breast, broccoli and 
cauliflower were fresh products purchased from local supermarket.  
All the foods were analysed in the form they are usually consumed. Pasta, brown pasta, rice, 
potatoes, broccoli, cauliflower and codfish were boiled in the water and then dripped into a 
colander. Anchovies were cooked in a pan whereas meat and chicken were grilled. Eggs were 
hard-boiled. Coffee using 11 g of coffee powder and a volume of 80 mL of water by using a 
moka machine was prepared.  
40 
 
2.2.2 Extraction of NAPEs and NAEs from foods 
Freeze dried food samples (100 mg) were added with 25 µL of the internal standard 2 µg/mL 
solution of arachidonoylethanolamide d8 (AEA d8) (Cayman Chemical, Ann Arbor, MI).   
A solution of CHCl3/CH3OH (2:1) (4.5 mL) was used for the extraction. After 30 seconds of 
shaking, the mixture was centrifuged at 14800 rpm for 10 minutes at 10 °C.  
The supernatants were collected in a glass tube and dried under a nitrogen flow. The extract 
was suspended in a solution of CH3CN/C3H8O/H2O (60:35:5) before the HRMS analysis. 
2.2.3 Liquid Chromatography – High Resolution Mass Spectrometry (LC-HRMS) analysis 
LC-HRMS analysis was adapted from Gregory et al. (2012). The analyses were performed on 
an Accela U-HPLC system coupled to an Exactive mass spectrometer (Thermo Fisher 
Scientific, San Jose, CA). The Accela system consisted of a quaternary pump, a thermostated 
autosampler (8 °C). A Kinetex 2.6 μ C18 100 A column (100 mm × 2.1 mm) (Phenomenex, 
Torrance, CA) thermostated at 45 °C was used. The mobile phase consisted of 40:60 CH3CN/ 
H2O with 5 mM ammonium formate and 0.1% formic acid (A) and 90:10 C3H8O/ CH3CN with  
5 mM ammonium formate and 0.1% formic acid. (B). Gradient elution was linearly 
programmed as follows: 32 % B (0-1.5 min), 32–45 % B (1.5-4) min, , 45–52 % B (4-5 min), 
52-58 % B (5-8 min), 58-66 % B (8-11 min), 66-70 % B (11-14 min), 70-75 % B (14-18 min), 
75-97 % B (18-21 min), costant at 97% B (21-25 min) (Gregory et al., 2012) 
The flow rate was set at 200 μL/min and the injection volume was 10 μL. 
 The U-HPLC system was coupled to an Exactive Orbitrap MS operating with a heated 
electrospray interface (HESI), in positive and negative ionization mode, in the mass range of 
m/z 120–1200. Mass resolving power was set to 50,000 full width at half-maximum (FWHM, 
m/z 200), scan time was 1 s and the maximum injection time was 100 ms. The interface 
parameters were optimised using reference compounds of N-acylphosphatidylethanolamine, 
N-acylethanolamines and endocannabinoids  using the following parameters: spray voltage 3.5 
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kV (positive mode) and 3.0 kV( negative mode), capillary voltage 30V, heater temperature 
300 °C, capillary temperature 50 °C, sheath gas 35 arbitrary units, and auxiliary gas  15 
arbitrary units. 
The instrument was daily calibrated by following Thermo Exactive calibration procedure in 
positive and negative ions mode. 
The Xcalibur software (Thermo Fisher Scientific, San Jose, USA) was used for the 
chromatographic data acquisition and peak integration. 
N-Arachidonoylphosphatidylethanolamine standard was purchased from Santa Cruz 
Biotechnology (Santa Cruz Biotechnology, Inc., USA).  
The concentrations of different NAPEs were quantified as N-
Arachidonoylphosphatidylethanolamine equivalents by using the external calibration curve 
with the linear range (0.2-5µg/mL) and expressed as µg per g of dry food.  
ECs (2-arachidonylglycerol, 2-AG; anandamide, AEA; AEAd8) and NAEs (OEA: 
linoleoylethanolamide, LEA; palmitoylethanolamide, PEA) standards were purchased from 
Cayman (Cayman Chemical, Ann Arbor, MI). The concentrations were calculated by isotope 
dilution using calibration curve with the linear range (1-1000 ng/mL) and expressed as ng per 
g of dry food.  
In the chromatographic region between 19-23 min the NAPEs were detected in negative mode 
as [M-H]-. 
In the chromatographic region between 6-9 min the NAEs were detected in positive mode as 
[M+H]+. 
The compounds identification was performed by using the exact mass values up to the fifth 
decimal digit with a ± 5 ppm mass tolerance. In the Table 2.1 molecular formula, theoretical 
mass, experimental mass and mass accuracy have been shown. 
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Table 2.1. High-Resolution Mass Spectrometry identification of ECs, NAEs and NAPEs. 
 
Compound Molecular 
formula 
Theoretical mass 
[M+H]+ m/z         [M-H]- m/z 
Experimental 
Mass 
Mass 
accuracy 
(ppm) 
 ECs      
AEA C22H37NO2 348.28971  348.28877 -2.70 
2-AG C23H38O4 379.28429  379.28436 0.18 
NAEs      
OEA C20H39NO2 326.30536  326.30499 -1.13 
LEA C20H37NO2 324.28971  324.28995 0.74 
PEA C18H37NO2 300.28971  300.28976 0.17 
NAPEs      
16:0-18:2-N16:0 C55H104NO9P  952.73759 952.73984 2.36 
16:0-18:2-N18:2 C57H104NO9P  976.73759 976.73890 1.34 
18:2-18:2-N16:0 C57H104NO9P  976.73759 976.73890 1.34 
18:2-16:0-N18:2 C57H104NO9P  976.73759 976.73890 1.34 
16:0-18:2-N18:1 C57H106NO9P  978.75324 978.75163 -1.64 
16:0-18:1-N18:2 C57H106NO9P  978.75324 978.75163 -1.64 
18:2-18:2-N18:2 C59H104NO9P  1000.73759 1000.74099 3.40 
18:1-18:3-N18:2 C59H104NO9P  1000.73759 1000.74099 3.40 
18:2-18:1-N18:2 C59H106NO9P  1002.75324 1002.75533 2.08 
18:0-18:3-N18:2 C59H106NO9P  1002.75324 1002.75533 2.08 
18:3-18:2-N18:2 C59H102NO9P  998.72194 998.72536 3.42 
18:2-18:2-N18:3 C59H102NO9P  998.72194 998.72536 3.42 
18:1-18:2-N18:1 C59H108NO9P  1004.76889 1004.77163 2.73 
18:3-18:0-N18:1 C59H108NO9P  1004.76889 1004.77163 2.73 
18:3-16:0-N20:1 C59H108NO9P  1004.76889 1004.77163 2.73 
18:0-18:3-N18:1 C59H108NO9P  1004.76889 1004.77163 2.73 
18:2-18:1-N20:1 C61H112NO9P  1032.80019 1032.80093 0.72 
18:2-18:2-N20:0 C61H112NO9P  1032.80019 1032.80093 0.72 
16:0-18:2-N18:0 C57H108NO9P  980.76889 980.77113 2.28 
18:1-16:0-N18:1 C57H108NO9P  980.76889 980.77113 2.28 
18:2-18:1-N18:0 C59H110NO9P  1006.78454 1006.78540 0.85 
18:2-18:0-N18:1 C57H108NO9P  1006.78454 1006.78540 0.85 
18:0-18:1-N18:1 C59H112NO9P  1008.80019 1008.80127 1.07 
16:0-18:2-N20:0 C59H112NO9P  1008.80019 1008.80127 1.07 
 18:1-18:0-N20:4 C61H110NO9P  1030.78454 1030.78635 1.76 
18:2-18:0-N20:1 C61H108NO9P  1028.76889 1028.77166 2.69 
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2.2.4 NAPEs identification in food matrix 
Chromatographic separation was performed using a HPLC apparatus equipped with two 
Micropumps Series 200 (PerkinElmer, Shellton, CT, USA). 
The chromatographic conditions used for the analysis were the same present in the paragraph 
2.3. 
Mass spectrometry analysis was performed on an API 3000 triple quadrupole mass 
spectrometer (Applied Biosystems, Canada) equipped with a TurboIonSpray source working 
in the negative ion mode. Acquisition was performed in scan in the range m/z 120-1200 and in 
MRM (Multiple Reaction Monitoring). 
2.2.5 NAPEs, NAEs and ECs content in typical diets 
Three diets of 2000 kcal were developed on the basis of the frequency of consumption of 
vegetal and animal food products typical of the dietary patterns defined as Western, 
Mediterranean and Vegetarian.  
Western diet (WD) is characterised by high intakes of red and processed meat, butter, fried 
foods, high-fat dairy products, eggs, refined grains, potatoes, and high-sugar drinks (Myles, 
2014). 
Mediterranean diet (MD) is characterised by daily intakes of whole grain pasta and bread, high 
intakes of legumes and fish, low intake of poultry, eggs and dairy products instead of red and 
processed meat as source of animal proteins, low intake of potatoes and unique use of virgin 
olive oil as food condiment (Martinenz-Gonzalez, Bes-Rastrollo, Serra-Majem, Lairon, 
Estruch & Trichopoulou, 2009). 
Vegetarian diet (VD) is characterised by the absence of meats, seafoods or products containing 
these food but inclusion of dairy products and eggs (Craig & Mangels, 2009). 
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The Terapia Alimentare Dietosystem® (DS Medica, Milano, Italy) software was used to 
develop the three diets and the daily intake of NAPEs, NAES and ECs for each diet using the 
developed database was assessed. 
The MD was developed considering a daily consumption of fresh and dried fruit, legumes, 
vegetables, whole wheat bread, brown pasta, breakfast whole cereals, milk, coffee and red 
wine, while it was considered a weekly consumption of fish, meat and eggs. 
The VD was different to MD for the higher daily consumption of fresh fruit and vegetables, 
for the higher weekly consumption of egg and dairy products and for the absence of meat and 
fish consumption. 
However, in both the diets the extravirgin olive oil was considered as the unique condiment for 
the preparation of meals. 
On the other hand, the WD was devolped considering a weekly consumption of fresh fruit and 
nuts, legumes and vegetables (mostly potatoes), eggs and daily consumption of bread, pasta, 
meat, milk and dairy products, coffee and red wine.  The extravirgin olive oil and butter were 
considered as the condiments in the preparation of meals. 
2.2.6 Statistical analysis 
Results were expressed as means ± standard error of means (SEM). Statistical analyses were 
performed with the statistical package SPSS for Windows (version 20, SPSS Inc. Chicago, IL, 
USA). 
Levene’s test was used to evaluate the normality of distribution and the homogeneity of 
variance of all monitored variables. The difference between means were tested using Student’s 
t-test. Statistical significance was set at level of p<0.05. 
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2.3 Results  
2.3.1 Identification of NAPEs 
NAPEs identification in food matrices was carried out by considering chemical structures of 
compounds and their retention times as obtained by HRMS analysis. 
In HRMS analysis NAPEs were characterised by exact mass. However, since several NAPEs 
species can have the same molecular weight due to the combination of different acyl residues 
on the ethanolamine bone, NAPEs were tentatively identified using an API 3000 triple 
quadrupole mass spectrometer. The analyses were firstly performed in scan using cone-induced 
fragmentation to detect the deprotonated molecules of NAPEs and the carboxylate ions in sn-
2 and sn-1 position. The acquisition was then performed in MRM, to confirm the position of 
fatty acids by considering the information obtained in scanning experiments. 
The position of fatty acid was assigned studying the fragmentation patterns of NAPEs in 
accordance with the method described by Hansen, Hansen, Bjørnsdottir & Hansen, (1999) and 
Sandoval et al., (1995). They reported that the sn-2 fatty acid carboxylate anion [R2CO2]
- 
appeared at higher intensities than the sn-1 fatty acid carboxylate anion [R1CO2]
-, thereby the 
positioning of individual acyl groups along the glycerol backbone of diacyl-NAPE was 
facilitated. MS/MS fragmentation pattern showed fragment ions correspondent to neutral loss 
of fatty acids from the sn-2 [M-H-R2CO2H]
- and the sn-1 [M-H-R2CO2H]
- position and 
fragment ions correspondent to neutral loss of dehydrate of fatty acids from the sn-2 [M-H- 
R2CH=CO]
- and the sn-1 [M-H-R1CH=CO]
- position.  
Furthermore, the fragment ion [R3CONHCH2CH2OPO3H]
- was specific of NAPEs species and 
excluded any confusion with acylphospatidylglicerol because it corresponded to the 
phosphorylated N-fatty amide head group (Coulon & Buré, 2015).   
R1, R2, and R3 refer to the hydrocarbon chains of the acyl groups at sn-1, sn-2, and N-acyl 
position.   
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NAPEs identification by mass spectrometry is shown in Table 2.2. 
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Table 2.2. NAPEs identification by mass spectrometry. 
NAPE  
sn-1, sn- 2 
[M H]-
m/z 
[R2CO2]- [R1CO2]- [R3CO2]- [M-H-R2CO2H]- [M-H-R1CO2H]- [M-H-R’2CH=CO]- [M-H-R’1CH=CO]- [R3CONHCH2CH2OPO3H]- 
16:0-18:2-N16:0 952.7 279.0 255.0 255.0 672.7 696.7 690.7 714.7 378 
16:0-18:2-N18:2 976.7 279.0 255.0 279.0 696.7 720.7 714.7 738.7 402 
18:2-18:2-N16:0 976.7 279.0 279.0 255.0 696.7 696.7 714.7 714.7 378 
18:2-16:0-N18:2 976.7 255.0 279.0 279.0 720.0 696.0 738.0 714.0 402 
16:0–18:2-N18:1 978.7 279.0 255.0 281.0 698.7 722.7 716.7 740.7 404 
16:0-18:1-N18:2 978.7 281.0 255.0 279.0 696.7 722.7 714.7 740.7 402 
18:2–18:2-N18:2 1000.7 279.0 279.0 280.0 720.7 720.7 738.7 738.7 402 
18:1-18:3-N18:2 1000.7 277.0 281.0 279.0 718.7 718.7 736.7 736.7 402 
18:2-18:1-N18:2 1002.7 279.0 281.0 279.0 722.7 720.7 740.7 738.7 402 
18:0-18:3-N18:2 1002.7 277.0 283.0 279.0 724.7 718.7 742.7 736.7 402 
18:3-18:2-N18:2 998.7 279.0 277.0 279.0 718.7 720.7 736.7 738.7 402 
18:2-18:2-N18:3 998.7 279.0 279.0 277.0 718.7 718.7 736.7 736.7 400 
18:2 18:2-N20:0 1032.7 279.0 279.0 311.0 752.7 752.7 770.7 770.7 434 
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18:2 18:1-N20:1 1032.7 279.0 281.0 309.0 752.7 750.7 770.7 768.7 432 
18:1-18:2-N18:1 1004.7 281.0 279.0 281.0 722.7 724.7 740.7 742.7 404 
18:0-18:3-N18:2 1004.7 283.0 277.0 281.0 720.7 726.7 738.7 744.7 404 
18:2 18:1-N18:1 1004.7 279.0 281.0 281.0 724.7 722.7 742.7 740.7 404 
18:3 18:0-N18:1 1004.7 279.0 279.0 283.0 724.7 724.7 742.7 742.7 406 
18:0-18:2-N20:1 1004.7 255.0 277.0 309.0 748.7 726.7 766.7 744.7 432 
18:3-16:0-N20:1 1004.7 255.0 277.0 309.0 748.7 726.7 766.7 744.7 432 
18:2-18:0-N-18:2 1004.7 279.0 283.0 279.0 724.7 720.7 742.7 738.7 402 
16:0–18:2-N18:0 980.7 279.0 255.0 283.0 700.7 724.7 718.7 742.7 406 
18:1-16:0-N18:1 980.7 281.0 255.0 281.0 698.7 724.7 716.7 742.7 404 
18:2-18:1-N18:0 1006.7 281.0 279.0 283.0 724.0 726.0 742.0 744.0 406 
18:2-18:0-N18:1 1006.7 283.0 279.0 281.0 722.7 726.8 740.7 744.8 404 
18:0-18:1-N18:1 1008.7 281.0 283.0 281.0 726.0 724.0 744.0 742.0 404 
16:0-18:2-N20:0 1008.7 279.0 255.0 311 728.8 752.8 746.8 770.8 434 
16:0-18:2-N20:1 1030.7 279.0 255.0 309.0 748.0 772.0 766.0 790.0 432 
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18:1-18:0-N20:4 1030.7 283.0 281.0 303.0 746.7 748.7 764.7 766.7 426 
18:2-18:0-N18:1 1028.7 283.0 279.0 281.0 744.0 748.0 762.0 766.0 404 
 
 
* R1, R2, and R3 refer to the hydrocarbon chains of the acyl groups at sn-1, sn-2, and N-acyl position 
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In the Figure 2.2 the extracted ion chromatograms of NAEs and NAPEs identified in the 
walnuts are shown. 
 
 
Figure 2.2 Extracted ion chromatograms (XICs) of NAEs and NAPEs present in the walnuts 
obtained using the high-resolution mass spectrometry in positive and negative ions. 
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2.3.2 NAPEs content of food products 
The concentration of the total NAPEs in foods is shown in Figure 2.3. 
 
Figure 2.3. Total NAPEs concentration in foods of animal and vegetable origin. Student’s t 
test was used and different letters on the bars indicate p<0.05 (number of replicates=3). 
 
 
Figure 2.3 shows the concentration of the total NAPEs in foods. They were more abundant 
from vegetal products than in animals. The highest concentration of total NAPEs was found in 
chickpeas and in brown and white pasta which belong to the food categories of legumes and 
cereal products, respectively. Those food sources were followed by beans and lentils as well as 
refined flour whose content of NAPEs was 2.8, 2.8 and 4.5 folds lower than brown pasta, 
respectively. Breakfast cereals and cocoa powder showed a similar content and were 
immediately followed by whole wheat flour, bread and walnuts. The latter showed a NAPEs 
content similar to parmigiano cheese that was the richest source in animal products followed 
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by tuna fish and codfish. On the other hand meats and eggs were the poorest source of NAPEs 
among animal products, indeed their mean concentration was 5.5 and 7.6 folds lower than 
fishery and dairy products, respectively. A similar content of NAPEs, between 58 µg/g dw and 
248 µg/g dw, was found in 4 out of 6 analysed vegetables whereas potatoes and broccoli had a 
10 folds lower content. Between oils and fats category, margarine was the richest source of 
NAPEs, followed by hemp oil whereas no traces of NAPEs in EVOO, palm oil and coconut oil 
were found. In beverages NAPEs were found only in coffee at a concentration of 1.81 µg/g dw.  
In a selection of foods such as flour, walnuts, parmigiano cheese, eggs, tomatoes and chickpeas, 
exact NAPEs, as precursors of LEA, PEA, OEA and AEA, were identified and quantified. 
Data are reported in Table 2.3. 
 
Table 2.3. Total concentration of LEA, OEA, PEA precursors in foods. Student’s t test was 
used and different letters in the column indicate p<0.05 (number of replicates=3). 
 
Food LEA 
precursors 
(µg/g dw) 
OEA  
precursors 
(µg/g dw) 
PEA  
precursors  
(µg/g dw) 
 Means ± SEM Mean ± SEM Mean ± SEM  
Flour 353.71±37.30b 231.9 ±3.38b  4.06±0.46c  
Walnuts 232.64±9.05b 105.67±75.46c  24.47±1.07b  
Chickpeas 1701.1±135.23a 1598.12±75.46a  150.53±7.80a  
Parmigiano 
cheese 
28.42±0.78d 235.51±8.12b  20.74±1.23b  
Tomato 78.61±3.81c 43.59±1.28d  NF ± NF  
Eggs 1.27±0.17e 9.72±0.87e  0.88±0.05d  
 
The highest concentrations of NAEs precursors were found in chickpeas, while the lowest 
concentrations were found in eggs. Specifically, the concentration of LEA, OEA and PEA 
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precursors were the 49%, 46% and 4% of total NAPEs in the chickpeas, and the 8%, 63% and 
6% of total NAPEs in eggs, respectively. 
2.3.3 NAEs and ECs content of foods 
Figure 2.4A shows the concentration of LEA in foods.  Cereal products showed the highest 
mean concentration of LEA (65.0-30292.9 ng/g dw), refined flour was the richest product 
followed by whole wheat flour and by brown pasta, breakfast whole cereals and bread which 
had a similar content. After cereal products the highest content of LEA was found in cocoa and 
coffee powder (809.5-3167.0 ng/g dw), nuts (17.6-1326.7 ng/g dw) and vegetables (1.5-1866.7 
ng/g dw) which showed a mean LEA content that was ~ 3.1, 9.2 and 14.4 folds lower than 
cereals, respectively. Among oil and fats, margarine and hemp oil were the richest sources 
while 10 and 11 folds lower amount of LEA were found in EVOO and palm oil, respectively. 
Among animal products, eggs were the richest source of LEA being about 2.8 folds higher than 
butter, 4.8 folds higher than chicken 5.5 folds higher than salami and 5.7 folds higher than 
codfish as well as 8.9 folds higher than gorgonzola and parmigiano cheese.  
Figure 2.4B shows the concentration of PEA in foods. Coffee powder is the richest source of 
PEA (897.7 ng/g dw). A similar content was found in refined flour (803.7 ng/g dw) which was 
the richest source of PEA in cereal products followed by whole wheat flour. Breakfast whole 
cereals and brown pasta showed a similar content of PEA that was about 16 folds lower than 
that of flour. Margarine and walnuts were the richest source of PEA in their categories (302.3 
ng/g dw and 253.3 ng/g dw, respectively) with a concentration similar to whole wheat flour. 
Among animal products, similar amounts in fishery and meat products as well as in eggs were 
found whereas milk and dairy products were a bit less abundant being respectively 2.8, 2.1, 
and 5.7 folds lower than in cereal products. PEA was not found in coffee and red wine. 
Figure 2.4C shows the concentration of OEA in foods. The highest concentration of OEA was 
found in refined flour followed by cocoa, whole wheat flour and coffee powder which showed 
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a content of OEA that was 1.3, 1.5 and 3.6 folds lower than flour, respectively. Interestingly, 
for OEA compared to LEA and PEA concentrations, animal products were ranked higher than 
nuts, legumes and vegetables. In particular, fishery and meat products, such as codfish and read 
meat, showed an OEA content that was 6 and 12 folds lower than refined flour, respectively. 
OEA in legumes and vegetables was found at a mean concentration similar to EVOO and palm 
oil. On the other hand, margarine and hemp oil were found the best sources of OEA in oils and 
fats category with a content that was similar to walnuts and parmigiano cheese, respectively. 
Thus looking at the sum of all NAEs (Figure 2.4D) the highest concentration of NAEs was 
found in flour and whole wheat flour followed by coffee and cocoa powders (34757.4 ng/g dw, 
18146.0 ng/g dw, 5086 ng/g dw and 3700.2 ng/g dw, respectively). Brown pasta, breakfast 
cereals and bread showed a similar content of NAEs (~ 1351.3 ng/g dw) that is very close to 
that found in carrots, walnuts and margarine, which are the richest sources of NAEs in 
vegetables, nuts and oils and fats, respectively. In general, among vegetal products legumes 
were the poorest source of NAEs (177.53 ng/g dw) with chickpeas and beans being 5.3 folds 
higher than lentils and showing a concentration level similar to cauliflower, tomatoes and 
lettuce. Among animal products codfish (674.7 ng/g dw) was the richest source of NAEs and 
it was immediately followed by eggs and red meat. On the other hand milk and dairy products 
were the poorest animal sources of NAEs (mean concentration of 46.6-229.6 ng/g dw) with 
butter and parmigiano cheese showing the highest concentration. Beverages and fresh fruits 
were at the bottom of the concentration ranking list being at a level below 100 ng/g dw. 
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Figure 2.4. LEA (A), PEA (B) and OEA (C) and total NAEs (D) concentration in foods of 
animal and vegetable origin. Student’s t test was used and different letters on the bars indicate 
p<0.05 (number of replicates=3). 
 
 
 
Figure 2.5 shows the concentration of AEA, 2-AG and total ECs. Interestingly, ECs were not 
found in the foods of plant origin but in cocoa, where AEA was 6.6 ng/g dw, and in cauliflower, 
where 2-AG was 74.8±2.9 ng/g dw. 2-AG was at a concentration level 1500 folds higher than 
AEA. Thus total ECs in foods mirrored their 2-AG content. The highest concentration of 2-AG 
was found in tuna fish (33466.3 ng/g dw), followed by eggs (2403.9 ng/g dw) and anchovies 
(416.9 ng/g dw). The highest concentration of AEA was found at a similar level in eggs, 
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chicken and red meat (mean value ~ 16.27 ng/g dw) followed by parmigiano cheese at 8.92 
ng/g dw and anchovies at 1.21 ng/g dw.  
 
 
 
Figure 2.5. AEA (A), 2-AG (B) and total ECs (C) in the animal origin food. Student’s t test 
was used and different letters on the bars indicate p<0.05 (number of replicates=3). 
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2.3.4 NAPEs, NAEs and ECs daily intake in Western, Mediterranean and Vegetarian diet 
The Table 2.4 shows the daily intake of NAPEs, NAEs and ECs upon consumption of a MD, 
a VD and a WD. 
 
 
Table 2.4. Daily intake of NAPEs, NAEs and ECs by a Western Diet, a Mediterranean Diet 
and Vegetarian Diet providing 2000 kcal/day.  
 
 Western Diet Mediterranean Diet Vegetarian Diet 
NAPEs (mg/day) 163 263 242 
NAEs (mg/day) 0.08 0.25 0.28 
ECs (mg/day) 0.17 0.17 0.01 
 
Data showed that the daily intake of NAPEs and NAEs was higher in VD and MD than in WD 
(Figure 2.6A and Figure 2.6B, respectively), while the daily intake of ECs in MD and WD 
was similar and higher than in VD (Figure 2.6C). 
 
 
 
Figure 2.6. Daily intake of NAPEs (A), NAEs (B) and ECs (C) in Mediterranean diet, 
Western diet and Vegetarian diet. 
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2.4 Discussion 
For the first time in this study, the content of NAPEs, NAEs and ECs in 43 food products was 
assessed. Data showed that both NAPEs and NAEs were present at higher concentration in 
vegetal than animal food products whereas ECs were mainly found in animal products. 
The concentration of NAPEs in wheat flour was in accordance with previous studies showing 
concentrations in the range of 250 µg/g dw and 896.7 µg/g dw (Kotel’nikova, 2011; 
Schaffarczyk, Østdal & Koehler, 2014). On the other hand NAPEs content of legumes was 
about 4 folds higher than that reported by Kotel’nikova (2011) showing concentration range of 
50-350 µg/g dw depending from the beans cultivar. The different analytical method used for 
quantification, a possibly different cultivar of legumes as well as the fact that in this study 
legumes were cooked might determine the differences with Kotel’nikova’s study.  
In the animal food products the highest concentration of NAPEs was found in parmigiano 
cheese (397.7±19.04 µg/g dw), and the lowest concentration was in salami (3.71±0.14 µg/g 
dw). Only one study is present in the literature reporting NAPEs content in five species of 
bivalve mollusks (Sepe, De Petrocellis, Montanaro, Cimino & Di Marzo, 1998). 
Data showed that wheat flour is the best source of NAEs (mainly LEA) among the plant origin 
products. Previous evidence of NAEs in vegetal products is limited to seeds and showed that 
cotton seeds had the highest concentration (1600 ng/g fresh weight) while pea had the lowest 
one (450 ng/g fresh weight) with LEA and PEA being the most abundant compounds 
(Chapman et al., 1999). 
In the present study the individual contribution of each compound to the total content of NAEs 
in beans was in the order LEA>PEA>OEA, in the chickpeas it was LEA>OEA>PEA and in 
the lentils LEA>OEA>PEA. The difference in the pattern composition of NAEs as well as the 
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concentration levels in legumes were generally in accordance with previous findings by 
Venables and colleagues (2005). 
Similarly, the concentration of total NAEs in cocoa powder and a concentration level in the 
order OEA>LEA>PEA>AEA was partially in agreement with previous studies by Di Marzo et 
al. (1998) and di Tomaso, Beltramo & Piomelli (1996). 
Regarding animal food products, the highest concentration of NAEs was found in the codfish 
(674.70±34.46 ng/g dw), while the lowest concentration was found in milk (46.63±1.26 ng/g 
dw). No previous papers about NAEs content in fishery products were published whereas some 
data on NAEs content only in human milk exist (Di Marzo et al., 1998). 
Data showed that among vegetable oils, hemp oil provided the highest amount of NAEs 
whereas among animal products tuna fish was the best food source of ECs. Within oils and 
fats, LEA concentration in EVOO was 53.9 ng/g dw and OEA concentration was 85.7 ng/g dw. 
Those concentrations were pretty lower than those reported by Bradshaw & Leishman (2016). 
Different analytical methods, olive cultivars and processing might explain the differences. 
Regarding the ECs in animal products, tuna fish was the best source of 2-AG whereas AEA 
was not found. Interestingly, other NAEs were present in tuna fish with PEA being the most 
abundant followed by OEA and LEA and the same pattern was found by Sepe and co-workers 
(1998) in molluscs. 
AEA was only found in meat and eggs, in fishery and in milk and derivative products, the 
highest concentration being in eggs, and the lowest in anchovies. Sepe and co-workers (1998) 
showed the presence of AEA in different species of molluscs in the range of 2.6-4.9 ng/g wet 
tissue weight. 
In 2010 MD was recognized by UNESCO as an intangible heritage of humanity. Meta-analyses 
of observational studies and randomised controlled trials showed that the MD reduces the risk 
of chronic disease and mortality and it modulates the anthropometrical, metabolic and 
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inflammatory parameters thus aiding in reduction of glycaemia, insulin-resistance and 
metabolic syndrome as well as in prevention of some types of cancer (Dinu, Pagliai, Casini & 
Sofi, 2017). 
On the other hand VD was associated with a better control of blood pressure and lipids as well 
as a lower risk of cardiovascular diseases and type 2 diabetes compared with an omnivorous 
diet (Craig & Mangels, 2009; Kwok, Umar, Myint, Mamas, & Loke, 2014).Very recently Sofi 
et al. (2018) showed that 3 months of a MD or VD in overweight subjects were both effective 
on reduction of body weight and fat mass but MD also decreased blood triglycerides while VD 
decreased blood LDL-cholesterol.  
On the contrary, WD is well known to be positively associated with obesity and metabolic 
disease as well as with a modification of human gut microbiota towards endotoxin-producing 
bacteria (Zinöcker & Lindseth, 2018). 
By using the food database of NAPEs, NAEs and ECs here developed, the content of those 
compounds from a MD, VD and WD was calculated. Data showed that MD and VD provide a 
similar intake per day of NAPEs and NAEs that is higher than WD. In particular, NAPEs and 
NAEs in MD and VD exceeded the 250 mg and the 300 µg per day while they were around 
two and four folds lower in WD, respectively. On the other hand ECs were at a concentration 
level around 200 µg per day in MD and WD while they were twenty folds less in VD. 
Moreover, we have found that an amount of NAPEs ranging between the 4% and 63% may act 
as NAEs precursors. That observation means that more than half of NAPEs present in foods 
may deliver NAEs when hydrolysed by NAPE-PLD once ingested.  
All in all these data could suggest that even if NAPEs and NAEs are subjected to 
biotransformation processes due to degrading enzymes along the GIT, a certain amount of 
NAEs and NAPEs travel along the GIT inside the foods and may be released during the 
digestive processes and exert biological activity through receptors and nervous system 
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terminals lining in the GIT mucosa or may reach the colon and interact with microbiota. 
Looking at the diet content it is possible to think that food NAPEs, NAEs and ECs may be 
physiologically relevant. Indeed, in vitro studies, showed that NAEs have agonist activity on 
GPR119, with an EC50 that was found between 65 µg/L and 1.0 mg/L for OEA, 180 µg/L for 
LEA and 250 µg/L for PEA (Hansen et al., 2011; Overton et al., 2006). Furthermore, Fu et al., 
(2003) showed that OEA can activate PPAR-α with an EC50 of  39 µg/L. 
Thus, NAPEs and NAEs travelling in the GIT upon food consumption may contribute to 
nutrient metabolism, to the regulation of food intake and body weight as well as to the gut 
permeability and GIT motility through the nutrient sensing in the gut. Future studies should be 
performed to demonstrate this hypothesis. 
2.5 Conclusions  
In conclusion the present study provide a database of NAPEs, NAEs and ECs in food products 
highly consumed worldwide. Data demonstrated that the concentrations of NAPEs and NAEs 
are higher in the products of vegetal origin than in animal ones, whereas the ECs (AEA and 2-
AG) are almost exclusively present in the products of animal origin. 
Furthermore, it was shown that dietary patterns inspired on principles of a MD, a VD and a 
WD provide different daily intakes of NAPEs, NAEs and ECs that may be in a sufficient 
amount to activate receptors along the GIT. Further studies are warranted to evaluate the 
contribution of those compounds on health benefits associated with MD and VD.  
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2.6 Abbreviations 
GIT: gastrointestinal tract; GPRs: G-protein-coupled receptors; NAPEs: N-
acylphosphatidylethanolamines; NAEs: N-acylethanolamines; ECs: endocannabinoids; 
NAPE-PLD: N-acyl-phosphatidylethanolamine-specific phospholipase D; NAAA: N-
acylethanolamine-hydrolyzing acid amidase; FAAH: fatty acids amide hydrolases; PLD-β: 
phospholipase-β; CB1: cannabinoid receptor-1; GLP-1: glucagone-like-peptide-1; TRPV1: 
transient receptor potential vanilloid 1; PPAR-α: peroxisome proliferator-activated receptor-α; 
LC-HRMS: liquid chromatography–high resolution mass spectrometry; AEAd8: anandamide-
d8; LEA: linoleoylethanolamide; PEA: palmitoylethanolamide; OEA: oleoylethanolamide; 
AEA: anandamide; 2-AG: 2-arachidonylglycerol; MD: Mediterranean diet; VD: Vegetarian 
diet; WD: Western diet;  Bev: Beverages. 
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Abstract  
The primary objective of this study was to evaluate whether the amount and type of food dietary 
fiber influenced salivary concentrations of N-acylethanolamines (NAEs) and glucose upon 
food mastication and in the post-prandial phase. 
Three types of biscuits enriched with 3% barley β-glucan (βGB) or whole-wheat bran (WWBB) 
or without dietary fiber (control, CB) were developed. A crossover randomised human study 
with 18 healthy and fasting participants collecting saliva samples in a resting condition, upon 
mastication of parafilm and one of the three biscuits was carried out. Subsequently, the amount 
of biscuits consumed in an ad-libitum breakfast was measured and post-prandial saliva 
samples, blood glucose, appetite, and food liking were collected over the following two hours. 
Salivary concentration of oleoylethanolamide (OEA) and linoleoylethanolamide (LEA) 
significantly increased upon all biscuits mastication compared to non-food conditions, OEA 
increasing more (~138 folds) than LEA (~7 folds). Subjects consumed always 75g of biscuits 
at breakfast. Salivary OEA peaked at 15min and returned to baseline concentration at 60 min 
after consumption of all types of biscuits whereas LEA peaked only after WWBB. Fifteen 
minutes after βGB consumption all NAEs were significantly lower than after WWBB. No 
difference of biscuit type on post prandial blood glucose was recorded. 
Data demonstrated that NAEs were released in saliva during biscuit mastication, independently 
from dietary fiber composition. The type of dietary fiber could influence the persistence of 
NAEs in saliva over 30 min after consumption. Future studies will clarify the mechanisms 
behind these findings and the role of salivary NAEs in food liking and appetite cues after food 
consumption. 
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3.1 Introduction 
Satiation is the satisfaction of appetite developing during eating and eventually resulting in the 
termination of eating (Slavin & Green, 2007; Suzuki, Jayasena, & Bloom, 2012). Satiation is 
influenced by a series of fine physiological factors comprised in the cephalic phase response 
to eating and including the action of homeostatic and tonic signals from the gastro-intestinal 
tract and adipose tissue as well as the reward signals (Hansen, 2014).  
Food composition and structure can modulate satiation by influencing chewing time and 
individual hedonic value of the food (Blundell & Halford, 1994; De Graaf, Blom, Smeets, 
Stafleu, & Hendriks, 2004). Among food constituents, fats and sugars are positively associated 
with food palatability and overeating (D’Addario et al., 2014; Ifland et al., 2009) whereas 
dietary fibers can increase satiation through their bulking and textural properties thus possibly 
beneficing the control of energy balance (Howarth, Saltzman, & Roberts, 2001; Slavin & 
Green, 2007). This is well documented in short-term studies where reduced appetite feelings 
and energy intake at the meal containing dietary fiber and to that following dietary fiber 
consumption were associated with the amount of fiber consumed and, sometimes, to its 
viscosity (Slavin & Green, 2007). 
However, the reduced palatability of dietary fiber rich foods is often an issue for long-term 
consumption of these products thus failing the possibility to work for weight management 
(Alfieri et al., 1995; Hess, Birkett, Thomas, & Slavin, 2011; Howarth et al., 2001). A better 
understanding of the physiological factors underpinning sensory mechanisms may help to 
develop new foods being both satiating and palatable.  
In this context we have recently demonstrated that tasting of a food (before swallowing) 
influences plasma levels of the endocannabinoids (ECs) - 2-acylglycerol (2-AG) and 
arachidonylethanolamide (AEA) -, of the congeners NAEs - OEA, linoleoylethanolamide 
(LEA) and palmitoylethanolamide (PEA) – and of gut peptides in a manner that is dependent 
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from the individual liking of the tasted food (Mennella, Ferracane, Zucco, Fogliano, & 
Vitaglione, 2015). This finding was in line with the well-known role of gustatory system on 
the cephalic phase of eating and suggested that some mediators could act during mastication 
and elicit the plasma response. 
Post-prandial variation of plasma ECs and NAEs were also reported in the literature with 
different effect on appetite: ECs being mainly associated with an increase and NAEs with a 
decrease of appetite (Hansen, 2014; Nielsen, Petersen, Astrup, & Hansen, 2004). In addition, 
intestinal levels of NAEs and AEA were correlated with the levels of the constituting fatty 
acids (Hansen, 2014). 
Matias et al. (2012) demonstrated that ECs and NAEs are present in human saliva at a 
concentration dependent from people nutritional status: higher is individual body mass index, 
higher is the salivary ECs and NAEs level. Moreover they showed no variation of salivary ECs 
and NAEs concentration one hour after meal consumption. 
In this study the hypothesis that NAEs could be formed in the mouth during food mastication 
and might influence satiation upon eating biscuits with different content and types of dietary 
fiber was tested. Moreover, the appetite sensations and liking of the different biscuits over two 
hours after food consumption was monitored together with salivary NAEs and blood glucose. 
To this purpose, biscuits enriched with 3% gel-forming barley β-glucan (βGB), 3% insoluble 
whole wheat bran (WWBB) and without dietary fiber (CB) were developed and a crossover 
randomised design protocol was performed in healthy normal weight subjects. 
3.2 Materials and methods 
3.2.1 Foods 
Three types of biscuits containing 3.0% barley β-glucan (βGB), 3.0% whole wheat bran 
(WWBB), or without dietary fiber (CB) were developed using a traditional recipe for biscuits. 
All the biscuits were prepared with the following ingredients purchased by local supermarket: 
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flour (Divella, Bari, Italy), sugar (Eridania, Bologna, Italy), margarine (Vallé, Milan, Italy), 
yeast (PaneAngeli, Brescia, Italy). To produce βGB, 3% wheat flour were replaced by a barley 
β-glucan concentrate (GlucagelTM, containing more than 77.5% dietary fiber) purchased from 
DKSH (Miribel Cedex, France); whereas for WWBB, a whole-wheat bran concentrate 
(VITACEL, containing 97% dietary fiber) purchased from ITALI (Reggio Emilia, Italy) was 
used. 
The dough was prepared and after layering, circular biscuits with a diameter of 3.5 cm were 
formed and baked at 190°C for 15 minutes. 
3.2.2 Subjects selection 
The recruitment was performed among the students of the Department of Agricultural Sciences 
of University of Naples, who were interviewed about their medical status, subjective eating 
habits and food preferences (100 recipes, scores from 1 to 9). The selected subjects were 
healthy, they were not undergoing any medication or drug therapy, they usually had breakfast, 
they were not on a restrictive diet and had a normal eating behavior as assessed by the TFEQ 
(Stunkard & Messick, 1985). 
Eligible subjects signed an informed written consent before entering this study. They were 
advised not to vary their physical activity during all the period of the study, always avoiding it 
the day before the experimental days. 
3.2.3 Study design 
The study design and protocol were approved by the Ethics Committee of University of Naples. 
The protocol had a crossover, single blind, randomised design. It was characterised by three 
treatments per each subject that were conducted on separate days with a 1-week washout period 
from each other (Figure 3.1). Each subject participated to three tests and to a training session 
that was performed two days before the first test and was finalized to train subjects on detailed 
procedures to collect saliva samples, to rate their appetite feelings and food liking on VAS 
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questionnaires and to set chewing time and rate for the mastication protocol. The subjects were 
instructed to consume a standardized dinner in the evening before the experimental days within 
the 22:00 h. On the experimental days fasting subjects reached the nutritional laboratory of the 
Department of Agricultural sciences at 08:30 h and after 10 minutes of rest, baseline blood 
glucose was measured and they were asked to collect baseline non-stimulated and mechanically 
stimulated (by parafilm and by food) saliva samples. Immediately after, participants were 
offered a breakfast comprising 150 g of the same type of biscuit they had just masticated and 
were asked to eat biscuits until they felt satisfied within 15 min. A glass of water (125 mL) was 
also offered. The remaining biscuits in subject plates were weighted and energy intake 
consumed was calculated. After breakfast and 15, 30, 60 and 120 min after breakfast, subjects 
were asked to collect saliva for 5 min, and to rate appetite feelings and actual liking of the 
biscuit on VAS questionnaires. Blood glucose at the same time points was also measured.  
 
 
Figure 3.1. Study design 
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3.2.4 Saliva sample collection and preparation for analysis 
Resting drooling was used to collect non-stimulated saliva from the oral cavity. Participants 
were asked to sit comfortably in an upright position, to have their heads down slightly to pool 
saliva in the mouth and to let saliva fall into a pre-labeled sterile container for 5 minutes. 
To collect mechanically stimulated saliva samples, the participants were asked to chew onto a 
piece of inert and tasteless paraffin film (0.29 g; PARAFILM purchased by Sigma-Aldrich, St 
Louis, USA) for 160s at a speed of one mastication per second (every 40s saliva were collected 
as performed with real biscuits, rhythm was given by a metronome) and then expectorate only 
the saliva into a pre-labeled sterile container.  
Once collected both types of sample were immediately placed on ice to minimize degradation 
of components until further processing. Saliva samples were aliquoted in pre-labeled 
Eppendorf tubes (2 mL) and frozen (-40°C) for storage until analysis. Saliva was separated 
from the bolus immediately after collection by centrifuging samples at 4000 rpm/min per 10 
min at 4 °C. Then the supernatant saliva was collected and treated as above. 
3.2.5 Salivary N-acylethanolamines measurement 
NAEs (OEA, LEA, and PEA) were simultaneously quantified in saliva samples prepared as 
described above by LC/MS/MS. Extractions were performed using the solid-phase method. 
Saliva samples (1 mL) were centrifuged at 16000×g for 5 min at 4°C. The supernatants were 
collected and 1 mL were separated in another tube and spiked with 200 μg/mL of AEA-d8 
internal standards. Oasis HLB 1 cc, 30 mg cartridges (Waters) were preconditioned using 1 mL 
methanol and 1 mL H2O under a vacuum manifold. Samples were introduced onto the 
cartridges and drawn under gentle vacuum at a flow rate of approximately 1 mL/min. The 
cartridges were washed with 1 mL 40% aqueous methanol and NAEs were eluted in 1 mL 
acetonitrile. The eluents were dried under a stream of nitrogen before reconstitution in 
acetonitrile/water (50:50 v/v) (100 μL) for HPLC/MS/MS analysis. To estimate the extraction 
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efficiency, peak areas obtained for deuterated internal standards extracted from saliva were 
compared with non-extracted controls in 100 μL acetonitrile:water (50 : 50) (Lam, Marczylo, 
& Konje, 2010).  
The analysis was performed using an HPLC apparatus equipped with two micropumps Perkin-
Elmer series 200 (Norwalk, CT, USA). A Synergi Max RP 80 column, 50 × 2.1 mm 
(Phenomenex, USA) was used with flow rate set to 0.2 mL/min. Injection volume was 20 µL, 
as well as mobile phases and the gradient program were the same as reported by Lam et al. 
(2010). MS/MS analyses were performed by an API 3000 triple quadrupole mass spectrometer 
(Applied Biosystems, Canada) equipped with a TurboIonSpray source. The acquisition was 
carried out in Multiple Reaction Monitoring (MRM) in positive ion mode for each compound. 
Data acquisition and processing were performed using Analyst software v. 1.4. Acquisition 
parameters (Mennella, Savarese, Ferracane, Sacchi, & Vitaglione, 2015).  
3.2.6 Appetite and food liking questionnaires 
In the appetite VAS questionnaires, three main questions (‘How satiated do you feel?’, ‘How 
full do you feel?’ and ‘How hungry do you feel?’) were asked and subjects indicated “satiety”, 
“fullness” and “hunger” on 100 mm VAS, anchored to a minimum on the left as “not at all” 
and a maximum on the right as “extremely”, the point corresponding to their sensations (Green, 
Delargy, Joanes, & Blundell, 1997).  
Similarly, in the food liking VAS subjects were asked to evaluate the hedonic value for 
sweetness, salty, fatty perception, consistency and overall palatability of the biscuit they had 
for breakfast (‘How do you like for sweetness?’, ‘How do you like for saltiness?, ‘How do you 
like for fatness?’, ‘How do you like for consistency?’ and ‘How do you like for overall 
palatability?’). 
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3.2.7 Blood and salivary glucose  
Blood glucose by finger pricking and using a bedside glucometer (One Touch Ultra Easy; 
LifeScan Inc., Milpitas, CA) was measured. Accuracy of the glucometer has been evaluated by 
the manufacturer using least-squares linear regression analysis and found to be 97% “clinically 
accurate” when compared with reference (YSI2700) results. 
Salivary sugar concentration was measured using the same glucometer as previously reported 
(Neyraud, Prinz, & Dransfield, 2003). One sensor strip for each saliva sample (10 μL) was 
used. 
3.2.8 Statistical analysis 
Results were expressed as means ± SEM. Statistical analyses were performed with the 
statistical package SPSS for Windows (version 16). The biochemical analyses were analysed 
and expressed as the absolute variations from the baseline to eliminate the possible effects of 
inter-subject fasting variability. The total AUC for hunger, fullness and satiety (from baseline 
over 2 h from breakfast consumption) were estimated using the linear trapezoidal rule. 
Kolmogorov-Smirnov and Shapiro tests as well as Levene’s test were used to evaluate the 
normality of distribution and the homogeneity of variance of all monitored variables, 
respectively. Logarithmic transformation was applied to non normally distributed data. 
Differences of subjective appetite and food liking recorded after the consumption of the three 
types of biscuit and the response curves of salivary glucose and NAEs were tested by ANOVA 
for repeated measures in combination with Bonferroni test; p < 0.05 was considered statistically 
significant; p < 0.1 was considered as a trend. 
Pearson correlation coefficients were calculated to assess bivariate associations between data 
sets (p<0.05 was considered significant). 
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3.3 Results  
3.3.1 Foods 
The nutritional compositions of the three types of biscuit are reported in Table 1. 
They differed only for the content and type of dietary fiber being the soluble and gel-forming 
barley β-glucan or the insoluble whole-wheat bran.    
Table 3.1: Nutritional composition of 100 g biscuits. CB: control biscuits; βGB: β-glucan 
biscuits; WWBB: whole wheat bran biscuits. 
 
  CB βGB WWBB 
Energy (kcal) 419 395 396 
Protein (g) 6.5 6.0 6.0 
Fat (g) 8.5 8.3 8.2 
Carbohydrate (g) 79 74 74 
β-glucan (g) 0 3.0 0 
Whole-wheat bran (g) 0 0 3.0 
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3.3.2 Subjects 
Eighteen volunteers (7 M/11 F), with mean age of 27 ± 1 years (range 20 – 37) and with mean 
body mass index (BMI) of 23.3 ± 0.58 kg/m2 (range 19.5-28.0 kg/m2), participated in this study. 
Among them, 5 subjects were overweight with BMI ≥ 25 kg/m2. 
3.3.3 Salivary NAEs upon mastication  
The concentration of NAEs in saliva samples collected upon mastication is reported in Figure 
3.2.  
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Figure 3.2. Concentration of salivary NAEs from fasting subjects at baseline (resting 
condition) and upon mastication of parafilm or control biscuits (CB), barley β-glucan-
enriched biscuits (βGB) or whole wheat bran–enriched biscuits (WWBB). Different letters on 
the bars indicate p<0.05
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The concentrations of OEA and LEA in saliva samples collected upon food mastication were 
significantly higher than in non-stimulated (baseline) and parafilm-stimulated saliva samples, 
whereas no difference between the last two was found. No differences nor trends were found 
for salivary PEA between samples. 
3.3.4 Salivary glucose upon mastication  
Concentration of salivary glucose in baseline and non-stimulated saliva samples was below 20 
mg/dL. It was significantly different from glucose concentration of food-stimulated saliva 
being about 303.7 mg/dL. No significant difference between salivary glucose released upon 
different food mastication was found because it was 374.3 ± 44.7 mg/dL upon βGB, 282.3 ± 
20.9 mg/dL upon WWBB and 261.9 ± 31.1 mg/dL upon CB (p > 0.05).  
Interestingly, significant positive correlations between the concentrations of OEA and glucose 
in saliva from chewed CB (R2=0.682; p=0.015) and WWBB (R2=0.742; p=0.002) and a 
tendency towards a negative correlation in saliva from βGB (R2=-0.403; p=0.154) were found.  
3.3.5 Food intake  
No significant different food intake was recorded upon the three food conditions as energy 
intake at breakfast was 282 ± 40 kcal, 313 ± 33 kcal and 307 ± 40 kcal when subjects were 
offered βGB, CB and WWBB, respectively. 
3.3.6 Postprandial salivary NAEs 
The variation from baseline of salivary NAEs concentration over 2 hours following biscuit 
consumption and the AUC of each NAE are reported in Figure 3.3. 
Salivary concentration of all NAEs, except PEA following βGB, peaked at 15 minutes post-
breakfast compared to baseline, this increase being significant for OEA after all types of 
biscuits and for LEA only after WWBB. From 15 min to 60 min, a general trend towards 
reduction of mean concentrations following consumption of all three types of biscuit was 
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found. At 60 min, concentrations of LEA and OEA returned to the baseline values (Figure 
3.3). 
Fifteen minutes after the consumption of βGB lower concentrations of OEA (p = 0.017), LEA 
(p = 0.001) and PEA (p = 0.038) than after WWBB were observed. The AUCs of NAEs did 
not significantly change after the consumption of the different biscuits (although the mean 
magnitude was always in the order WWBB > CB > βGB) (Figure 3.3). 
 
 
 
Figure 3.3. Concentration-time curves and AUC (0-120) of postprandial salivary NAEs. 
*, +, #p < 
0.05 vs baseline. 
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3.3.7 Postprandial appetite and food liking 
Table 3.2 shows mean appetite and food liking scores recorded over the 2 hours post-breakfast. 
Data showed no effect of the types of biscuit on postprandial appetite sensations as well as on 
liking of biscuits for sweetness, salty, fat perception, consistency and overall palatability. 
Interestingly, fullness and satiety sensations positively correlated with salivary OEA 
concentration at 30 min post breakfast (R=0.424; p=0.031 and R = 0.451; p=0.021, 
respectively).  
In addition, an inverse correlation between liking of biscuits for sweetness and salivary OEA 
concentration at 15 min (R = -0.55; p = 0.002) was found. 
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Table 3.2: Appetite and food liking scores (means ± SEM) collected over 120 min after consumption of the three types of biscuits (CB: control 
biscuits; βGB: β-glucan biscuits; WWBB: whole wheat bran biscuits). 
 
 Baseline 15 min 30 min 60 min 120 min 
 CB βGB WWBB CB βGB WWBB CB βGB WWBB CB βGB WWBB CB βGB WWBB 
Appetite                
Hunger 70±7 57±6 52±8 25±4 22±5 17±3 38±7 29±4 24±4 45±6 34±5 28±4 60±7 64±6 57±5 
Fullness 24±7 29±7 36±8 53±7 66±6 59±8 60±6 54±6 57±7 51±6 48±6 48±6 30±6 28±6 30±5 
Satiety 29±8 32±7 28±7 50±6 66±5 49±7 51±7 56±6 50±7 49±6 46±5 45±7 32±5 27±6 29±6 
Liking                
Sweetness 49±6 44±7 48±5 44±7 42±6 38±6 43±6 41±6 34±5 40±7 38±6 33±5 38±7 35±6 33±6 
Saltiness 31±5 26±6 37±8 24±5 26±6 28±6 26±5 26±5 30±6 25±5 23±4 32±6 30±6 22±4 31±6 
Fatness 40±7 36±7 34±8 36±7 34±7 29±6 32±7 26±6 33±7 36±7 28±6 29±7 34±7 26±5 30±7 
Consistency 33±7 30±6 28±6 24±5 26±5 24±5 27±6 24±5 28±6 24±5 30±5 28±6 27±5 31±5 24±5 
Overall palatability 39±6 43±6 39±6 37±7 33±5 37±5 40±6 36±4 39±6 38±6 39±5 39±6 40±7 46±6 33±4 
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3.3.8 Blood glucose response 
Blood glucose concentration peaked at 15 min after βGB and CB, and at 30 min after WWBB 
consumption (Figure 3.4). In particular, considering concentration values measured at peak 
point, a mean concentration of 133 ± 8 mg/dL vs a mean baseline value of 93 ± 5 mg/dL was 
found when βGB was consumed, while concentrations of 136 ± 6 mg/dL vs 93 ± 3 mg/dL, and 
143 ± 6 mg/dL vs 93 ± 2 mg/dL, respectively, were elicited by WWBB and CB.  
The AUC of blood glucose was 13835 ± 546 mg min/dL, 14231 ± 604 mg min/dL and 13824 
± 372 mg min/dL after βGB, WWBB and CB, respectively and no significant difference among 
the types of biscuit was found (glycaemia × treatment interaction; p > 0.05). Pearson’s analysis 
showed a negative correlation between salivary OEA concentration and blood glucose at 30 
min (-0.480, p = 0.044) and a tendency at 15 min (-0.456, p = 0.066).   
 
 
 
Figure 3.4. Concentrations of blood glucose (Means ± SEM) over 2h following consumption 
of CB, βGB or WWBB. 
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3.4. Discussion 
For the first time in this study, the concentration of NAEs was measured in stimulated saliva 
samples and it was demonstrated that mastication itself did not cause variation of these 
compounds compared to baseline resting saliva in healthy normal weight subjects. Indeed the 
salivary concentrations of all NAEs meanly increased in saliva only upon food mastication, 
independently from the type of biscuit, compared to non-food (parafilm) condition mastication. 
In particular data showed that only OEA and LEA significantly increased upon all biscuits 
mastication, OEA increasing  more (~138 folds) than LEA (~7 folds) and PEA (~2 folds).  
These findings strongly suggested that NAEs directly derived from the food. So, in attempt to 
demonstrate this hypothesis biscuits were analysed for NAEs content and data showed that all 
NAEs were present in the 3 types of biscuit with mean concentrations of OEA of 14.0 nmol/g, 
LEA 1.2 nmol/g and PEA 0.1 nmol/g. Moreover OEA and LEA were in CB at a double 
concentration compared to βGB and WWBB whereas PEA was at a similar concentration in 
all the biscuits.  
The presence of NAEs in the biscuits was in line with previous literature reporting that NAEs 
can be endogenously formed in the intestine (Artmann et al., 2008; Hansen & Diep, 2009; 
Hansen, 2014; Petersen et al., 2006; Sarro-Ramirez, 2013), brain (Artmann et al., 2008; 
Hansen, 2014; Simon & Cravatt, 2010; Tsuboi et al., 2013), liver (Artmann et al., 2008) and 
other mammalian tissues (Hansen & Diep, 2009; Hansen, 2014), and they are also largely 
diffused, together with their natural precursors NAPEs, in both plant and animal kingdoms 
being found in plants, yeast, slime molds, insects, and mammals (Coulon, Faure, Salmon, 
Wattelet, & Bessoule, 2012; Fezza et al., 2003; Hansen & Diep, 2009; Hansen, 2014; Hayes, 
Stupak, Li, & Cox, 2013; Muccioli, Sia, Muchowski, & Stella, 2009; Bomstein, 1965). 
However, we could not exclude that some NAEs could also come from the biotransformation 
of their NAPE precursors during mastication upon the action in the mouth of NAPE-PLD 
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(Matias et al., 2012). Future studies should verify this hypothesis. 
The lacking differences of salivary OEA and LEA upon mastication of different types of 
biscuits, although a double concentration of these NAEs was found in CB compared to βGB 
and WWBB, suggested that the oral factors and processes that might underpin the release of 
NAEs from the biscuits and their persistence in the mouth could be majorly influenced from 
the chewing time and speed (that was fixed in the present study) compared to other factors such 
as the amplitude of muscular activity or non-chewing processes such as the tongue movement 
(Yven et al., 2012). In this respect, the fixed rate of bites and time during mastication protocol 
could be considered as a limitation of the study because it did not allow us to evaluate whether 
normal chewing behavior of subjects could led to salivary concentrations of NAEs more closely 
mirroring their content in the biscuits.  
A further study specifically focused on the mechanisms and individual factors behind the 
formation and fate of salivary NAEs with freely chewing subjects should be performed.  
However, the chewing speed and time in the mastication protocol was established on the basis 
of a preliminary experiment conducted in the training session (data not shown) where 
participants’ behavior and possibility to chew the biscuits and spit the chewed food without 
swallowing were evaluated. In other words, the mastication protocol was tailored on the 
participants and the best conditions to collect all chewed food avoiding any loss due to 
unwanted swallowing were used. 
So, it was assumed that individual way of eating biscuits during the protocol to assess satiation 
at breakfast was similar to that adopted during mastication protocol and caused similar 
concentrations of NAEs in the food boluses that were ingested. Data showed that no effects of 
the different types of biscuits on satiation was present. This feature was in line with the similar 
palatability showed by the three types of biscuit and could be addressed to the level of dietary 
fiber enrichment of the biscuits thus indicating that a 3% increase of a viscous or insoluble 
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dietary fiber in a bakery food product did not create the physiological conditions responsible 
for a sooner meal termination in normal weight and fasting subjects (Howarth et al., 2001; 
Burton-Freeman, 2000). Interestingly, the types of dietary fibers in the biscuits influenced 
immediate post-prandial salivary concentration of NAEs.  
To the best of our knowledge no one before us studied saliva composition in the immediate 
post-prandial phase. Matias and co-workers (2012) collected saliva after 1h from meal 
consumption and demonstrated that ECs and NAEs (AEA, 2-AG, OEA and PEA) did not 
change in the post-prandial compared to the pre-prandial phase. On the contrary, data of the 
present study clearly showed that in the immediate post-prandial phase NAEs formed from the 
food during mastication was still present in the mouth and did not reduce equally after eating 
the different types of biscuits. In particular, a faster and dramatic decrease of all salivary NAEs 
after βGB consumption than CB or WWBB was observed. This finding might depend from the 
physical properties of the βGB bolus. In fact, it could be hypothesised that the βGB bolus, 
thanks to its content of barley β-glucan having a gel-forming capacity and binding ability 
(Hughes & Swanson, 1989; Mudgil & Barak, 2013), could better entrap compounds and let the 
mouth free from NAEs upon swallowing determining a better effect of mouth cleaning 
compared to WWBB and CB. This hypothesis well fits with the food origin of salivary NAEs 
and it is in accordance with the recommendation to study saliva composition by avoiding eating 
just before the collection because residues of foods present in the mouth can influence results 
(Kaufman & Lamster, 2002; Yoshizawa et al., 2013). However, it should be noticed that 
together with biscuits, participants drank a glass of water that caused a rinsing of their mouths 
as evidenced by the fact that the post-prandial saliva samples appeared free from food residues 
at all the time points. Another hypothesis might be that even small β-glucan residue in the 
mouth after βGB swallowing might differently influence the activity of oral NAPE-PLD or 
FAAH, the enzyme degrading NAEs (Matias et al., 2012), compared to WWBB and CB, and 
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this effect could be evident in presence of few food residue that might remain in the mouths 
even after drinking.  
Further studies should test these hypotheses and clarify the mechanisms behind the present 
findings.  
Worth of notice were the positive associations found between post-prandial salivary OEA with 
fullness and satiety sensations as well as the inverse associations with liking of biscuits for 
sweetness. From these findings it could be speculated that the increase of OEA in saliva during 
eating and in the immediate post-prandial phase might have modulated anandamide (AEA) 
concentration in saliva. Indeed OEA was shown to reduce AEA degradation by substrate 
competition for FAAH (Maurelli et al., 1995; Jonsson et al., 2001). Survival of AEA could in 
turn selectively enhance sweet taste, and consequent liking of biscuits for sweetness, as 
previously demonstrated in rats (Yoshida et al., 2010). In general those associations also 
suggested that salivary OEA may be implicated in the sensory mechanisms occurring in the 
post-ingestive phase and influencing the flavor-consequence learning that underpin individual 
food preference and choice (Yeomans, 2006). In this study fasting subjects were asked to eat 
the biscuits until they felt comfortably satisfied and no other food was available. However, in 
a normal life condition it may also be possible that the salivary OEA may have a role on the 
amount or type of foods people can eat when exposed to different food cues, as it happens for 
example in a buffet-style meal.  
Appropriate studies should be performed to test these hypotheses. 
Finally, in this study no effect of βGB consumption on the postprandial blood glucose was 
found compared to WWBB and CB. The amount of biscuits eaten by subjects (75g on average) 
could explain this result. In fact considering the amount of biscuits consumed and the 3% 
enrichment with the dietary fiber, βGB provided 2g of barley β-glucans corresponding to a 
3.9% of the dietary fiber by available carbohydrates. In these conditions the lacking effect of 
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βGB in modulation of blood glucose was in line with a previous study from our research group 
showing that a meal providing 3g of barley β-glucans (2.3% by available carbohydrates) did 
not influence blood glucose response compared to the control meal (Barone Lumaga, Azzali, 
Fogliano, Scalfi, & Vitaglione, 2012). On the contrary meals providing 3g of barley β-glucans 
(5.2% by available carbohydrates) (Vitaglione, Lumaga, Stanzione, Scalfi, & Fogliano, 2009) 
or 6.2g - 7.3g β-glucans (12.4% or 14.6% by available carbohydrates) (Jenkins, Jenkins, 
Zdravkovic, Würsch, & Vuksan, 2002) showed the hypoglycaemic effect of the barley β-
glucans-enriched meal compared to the control.  
3.5. Conclusions 
Data of this study clearly demonstrated that no salivary response of NAEs is elicited by 
mastication itself in healthy and normal weight subjects but NAEs can be originated in the 
mouth from foods upon mastication. Enrichment of biscuits with a 3% dietary fiber did not 
influence NAEs released in the mouth upon mastication as well as the biscuits-induced satiation 
in fasting subjects. However, the types of dietary fiber (gel-forming or insoluble) influenced 
the concentration of these compounds in the mouth within the first hour from food 
consumption. The associations found between salivary OEA concentration in the immediate 
post-prandial phase and actual liking of the biscuits consumed as well as fullness and satiety 
sensations suggested some role of OEA in the sensory mechanisms underpinning food behavior 
and choice. Further studies are warranted to clarify the mechanisms and the individual factors 
underpinning NAEs release in the mouth upon eating different types of foods from different 
types of subjects. 
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3.6 Abbreviations 
 
βGB: β-glucan biscuits; WWBB: Whole-wheat bran biscuits; CT: Control biscuits; NAEs: N-
acylethanolamines; OEA: Oleoylethanolamide; LEA: Linoleoylethanolamide; PEA: 
Palmitoylethanolamide; ECs: Endocannabinoids; 2-AG: 2-acylglycerol; AEA: 
Arachidonylethanolamide; TFEQ: Three Factor Eating Questionnaire; LC/MS/MS: Liquid 
chromatography tandem mass spectrometry; AUC: Area under the curve; 
ANOVA: Analysis of variance; NAPEs: N-acylphosphatidylethanolamines; 
NAPE-PLD: N-acylphosphatidylethanolamine-phospholipase D. 
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Abstract 
N-acylphosphatidylethanolamines (NAPEs) and N-acylethanolamines (NAEs) are bioactive 
compounds present in human saliva at concentrations depending from individual nutritional 
status. Recent evidence shows that their concentration in saliva increase upon food mastication 
and persist depending from the food matrix. 
The objective of this study was to evaluate the influence of individual nutritional status on the 
salivary NAPEs/NAEs upon mastication of biscuits prepared with different fats. Three types 
of biscuits were prepared with 8% of extravirgin olive oil (EVOB), 8% of palm oil (PALMB) 
and without added fat (CONB) and a cross-over modified sham feeding protocol was carried 
out in 25 (12 normalweight, NW, and 13 obese, OB) subjects. Unstimulated (US) and 
stimulated (by a parafilm piece, SS, and by the three biscuits) saliva samples were collected 
and analysed by LC-HRMS to assess NAPEs and NAEs concentrations.  
Salivary NAPEs concentration was higher in US from OB than from NW (0.28±0.05 µg/mL 
vs 0.12±0.02µg/mL), whereas NAEs concentration in both US and SS was higher in OB than 
in NW (10.82±1.41 ng/mL vs 4.82±0.19 ng/mL for US; 6.15±0.79 ng/mL vs 3.79±0.43 ng/mL 
for SS). 
In comparison with SS, concentrations of NAPEs and NAEs (but not PEA) always increased 
in saliva upon biscuit mastication at a higher extent in NW than in OB. Mastication of EVOB, 
determined in OB 2.2 folds higher salivary NAPEs than in NW, whereas CONB and PALMB 
determined in NW a 4.3 and 1.6 folds higher increase of NAEs than in OB, respectively. 
 
Keywords: saliva, NAEs, NAPEs, Body Mass Index, mastication. 
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4.1 Introduction 
Mastication is the first step of digestion preparing the food to be swallowed and the 
gastrointestinal tract to efficiently digest and absorb nutrients. During mastication saliva allows 
the humidification of the food matrix, the dissolution of nutrients and their contact with sensory 
receptors in the mouth as well as the initiation of lipid and starch breakdown through the action 
of endogenous enzymes  such as  lipase and α-amylase, respectively (Spielmann & Wong, 
2011; Chen, 2009; Yoshizawa et al., 2013).  
Saliva is produced by major and minor salivary glands. The major glands are the parotid, 
submandibular and sublingual which produce >90% of the total volume of saliva, while the 
minor glands are present in the oral mucosa at lower lip, tongue, palate, cheeks and pharynx. 
Stimulated saliva (SS) is secreted by the parotid gland upon mastication, while unstimulated 
saliva (US) is secreted by both the submandibular and sublingual glands even in absence of 
mastication. SS has higher protein content and lower viscosity than US (Mosca & Chen, 2017). 
Among other constituents such as proteins, enzymes, mucins, nitrogen compounds, 
electrolytes, saliva contains N-acylethanolamines (NAEs). They are bioactive lipid compounds 
present in small concentrations in animals, plants, bacteria and yeasts. They are involved in 
different physiological processes (Coulon et al., 2012) such as the regulation of feeding 
behaviour, lipid metabolism, pain regulation system (Hansen, 2014; Witkamp, 2018).  
The concentration of NAEs in human saliva from fasting subjects was associated with 
individual nutritional status because higher levels were present in obese (OB) than in normal 
weight (NW) subjects (Matias et al., 2012). However, we demonstrated that NAEs in saliva 
could also derive from foods upon mastication with concentrations depending from food type 
and composition (Kong et al., 2016; Mennella et al., 2018). That evidence was in line with 
recent findings that NAEs and ECs are present in many food products at concentrations ranging 
between 0.1-0.7 µg/g d.w. vs 0-35 µg/g d.w. for NAEs and 0-34 µg/g d.w. vs 0-0.2µg/g d.w. 
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for ECs in animal vs vegetal products, respectively (De Luca et al., 2018-submitted to Food 
Chemistry). Strikingly N-acyl-phosphatidylethanolamines (NAPEs) were even 100 times 
higher than NAEs in foods. Thus, considering that N-acylphosphatidylethanolamines (NAPEs) 
are known precursors of NAEs through the action of NAPE-specific phospholipase D (NAPE-
PLD) and this enzyme is also expressed in salivary glands (Hansen, 2014, Coulon et al., 2012; 
Matias et al., 2012) we hypothesised that food is a source of NAEs continuously forming along 
the gastro-intestinal tract and possibly interacting with local receptors that has been highly 
underestimated until now. 
Indeed, NAEs can interact with several types of receptors such as a G-protein-coupled receptor 
GPR119 (Janssen & Depoorter, 2013; Izzo & Sharkey, 2010), lining on the mucosa of the small 
intestine, colon and stomach, and influencing food intake as well as insulin secretion in the 
presence of glucose (Borrelli & Izzo, 2009; Coulon et al., 2012; Spreckley and Murphy, 2015). 
Moreover, in the area under the gastro-intestinal mucosa NAEs could also interact with 
cannabinoid receptors type 1 (CB1) and type 2 (CB2), transient receptor potential vanilloid 
type 1 (TRPV1) and peroxisome proliferator-activated receptor-α (PPAR-α) (Borrelli et al., 
2015; Izzo & Sharkey, 2010). 
In this frame, the objective of this study was to evaluate the influence of individual nutritional 
status on the salivary NAPEs and NAEs upon mastication of biscuits with a different fat 
composition. For this purpose three model of biscuits prepared with 8% of extra-virgin olive 
oil, 8% of palm oil and without fats were developed and a cross-over modified sham feeding 
protocol was carried out. Saliva samples were collected and analysed by LC-HRMS-analysis. 
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4.2 Materials and methods 
4.2.1 Foods 
Three types of biscuits were developed using a traditional recipe (Kong et al., 2016) and 
differing for the type and amount of fats.  
The biscuits were prepared with the following ingredients that were purchased by local 
supermarket: flour (Divella, Bari, Italy), extravirgin olive oil (Monini, Spoleto,PG, Italy), palm 
oil (Italy), paraffin oil (FaDem, Naples, Italy), sugar (Eridania, Italy) and yeast (Pane Angeli, 
Brescia, Italy).  
The recipe of the biscuits included 55% flour, 17.5% sugar, 18.75% oil, 21.5% water, 0.5% 
yeast. 
All biscuits were formed with a diameter of 3.5 cm and were baked at 190°C for 15 minutes in 
a forced-air circulation oven. 
4.2.2 Subjects selection 
Twenty five healthy subjects were selected among students and staff of Department of 
Agriculture of University of Naples. They were not undergoing any medication or drug therapy 
or presenting diseases.  
The participants were divided into two groups depending on their body mass index (BMI): 
ormal weight (NW; BMI<25 kg/m2) and obese (OB; BMI>30 Kg/m2) subjects. The eating 
behaviour was assessed for the Restraint, Disinhibition, and Hunger factors using the Three 
Factor Eating Questionnaire (TFEQ) as described by Stunkard & Messick (1985). The 
preference and the consumption of high fat foods was assessed by the Fat Preference 
Questionnaire (FPQ) as reported by Ledikwe et al. (2007) to adapt to an Italian population. 
The Power of Food Scale (PFS) was used in order to assess the psychological impact of living 
in food-abundant environments (Lowe et al., 2009). 
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All experimental procedures were approved by the Ethics Committee of the University of 
Naples. 
4.2.3 Study design 
The study was conducted at the Department of Agricultural Sciences of the University of 
Naples. It was a randomised, crossover study. The experimental tests consisted in three 
treatments performed by each subject on two separate days with one week in between. On the 
experimental days, subjects were instructed not to eat, not to drink beverages (except water) 
and not to smoke two hours before the test, and were asked to clean their teeth no later than 
one hour before the outset of the study.  
Figure 4.1 shows the study design. 
 
 
 
Figure 4.1. Study design 
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4.2.4 Saliva sample collection and preparation for analysis 
Resting drooling was used to collect US from the oral cavity. Participants were asked to sit 
comfortably in an upright position, to have their heads slightly bent forward in order to pool 
saliva in the mouth and to let saliva fall into a pre-labeled sterile container for 10 minutes. 
Then, after drinking some water the subjects were asked to collect SS by chewing a piece of 
paraffin film (0.29 g; PARAFILM purchased by Sigma-Aldrich, USA) and expectorating the 
accumulated saliva every 40 sec into sterile tubes for 160 sec. Subsequently with applying the 
same procedure by replacing parafilm with biscuits, subjects collected the bolus (chewed 
biscuit).  
After collection each type of saliva sample was aliquoted in pre-labeled Eppendorf tubes (2 
mL) and frozen (-40°C) for storage until analysis. Bolus samples were centrifuged 4000 
rpm/min for 10 min at 4°C and supernatants were stored like US and SS samples for further 
analysis. 
The flow of US and SS was calculated by subtracting the weight of the tube filled with saliva 
to the weight of the empty tube, divided by collection time and it was expressed as mL/min 
(Agha–Hosseini et al., 2010). 
4.2.5 Determination of salivary NAPEs and NAEs 
To the saliva samples (500 µL) were added 25 µL of 2 µg/mL of Arachidonoyl Ethanolamide-
d8 (AEA-d8) (Cayman Chemical, Ann Arbor, MI) as internal standard and extracted with 4.5 
mL of a solution of CHCl3/CH3OH (2:1). After 30 seconds of shaking, the mixture was 
centrifuged at 14800 rpm for 10 minutes at 10 °C.  
The organic phase was dried under nitrogen stream and the dried extract was dissolved in 500 
µL of C2H3N/C3H8O/H2O (65:30:5) immediately before the LC-HRMS analysis. 
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4.2.6 Determination of NAPEs and NAEs in biscuits 
To the biscuit (100 mg) was added 25 µL of the internal standard 2 µg/mL solution of 
arachidonoylethanolamide d8 (AEA d8) (Cayman Chemical, Ann Arbor, MI). 4.5 mL of a 
solution of CHCl3/CH3OH (2:1) was used for the extraction. After 30 seconds of shaking, the 
mixture was centrifuged at 14800 rpm for 10 minutes at 10 °C.  
The supernatants were collected in a glass tube and dried under a nitrogen flow. The extract 
was suspended in a solution of C2H3N/C3H8O/H2O (65:30:5) before the HRMS analysis (De 
Luca et al., 2018 submitted Food Chemistry). 
4.2.7 Liquid Chromatography – High Resolution Mass Spectrometry (LC-HRMS) analysis 
LC-HRMS analysis was adapted from Gregory et al. (2012). Data were acquired on an Accela 
U-HPLC system coupled to an Exactive mass spectrometer (Thermo Fisher Scientific, San 
Jose, CA). The Accela system consisted of a quaternary pump, a thermostated autosampler (10 
°C) and a column oven. A Kinetex 2.6 μ C18 100 A column (100 mm × 2.1 mm) (Phenomenex, 
Torrance, CA) thermostated at 45 °C was used. The methods and the parameters were the same 
used by De Luca et al. (2018) (submitted Food Chemistry).  
N-Arachidonoylphosphatidylethanolamine standard was purchased from Santa Cruz 
Biotechnology (Santa Cruz Biotechnology, Inc., USA).  
The concentrations of different NAPEs were quantified as N-
Arachidonoylphosphatidylethanolamine equivalents by using the external calibration curve 
with the linear range (0.2-5µg/ml) and expressed as µg per mL of saliva. 
NAEs (oleoylethanolamide, OEA; linoleoylethanolamide, LEA; palmitoylethanolamide, PEA) 
standards were purchased from Cayman (Cayman Chemical, Ann Arbor, MI). The 
concentrations were calculated by isotope dilution using calibration curve with the linear range 
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(1-1000 ng/ml) and expressed as ng per mL of saliva. In the chromatographic region between 
19-23 min the NAPEs were detected in negative mode as [M-H]- . 
In the chromatographic region between 6-9 min the NAEs were detected in positive mode as 
[M+H]+. 
The identification of compounds was performed by using the exact mass values up to the fifth 
decimal digit with a ± 5 ppm mass tolerance. 
4.2.8 NAPEs identification in food matrix 
Chromatographic separation was performed using a HPLC apparatus equipped with two 
Micropumps Series 200 (PerkinElmer, Shellton, CT, USA). 
The chromatographic conditions used for the analysis were the same as described above. 
Mass spectrometry analyses were performed on an API 3000 triple quadrupole mass 
spectrometer (Applied Biosystems, Canada) equipped with a TurboIonSpray source working 
in the negative ion mode. Acquisition was performed in scan in the range m/z 120-1200 and in 
MRM (Multiple Reaction Monitoring). 
4.2.9 Salivary lipase activity by spectrophotometric assay 
Lipase activity was measured by the method described by Mennella et al. (2014). Into 1.5 mL 
centrifuge tubes 0.1 mL saliva was mixed with 1 mL of 100 mM Tris–HCl buffer (pH 8.3) 
containing 0.3 mM 5-5′-dithio-bis (2-nitrobenzoic acid) (DTNB). Then 20 μL of 
phenylmethylsulfonyl fluoride (PMSF) 20 mM in ethanol was added as a non-specific esterase 
inhibitor and tubes were incubated for 5 min at 37 °C. The ability of 0.4 mM PMSF to inhibit 
salivary esterases, without modifying lipase activity as described by Kurooka et al. (1977) was 
demonstrated during the set-up of the assay. Finally, 0.1 mL of 20 mM 2,3-dimercapto-1-
propanol tributyrate in ethanol was added and samples were incubated for 60 min at 37 °C. 
Salivary lipase released 2,3-dimercapto-1-propanol that reacted with DTNB to release TNB 
anions. Tubes were then centrifuged at 14800 rpm for 10 min at 4°C and the absorbance at 412 
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nm was measured. Colour intensity was proportional to the lipase activity that was quantified 
in saliva samples using a specific calibration curve. It was done using triacylglycerol lipase 
from Aspergillus niger (200 U/g, purchased by Sigma, St. Louis, MO, USA) as a standard. A 
mother solution of 1 U/mL was prepared dissolving the powder in Tris–HCl buffer (pH 8.3) 
and consecutive dilutions were carried out to obtain a curve ranging from 9.375 to 150 U/L.  
4.2.10 Statistical analysis 
By considering inter-individual variations for salivary NAEs and ECs found in our previous 
works (Kong et al., 2016; Mennella et al., 2018), we calculated that a sample size of 12 subjects 
was sufficient to detect 40% variations of salivary NAEs with an 80% power and an α = 0.05.  
Statistical analysis was performed using IBM SPSS Statistics version 20 (IBM Corporation, 
Armonk, New York, USA).  
Kolmogorov-Smimov and Shapiro tests, as well as Levene's test were used to evaluate the 
normality of distribution and the homogeneity of variance of all monitored variables, 
respectively. Logarithmic transformation was applied to non-normally distributed data and 
mean values were compared through non-parametric Mann-Whitney U test, since normal 
distribution was not observed.  
For correlation analysis, Pearson’s was used when appropriate, p values less than 0.05 indicate 
statistical significance. 
Statistical significance was defined as p<0.05 and results were expressed as means ± standard 
error of means (SEM). 
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4.3 Results 
 
4.3.1 General and psychometric characteristics of subjects 
The general and psychometric characteristics of subjects are reported in Table 4.1.  
Table 4.1. Characteristic of participants. Asterisk indicates p<0.05 for OB vs NW. 
 NW (mean±SD) OB (mean±SD) P-values 
Number (n) 12 13  
Women 9 8  
Men 3 5  
Age (years)  30.4±8.7 35.5±10.7 p=0.318 
BMI (kg/m2) 22.4±2.2 32.6±3.6* p=0.000 
Unstimulated Saliva Flow 
Rate (mL/min) 
0.6±0.4 0.4±0.2 p=0.828 
Stimulated Saliva Flow 
Rate (mL/min) 
2.0±1.2 1.9±0.8 p=0.807 
Lipase (U/L) 13.02±1.2 18.5±2.0 p=0.04 
TFEQ    
Dietary restraint (score) 6.8±1.0 10.7±1.3* p=0.032 
Disinhibition (score) 5.1±0.5 7.6±0.9* p=0.020 
Hunger (score) 2.2±0.6 4.5±1.1 p=0.209 
PFS    
Food Available (score) 12.6±1.4 14.0±1.5 p=0.498 
Food Present (score) 11.0±0.2 12.1±1.2 p=0.540 
Food Taste (score) 13.2±0.8 13.6±1.5 p=0.796 
FAT PREFERENCE 
 
   
Taste (%) 65.0±4.3 56.4±4.7 p=0.192 
Frequency (%) 44.5±3.9 40.5±4.57 p=0.519 
Difference (%) 24.3±4.8 19.8±4.2 p=0.480 
 
As expected OB had higher BMI and lipase activity than NW. No difference between NW and 
OB for the taste preference and frequency of consumption of high fat foods compared to the 
low fat counterparts were found through FPQ.  
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Similarly, no differences emerged between NW and OB subjects for the appetite for palatable 
foods at three levels of food proximity (food available, food present, and food tasted) as 
assessed by PFS questionnaire (Lowe et al., 2009).  
TFEQ showed that OB were more restrained than NW (10.7±1.32 vs 6.83±1.03, p=0.032) and 
less disinhibited (5.08±0.5 vs 7.62±0.86, p=0.020). 
No difference was found for the salivary flow between the two groups of subjects. 
4.3.2 Foods 
Table 4.2 shows the nutritional composition of the three types of biscuit. The only difference 
between biscuits was the type of fat or fat replacer used in the recipe: extravirgin olive oil, palm 
oil and paraffin oil. 
Table 4.2. Nutritional composition of 100 g biscuits. CONB: control biscuits; EVOB: Evoo 
biscuits and PALMB: palm biscuits. 
 
 CONB  EVOB PALMB 
Energy (Kcal) 344 435 443 
Protein (g) 7 7 7 
Carbohydrate (g) 79 79 79 
Fat (g) 0 10 11 
Saturated  1.4 4.7 
Monounsaturated  7.0 3.9 
Polyunsaturated  0.9 1.3 
 
4.3.3 NAPEs identification in biscuits 
NAPEs identification in biscuits was carried out by considering chemical structures of 
compounds and their retention times as obtained by HRMS analysis  
In HRMS analysis NAPEs were characterised by exact mass. However, since several NAPEs 
species can have the same molecular weight due to the combination of different acyl residues 
on the ethanolamine bone NAPEs were tentatively identified using an API 3000 triple 
quadrupole mass spectrometer. The analyses were firstly performed in scan using cone-induced 
fragmentation to detect the deprotonated molecules of NAPEs and the carboxylate ions in sn-
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2 and sn-1 position. The acquisition was then performed in MRM, to confirm the position of 
fatty acids by considering the information obtained in scanning experiments (De Luca et al., 
2018 submitted Food Chemistry). Details for NAPEs identification by mass spectrometry are 
reported in Table 4.3
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Table 4.3 NAPEs identification in biscuits by mass spectrometry. 
 
NAPE  
sn-1, sn- 2 
[M H]-
m/z 
[R2CO2]- [R1CO2]- [R3CO2]- [M-HR2CO2H]- [M-H-R1CO2H]- [M-H-R’2CH=CO]- [M-H-R’1CH=CO]- [R3CONHCH2CH2OPO3H]- 
 
16:0-18:2-N16:0 952.7 279.0 255.0 255.0 672.7 696.7 690.7 714.7 378 
16:0-18:2-N18:2 976.7 279.0 255.0 279.0 696.7 720.7 714.7 738.7 402 
16:0–18:2-N18:1 978.7 279.0 255.0 281.0 698.7 722.7 716.7 740.7 404 
18:2–18:2-N18:2 1000.7 279.0 279.0 280.0 720.7 720.7 738.7 738.7 402 
18:2-18:1-N18:2 1002.7 279.0 281.0 279.0 722.7 720.7 740.7 738.7 402 
18:3-18:2-N18:2 998.7 279.0 277.0 279.0 718.7 720.7 736.7 738.7 402 
18:2 18:2-N20:0 1032.7 279.0 279.0 311.0 752.7 752.7 770.7 770.7 434 
18:2 18:1-N20:1 1032.7 279.0 281.0 309.0 752.7 750.7 770.7 768.7 432 
 
* R1, R2, and R3 refer to the hydrocarbon chains of the acyl groups at sn-1, sn-2, and N-acyl position 
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4.3.4 NAPEs and NAEs concentration in biscuits 
Table 4.4 shows the total concentration of NAPEs and NAEs in the biscuits. 
Table 4.4. NAEs and NAPEs concentration in control biscuit (CONB), EVO-containing 
biscuit (EVOB) and palm oil containing biscuit (PALMB). The values are expressed as mean 
± error standard deviation. Student’s t test was used and different letters in the column 
indicate p<0.05 (number of replicates=3). 
 
 LEA(ng/g) PEA(ng/g) OEA(ng/g) Total NAEs(ng/g) NAPEs(µg/g) 
CONB 806 ± 263b 7.5±2b 86±29b 900±294b 876±42 
EVOB 1976±350ab 28.2±6ab 244±44a 2249±400ab 973±76 
PALMB 2388±194a 37.0±3a 297±20a 2722±216a 1091±46 
 
No difference between biscuits for the concentration of NAPEs was found. 
LEA and PEA concentrations were higher in PALMB than in CONB (2387±193.8 ng/g vs 
806.0±262.7 ng/g, p=0.017, for LEA and 37.0±3.0 ng/g vs 7.5±2.4 ng/g, p=0.003, for PEA). 
OEA concentration was higher in both PALMB and EVOB than in CONB (297.0±19.5 ng/g 
vs 86.4±29.0 ng/g, p=0.007, and 244.5±43.5 vs 86.4±29.0 ng/g; p=0.049, respectively). 
Total NAEs concentration was higher in PALMB than in CONB (2722±19.5 ng/g vs 900.6±2.4 
ng/g, p=0.015). 
4.3.5 NAPEs concentration in saliva  
Figure 4.2A shows concentrations of NAPEs in US, SS and upon  mastication of  the three 
types of biscuit. NAPEs concentration in US was higher in OB than in NW subjects (0.28±0.04 
µg/mL vs 0.12±0.025 µg/mL; p=0.015), whereas in SS no difference between OB and NW was 
found (0.26±0.05 vs 0.12±0.02 µg/mL, p=0.049).  
Data showed that upon mastication of food the concentration of salivary NAPEs was higher 
than in a no-food condition (SS) in both NW and OB subjects. Individual effect of each type 
of biscuit on salivary NAPEs concentration is shown in Figure 4.2B. 
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In NW a 41% higher concentration of salivary NAPEs with EVOB than PALMB was found 
whereas no difference between PALMB and EVOB compared to CONB was recorded. 
In OB, EVOB caused a 82% increase of NAPEs compared to PALMB and 145% increase 
compared to CONB, with no difference between PALMB and CONB. Only EVOB caused a 
different increase of salivary NAPEs between NW and OB with a 2.2 folds higher increase in 
OB than NW. 
 
 
Figure 4.2. Salivary concentration of NAPEs in NW and OB subjects at baseline and 
upon mastication of parafilm or biscuits. A) NAPEs concentration in unstimulated saliva 
(US), stimulated saliva (SS) and saliva collected upon mastication of control biscuit (CONB, 
paraffin oil), extra-virgin olive oil-containing biscuit (EVOB) and palm oil containing biscuit 
(PALMB). B) Effect of biscuit type on salivary concentration of NAPEs. The statistical tests 
used for analysis were Mann-Whitney and Wilcoxon tests. Different letters on the bars 
indicate p<0.05 (number of replicates=3). 
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4.3.6 NAEs concentration in saliva 
Figure 4.3 shows the concentration of individual and total NAEs in US, SS and in saliva upon 
mastication of the three types of biscuit as well as the effect of each type of biscuits on the 
variations of salivary concentration upon mastication. 
 
Figure 4.3. Salivary concentration of NAEs in NW and OB subjects at baseline and 
upon mastication of parafilm or biscuits. A) LEA concentration in unstimulated saliva 
(US), stimulated saliva (SS) and saliva collected upon mastication of control biscuit (CONB, 
paraffin oil), extra-virgin olive oil-containing biscuit (EVOB) and palm oil containing biscuit 
(PALMB). B) Effect of biscuit type on salivary concentration of LEA. C) OEA concentration 
in US, SS and saliva collected upon mastication of CONB, EVOB and PALMB. D) Effect of 
biscuit type on salivary concentration of OEA. E) PEA concentration in US, SS and saliva 
collected upon mastication of CONB, EVOB and PALMB. F) Effect of biscuit type on 
salivary concentration of PEA. G) Total NAEs concentration in US, SS and saliva collected 
upon mastication of CONB, EVOB and PALMB. H) Effect of biscuit type on salivary 
concentration of total NAEs. The statistical tests used for analysis were Mann-Whitney and 
Wilcoxon tests. Different letters on the bars indicate p<0.05 (number of replicates=3). 
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LEA concentration (Figure 4.3A) was higher in US and SS of OB than in NW subjects 
(7.44±1.04 ng/mL vs 3.22±0.55 ng/mL, p=0.001, in US and 4.86±0.65 ng/mL vs 2.71±0.33 
ng/mL, p=0.01 in SS). In NW and OB subjects, no difference was found between US and SS. 
Data showed that upon biscuit mastication the concentration of LEA was higher than in a no-
food condition (SS) in both NW and OB subjects. Individual effect of biscuits on salivary LEA 
concentration is shown in Figure 4.3B. 
In NW, no difference between biscuits was recorded. In OB, with EVOB a 83% and 363% 
higher concentration of LEA compared to PALMB and CONB was found. Moreover, a 153% 
higher concentration with PALMB than CONB was recorded.  
CONB and PALMB caused a different increase of salivary LEA between NW and OB with a 
3.8 and 1.6 folds higher increase in NW than in OB respectively. 
OEA concentration was higher in US of OB than in NW subjects (2.01±0.27 ng/mL vs 
1.04±0.13 ng/mL; p=0.008), whereas no difference between OB and NW was found in SS 
(0.81±0.08 ng/mL vs 0.85±0.09 ng/mL) (Figure 4.3C). 
OEA concentration was higher in US than in SS in NW and OB. Individual effect of each type 
of biscuit on salivary OEA concentration is shown in Figure 4.3D. 
In NW, no difference between biscuits was found. In OB, with EVOB a 122% and 500% higher 
concentration of salivary OEA compared to PALMB and CONB was found. Moreover, a 170% 
higher concentration with PALMB than CONB was recorded. 
Only CONB caused a different increase of salivary OEA between NW and OB with a 3.5 fold 
higher increase in NW than in OB. 
PEA concentration was higher in US of OB than in NW subjects (1.37±0.20 ng/mL vs 
0.56±0.13 ng/mL; p=0.002), whereas no difference was found in SS between OB and NW 
(0.56±0.08 ng/mL vs 0.37±0.05 ng/mL). PEA was higher in US than in SS of NW and OB 
subjects (Figure 4.3E). 
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Individual effect of each type of biscuit on salivary PEA concentration is shown in Figure 
4.3F. 
In both NW and OB, no difference between biscuits was recorded. 
CONB and PALMB caused a different reduction of salivary PEA between NW and OB with a 
10 and 3.6 folds higher reduction in OB than in NW, respectively. No difference was found 
between NW and OB. 
Finally, total salivary NAEs concentration in both US and SS was higher in OB than in NW 
subjects (10.82±1.41 ng/mL vs 4.82±0.79 ng/mL, p=0.002 for US and 6.15±0.79 ng/mL vs 
3.79±0.43 ng/mL, p=0.031, for SS) (Figure 4.3G). 
Total NAEs concentration was higher in US than in SS in both NW and OB groups. Individual 
effect of each type of biscuit on salivary total NAEs concentration is shown in Figure 4.3H. 
In NW, no difference between biscuits was found. In OB, with EVOB a 94% and 443% higher 
concentration of salivary total NAEs compared to PALMB and CONB was found. Moreover, 
a 180% higher concentration with PALMB than CONB was recorded. 
CONB and PALMB caused a different increase of salivary total NAEs between NW and OB 
with a 4.3 and 1.6 folds higher increase in NW than in OB respectively. Only CONB caused a 
different increase of salivary total NAEs between NW and OB with a 1.7 folds higher increase 
in NW than in OB. 
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4.4 Discussion  
This is the first study reporting the presence of NAPEs in saliva and their concentrations. 
NAPEs are membrane phospholipids and they are present in many organs such as brain, spinal 
cord, testis, spleen and in physiological fluids such as plasma and lymph, at very low 
concentration (Coulon et al., 2012). Gillum et al. (2008) showed that the plasmatic 
concentration of NAPEs in rat was 2.46 µmol/L while the concentration in lymph was 0.73 
µmol/L.  
Data showed that NAPEs, LEA, PEA, and OEA were present at higher concentrations in US 
from OB than NW being positively correlated with BMI (p=0.03; p=0.009; p=0.012; p=0.018; 
respectively). Data of PEA and OEA confirmed those previously found by Matias et al. (2012) 
while no previous literature exist on salivary LEA and NAPEs levels in NW and in OB. Since 
FAAH and NAPE-PLD are expressed in saliva producing organs (Matias et al., 2012), it was 
hypothesised that the differences between NW and OB might be due to a down-expression of 
FAAH and/or a decreased enzyme activity or to an over expression of NAPE-PLD and/or an 
increased activity as a result of obesity. 
Worth of notice is the different concentration of NAEs in US compared to SS, and the finding 
that NAEs level is reduced over mastication (US>SS). US is secreted by the submandibular 
and sublingual glands, while SS is secreted by parotid glands; SS has a higher protein 
concentration and lower viscosity than the US (Prinz et al., 2007). Therefore, it is likely that 
also hydrolytic enzyme as FAAH is more concentrated and/or active in SS than US thus 
lowering NAEs concentration.  
The increase of NAPEs in saliva upon biscuit mastication as well as their presence in the 
biscuits were a clear indication those molecules can derive directly from the biscuits.  
Data showed that upon EVOB mastication, NAPEs concentration in saliva was higher in OB 
than in NW subjects and, within the OB group, EVOB determined a higher increase of NAPEs 
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in saliva than PALMB and CONB. Contrarily, in NW no difference between EVOB and CONB 
was found whereas PALMB determined the lowest variation of NAEs levels compared to 
stimulation by parafilm.  
The difference between OB and NW for salivary NAPEs upon EVOB mastication might be 
due to a less active NAPE-PLD or by a different duration/efficiency of mastication in OB 
compared to NW.  
Individuals with higher BMI are known to eat faster (and masticate less) than those with a 
lower BMI (Zhu & Hollis 2014; Hill & McCutcheon, 1984) but because of the known higher 
activity of salivary alfa-amylase (Mennella et al., 2014) OB could be more efficient in 
delivering NAPEs from the biscuit compared to NW. In other word, even if OB masticated less 
the chemical breakdown of a starchy food matrix (as a biscuit) could happen faster in OB than 
NW thus delivering a higher amount of NAPEs into the saliva.  
In addition, the texture of EVOB could partly explain the findings in OB. Indeed, biscuits 
containing oil have a hard texture because a low quantity of air during the mixing of ingredients 
remains entrapped (Jacob & Leelavathi, 2007). Since rheological properties of foods influence 
the masticatory process and soft or water-rich foods are rapidly swallowed compared with hard 
foods, in this study OB might masticate EVOB for a longer time than for the other biscuits 
(Jalabert-Malbos et al., 2007). 
On the other hand the increase of NAEs concentration in NW and in OB subjects upon biscuit 
mastication compared to SS is in agreement with our previous studies where subjects 
masticated biscuits prepared with different dietary fibers (Kong et al., 2016) or puddings 
(Mennella et al., 2018). 
Regarding the effect of the biscuit type on salivary NAEs, no differences in NW between 
biscuits were found, whereas in OB salivary NAEs increased upon biscuit mastication 
following an order of magnitude that was for EVOB>PALMB>CONB. 
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The differences between OB and NW might result from different activities of alfa-amylase and 
FAAH. Similarly to what hypothesised for NAPEs from EVOB in OB, also NAES could be 
better released by OB from the food matrix due to a more efficient mechanical and enzymatic 
disruption of the food matrix, but a higher activity of FAAH in saliva of OB than NW might 
account for the low concentrations of NAEs in OB. This hypothesis was in line with the 
evidence of an over-expression of FAAH in the abdominal adipose tissue from OB compared 
to NW (Murdolo et al., 2007) and a higher FAAH activity in adipocytes from subjects with 
higher BMI and waist circumference (Cable et al., 2011). Contrarily, other authors showed that 
FAAH was under-expressed in adipose tissue from OB compared with NW (Bluher et al., 
2006; Lofgren et al., 2007). Future studies should clarify the mechanisms behind the different 
levels of NAEs in saliva of OB and NW upon food mastication. On the other hand, irrespective 
from individual nutritional status, data demonstrated a higher contribution of EVOB than 
PALMB and CONB to salivary NAEs levels. This finding was likely due to the ability of oleic 
acid (most abundant fatty acid of EVOO) to activate NAPE-PLD and inhibit FAAH. This 
hypothesis was in agreement with findings showed by Fu et al. (2007) and Schwartz et al. 
(2008) on the activity of NAPE-PLD and FAAH in duodenum and jejunum of rats as a response 
to oleic acid occurring within few minutes from stimuli presentation.  
Factors independent from specific fatty acid composition of palm oil and paraffin oil but most 
probably related to the mastication process such as differences in chewing cycles, bite force, 
degree of hunger, etc were hypothesised to be implicated in the different salivary NAEs 
concentrations upon mastication of PALMB and CONB. 
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4.5 Conclusions  
This study demonstrated that NAPEs and NAEs in saliva can derive from food upon 
mastication. The salivary concentrations of NAPEs and NAEs were higher in OB than in NW 
subjects. The increase of salivary NAEs upon food mastication was independent from the 
biscuit type in NW, while in OB the type of biscuits contributed to the salivary NAEs 
concentration in the following order: EVOB>PALMB>CONB. Future studies should evaluate 
the physiological role of increased concentration of salivary NAEs and NAPEs upon food 
mastication and the implications of NAPE-PLD and FAAH activities. 
4.6  Abbreviations 
NAEs: N-acylethanolamines; NAPEs: N-acylphosphatidylethanolamines; ENC: enteric 
nervous system; CB: cannabinoid receptors; TRPV1: transient receptor potential vanilloid type 
1; PPAR-α: peroxisome proliferator-activated receptor-α; BMI: Body Mass Index: BMI; 
TFEQ: Three Factor Eating; FPQ: Fat Preference questionnaire; PFS: Power of Food Scale; 
GI: gastrointestinal; GPR: G-protein-coupled receptor; CB1: cannabinoid receptors type 1; 
CB2: cannabinoid receptors type 2; TRPV1: transient receptor potential vanilloid type 1; 
PPAR-α: peroxisome proliferator-activated receptor-α; OB: obese; NW: normal weight; 
NAAA: N-acylethanolamine-hydrolyzing acid amidase; FAAH: fatty acids amide hydrolase; 
LC-HRMS: liquid chromatography–high resolution mass spectrometry; AEAd8: anandamide-
d8; OEA: oleoylethanolamide; LEA: linoleoylethanolamide; PEA: palmitoylethanolamide; 
EVOB: Evoo biscuits; PALMB: Palm biscuits; CONB: Control biscuits. US: unstimulated 
saliva; SS: stimulated saliva. 
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Abstract  
N-acylethanolamines (NAEs) and endocannabinoids (ECs) are bioactive molecules involved 
in different physiological and biochemical processes in both animal and plant tissues. NAPES, 
NAEs and ECs have been recently quantified in many foods and some evidence also suggests 
an interaction between gut microbiota and ECs system. The fate of dietary NAPEs, NAEs and 
ECs in the gastro-intestinal tract has been underestimated. 
In this study the bioaccessibility of NAEs and ECs from a Mediterranean (MD) and a Western 
diet (WD) along the gastrointestinal tract was assessed in vitro by using the simulated model 
of the human intestinal ecosystem (SHIME®).  
To this purpose two different diets such as a Mediterranean (MD) and a Western diet (WD) 
were prepared and used to feed the SHIME® system. The supernatants deriving from the 
different phases of the in vitro digestion were analysed to assess the concentrations of NAEs 
and ECs by LC-HRMS and the ability to inhibit FAAH by commercial kit. 
Data showed that both the concentration of total NAEs and FAAH inhibition upon a MD and 
a WD were not influenced by diets but mainly by fecal donor. This was associated with the 
different composition of the gut microbiota of the two donors.  
 
Keywords: microbiota, diets, N-acylethanolamines, SHIME® 
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5.1 Introduction 
N-acylethanolamines (NAEs) and endocannabinoids (ECs) are lipidic messengers involved in 
different physiological mechanisms in both animals and plants. 
In animals the enzyme involved in the synthesis of N-acylphosphatidylethanolamine (NAPEs) 
is N-acytransferase (NAT), while in plants the synthesis of NAPEs is possible by the NAPE 
synthase activity that promotes the N-acylation of phosphatidylethanolamine (PE) by free fatty 
acids (FFAs) (Coulon et al., 2012). The NAEs and ECs derive from hydrolysis of NAPEs by 
the N-acyl-phosphatidylethanolamine-specific phospholipase D (NAPE-PLD) enyzme, a 
specific membrane-bound phospholipase D (Ueda et al., 2010). In plants multiple isoforms of 
PLD are expressed such as PLDβ and PLDγ which are able to hydrolyse glycerophospholipids 
(including NAPEs).  
NAEs are hydrolysed in free fatty acid and ethanolamine by fatty acid amide hydrolase 
(FAAH) or N-acylethanolamine-hydrolyzing acid amidase (NAAA) (Coulon et al., 2012, Ueda 
et al., 2010). 
The glycerol ester 2-arachidonoylglycerol (2-AG) is synthesised from diacylglycerol via the 
enzyme diacylglycerol lipase (DAGL) and subsequently it is hydrolysed by monoacylglycerol 
lipase (MAGL) in arachidonic acid and glycerol (Witkamp, 2018). 
Different natural compounds are natural inhibitors of FAAH in vitro. They include some 
flavonoids such as kaempferol, apigenin, luteolin, quercetin, myricetin and genistein (Thors et 
al., 2007; Thors et al.,2008). 
The endocannabinoids (ECs), anandamide (AEA) and 2-AG activate cannabinoids receptors 
(CB1 and CB2) that are widely distributed into the human body. 
NAEs and ECs link various receptors present along the gastrointestinal tract (GIT) such as 
vanilloid receptors TRPV1, peroxisome proliferator-activated-α (PPAR-α), G protein-coupled 
receptors, GPR119 and GPR55 that are involved in the modulation of food intake either by 
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acting in the brain or by signaling from gastrointestinal system (Izzo & Sharkey,2010; Hansen 
& Diep, 2009). 
The activation of GPR119 by NAEs, and in particular by oleoylethanolamide (OEA), leads to 
enhanced glucose-dependent insulin secretion from pancreatic β-cells and influences the 
release of intestinal peptide glucagon like peptide-1 (GLP-1), glucose dependent insulinotropic 
peptide (GIP) and peptide YY (PYY) (Hansen et al., 2012).  
The concentration of NAEs and ECs in plasma and tissues of animals and humans and their 
involvement in the physiological processes are influenced by diet and its fat composition (Di 
Marzo, 2008; Pintus et al., 2013; Hansen et al.,2009; Banni et al., 2011; Artmann et al., 2008; 
Joosten et al., 2010; Diep et al., 2011; Mennella et al., 2015). 
NAPEs, NAEs and ECs are bioactive compounds present in nature but very little is known 
about their concentration in the food products  (Chapman et al., 1999; Di Marzo et al., 1998; 
Venables et al., 2005). 
We have recently shown that NAPEs, NAEs and ECs are present in food products and that 
NAPEs and NAEs are most abundant in vegetables products than in animal products, while the 
opposite was found for ECs (Kong et al., 2016; Mennella et al., 2018; De Luca et al., 2018-
submitted to Food Chemistry).  
The gut microbiota is able to influence the ECs system activity, the expression of FAAH in the 
colon and in other tissues as well as the mRna levels of NAPE-PLD in obese mice (Geurts et 
al., 2011; Muccioli et al., 2010). On the other hand, diet can influence the function of gut 
microbiota and dietary fats can induce obesity also through modification of gut microbiota 
composition (De Filippo et al., 2010; Mulders et al., 2018; Prieto et al., 2018). 
Lipopolysaccharide (LPS), which role in the development of metabolic disease is well known, 
can also influence the ECs system by inducing the production of ECs by immune cells (Cani, 
2012; Liu et al., 2003). 
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NAEs are modulated by gut microbiota and the interaction with GLP-1 can be involved in the 
cross-talk between the gut microbiota and regulation of host glucose metabolism (Everard & 
Cani, 2014). The ECs system or NAEs controlled by gut microbiota could contribute to control 
blood glucose, lipids and energy homeostasis. 
However, a relation between diet, gut microbiota, NAEs-ECs concentration and ECs system 
tone in humans has not yet demonstrated. 
In this study the fate of NAEs and ECs along the gastrointestinal tract (GIT) was assessed in 
vitro by using the simulated model of the human intestinal ecosystem (SHIME®) mimicking 
both physiological conditions and the microbial ecosystem found in the ascending (AC), 
transverse (TC) and descending (DC) colon. 
To this purpose two different diets such as a Mediterranean (MD) and a Western diet (WD) 
were prepared and used to feed the SHIME® system. The supernatants deriving from the 
different phases of the in vitro digestion were analysed to assess the concentration of NAEs 
and ECs by LC-HRMS and the ability to inhibit FAAH by commercial kit. 
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5.2. Material and methods 
5.2.1 Diets  
Two powders including food types and proportion typical of a Mediterranean Diet (MD) or a 
Western Diet (WD) were prepared.  
To prepare the MD based powder the following pattern was considered: a high intake of whole 
wheat cereals, legumes and fish, a low intake of dairy and poultry products and meat, low 
intake of potatoes and the use of the virgin olive oil as food condiment (Martinez-Gonzalez et 
al., 2009). For the WD powder a high intake of red and meat, butter, fried foods, high-fat dairy 
products, eggs, refined grains were considered (Myles, 2014). 
Table 5.1 shows the weight of lyophilised foods included in the MD and WD. 
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Table 5.1. Weight of foods used to develop Mediterranean (MD) and Western diet (WD). 
 
Dried Food MD 
(grams) 
WD 
(grams) 
Orange 2.22 0.69 
Walnuts 0.75 0 
Almond 0.75 0 
Beans 0.41 0.05 
Chickpeas 0.41 0.05 
Lentils 0.41 0.05 
Potatoes 0.17 1.7 
Tomatoes 1.01 0.1 
Cauliflower 0.5 0.05 
Broccoli 0.5 0.05 
Bread 0 4.19 
Whole wheat bread 2.15 0 
Pasta 0 4.19 
Brown pasta 4.19 0 
Breakfast whole cereals 2.15  
Codfish 0.38 0.05 
Anchovies 0.38 0.05 
Tuna fish 0.38 0.05 
Mozzarella cheese 0.40 1.38 
Gorgonzola cheese 0.40 1.38 
Parmigiano cheese 0.40 1.38 
Chicken 0.16 0.5 
Eggs 0.15 0.5 
Salami 0 1.6 
Red meat 0 1.5 
Extravirgin olive oil 1.76 0.23 
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5.2.2 TWIN SHIME® with MD and WD 
The SHIME® simulator (simulator of the human intestinal microbial ecosystem, ProDigest, 
Belgium) was used to mimic the in vivo human intestinal fermentation. 
Fresh fecal sample was used to inoculate a TWIN SHIME® set-up, consisting of ascending, 
transverse and descending colon for two different donors. The one male and one female fecal 
stool donors were non-smoking adults, between 25 and 31 years of age, with no prior history 
of antibiotic or probiotic use for 6 months and 3 weeks, respectively.  
For each donor, 3 double-jacketed vessels were used, simulating one combined stomach/small 
intestine, ascending (pH 5.6-5.9), transverse (pH 6.15-6.4) and descending (pH 6.6-6.9).  
Freshly donated fecal sample was stored in a collection box with an anaerobic AnaeroGen™ 
bag at 4°C for less than 8 hours. A 20% (w/v) solution of the fecal sample was homogenised 
with phosphate buffer for 10 min using a stomacher® 400 circulator. The sterilized phosphate 
buffer consisted of 8.8g/L K2HPO4, 6.8g/L KH2PO4 and 0.1g sodium thioglycolate in demi 
water. The pH was adjusted to 7 and 15 mg sodium thionite was added before use. After mixing, 
the inoculum was centrifuged for 2 min at 500g. Per 100mL vessel volume, 5mL of inoculum 
supernatant was used. After the two weeks stabilization period, the microbiota was collected 
and stored with 50% sterilized cryoprotectant (a final concentration of 42% glycerol in demi 
water, 0.5g/L cysteine HCl, 10g/L trehalose and 3g/L tryptic soy broth) at -80°C until further 
experiments. 
Before the experiment the microbiota was let overnight with pH controlled in the range 6.6-6.9 
followed then by a 3-day program with simulated feedings every 8 hours.  
Every 8 hours, 70ml fresh liquid feed with pH 2 entered the stomach vessel for each donor with 
a constant feed composition (1.2g/L arabinogalactan, 2.0g/L pectin, 0.5g/L xylan, 0.4g/L 
glucose, 3.0g/L yeast extract, 1.0g/L special peptone, 3.0g/L mucin, 0.5g/L l-cysteine-HCL, 
4.0g/L starch). After 90 minutes, 30ml of pancreatic juice, prepared with 12.5g/L NaHCO3; 
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6g/L Oxgall and 0.9g/L pancreatin from porcine ≥ 3 * USP, was added. After 90 minutes of 
small intestinal phase, the total volume was transferred to the ascending colon (pH 5.6-5.9, 
V=250mL), in series connected with the transverse (pH 6.15-6.4, V=400mL) and descending 
colon (pH 6.6-6.9, V=300mL). 
The vessel volumes, pH and retention times were kept constant at all times (Van den Abbeele 
et al., 2010). 
The experiment included three treatment days, with daily addition of dried foods per donor to 
the stomach phase. The experimental procedure consisted of the addition to the stomach phase 
of 10g/L of dried WD or MD per donor. During fermentation at 0, 1, 2, 4, 6 and 8 hours sample 
collections in all colon parts were carried out. Immediately after the collection, samples were 
centrifuged for 10 minutes at 9000rpm at a temperature of 4°C and the obtained supernatants 
were filtered using a 0.20µM RC syringe filter and stored at -20°C until analysis. 
The two donors were used as biological replicates. 
5.2.3 Extraction of NAEs and ECs from colon phase 
The extraction of NAEs and ECs from each colon phase was performed by using the protocol 
proposed by Gachet & coworkers (2015) with the addition of some modifications. 
500 µL of sample were added to 1 mL of the C2H3N solution and 50 µL of internal standard 
solution of 200 ng/mL arachidonoylethanolamide d8 (AEA d8) (Cayman Chemical, Ann 
Arbor, MI).  
The mixture was placed inside the refrigerator at 6◦C for 10 min to facilitate the protein 
precipitation. 
Subsequently, the samples were centrifuged at 14000 rpm at 4°C for 5 min.  
The supernatant was transferred to a tube, diluted with mL of H2O and extracted by solid-phase 
separation (C18 Sep-Pak cartridge pre-activated with 3 mL CH3OH and equilibrated with 3 mL 
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10% C2H3N). Cartridges were washed with 3 mL 10% C2H3N and eluted with 3 mL of 
C2H3N/C4H8O2 (1:1). 
The elutes were evaporated to dryness under nitrogen. The samples were reconstituted in 500 
µL C2H3N/C3H8O/H2O (60:35:5) and filtrated before the LC-HRMS analysis. 
5.2.4 Liquid Chromatography – High Resolution Mass Spectrometry (LC-HRMS) analysis 
LC-HRMS analysis was adapted from Gregory et al. (2012). The analysis was performed on 
an Accela U-HPLC system coupled to an Exactive mass spectrometer (Thermo Fisher 
Scientific, San Jose, CA). The Accela system consisted of a quaternary pump, a thermostated 
autosampler (8 °C). A Kinetex 2.6 μ C18 100 A column (100 mm × 2.1 mm) (Phenomenex, 
Torrance, CA) thermostated at 45 °C was used (De Luca et al., 2008 submitted to Food 
Chemistry). 
ECs (2-arachidonylglycerol, 2-AG; anandamide, AEA; AEAd8) and NAEs (OEA: 
linoleoylethanolamide, LEA; palmitoylethanolamide, PEA) standards were purchased from 
Cayman (Cayman Chemical, Ann Arbor, MI). The concentrations were calculated by isotope 
dilution using calibration curve with the linear range (1-1000 ng/mL) and expressed as ng per 
mL of colon phase.  
In the chromatographic region between 6-9 min the NAEs were detected in positive mode as 
[M+H]+. 
The compounds identification was performed by using the exact mass values up to the fifth 
decimal digit with a ± 5 ppm mass tolerance. 
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5.2.5 FAAH inhibition assay 
To check the ability of the supernatants to inhibit the FAAH a Fatty Acid Amide Hydrolase- 
Inhibitor Screening Assay (Cayman Chemical, Ann Arbor, MI) was used. 
170 µL of assay buffer (125 Mm Tris-HCl, pH 9, containing 1 mM of EDTA) was added with 
10 µL of FAAH (human recombinant) and 10 µL of supernatant or inhibitor (20 µM of  JZL 
195). 
The plate was incubated at 37° C for 5 minutes. 
Subsequently, 10 µL of substrate (20 µM of Arachidonyl amide) was added and the plate was 
incubated at 37°C for 30 minutes. 
The fluorescence was measured using a Spectramax M5 (Molecular devices, USA) with a 
wavelenght of 340-360 nm and an emission wavelenght of 450-465 nm. 
5.2.6 Statistical analysis 
Statistical analysis was performed using IBM SPSS Statistics version 20 (IBM Corporation, 
Armonk, New York,USA).  
Kolmogorov-Smimov and Shapiro tests as well as Levene's test were used to evaluate the 
normality of distribution and the homogeneity of variance of all monitored variables, 
respectively. Logarithmic transformation was applied to non-normally distributed data and 
mean values were compared through non-parametric Mann-Whitney U and Wilcoxon tests, 
since normal distribution was not observed.  
Statistical significance was defined as p<0.05 and results were expressed as means ± standard 
error of means (SEM). 
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5.3 Results 
Concentration of NAEs and ECs in stomach and small intestine 
Table 5.2 shows the concentration of NAEs and ECs in the stomach and small intestine phase. 
The values were expressed as means ± SEM. 
 
Table 5.2. NAEs and ECs in stomach and small intestine (SI) upon MD and WD in donor 1, 
in donor 2 and the mean concentration. The data are expressed as mean ± SEM. No 
difference between donors within stomach or SI was found for each monitored analyte. 
 
 
The concentration of ECs was higher in WD than in MD in stomach and in the small intestine. 
The concentration of LEA was similar in both the diets with an increase of concentration in the 
small intestine. 
The concentration of OEA, PEA and total NAEs was higher in WD than in MD, furthermore 
the concentration of OEA and total NAEs was higher in small intestine than in stomach for 
both the diets. 
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Concentration of ECs and NAEs in ascending colon (AC) 
The concentration of ECs in small intestine was 2.19 ng/mL in MD, while it was 17.6 ng/mL 
in WD. 
In order to highlight the effect of diets on bioaccessibility of NAEs and ECs, the baseline 
(before adding the diets to the small intestine) concentration at each colon tract was subtracted 
to those found at each time point and data were reported as variations from baseline. 
Figure 5.1 shows the mean of variation from baseline concentrations of the ECs in AC (A), as 
well as the individual variation from baseline in AC of donor 1 (AC1) (B) and donor 2 (AC2) 
(C) upon MD and WD.  
 
 
Figure 5.1. Variation from baseline of ECs in AC (mean of the two donors) (A), in AC1 
(donor 1) (B) and in AC2 (donor 2) (C). The statistical tests used for analysis were Mann-
Whitney and Wilcoxon tests.Different letters on the bars indicate significant differences 
(p<0.05) within the same diet. (number of replicates=3). 
 
 
No difference was found between two diets (Figure 5.1A). Looking at the concentration profile 
in individual donors (Figure 5.1B-C) no difference was found in AC1 and in AC2. 
Compared to the concentration in SI, the concentration of ECs in AC was reduced by a 
minimum of 91% after 1h to a maximum of 100% after 6h of treatment with MD, whereas the 
reduction ranged between 69% (after 1h) and 97% (after 8h) upon the WD. 
Figure 5.2 shows the variation from baseline of LEA in AC (A), LEA in AC1 (B), LEA in 
AC2 (C), OEA in AC (D), OEA in AC1 (E), OEA in AC2 (F), PEA in AC (G), PEA in AC1 
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(H), PEA in AC2 (I), total NAEs in AC (J), total NAEs in AC1 (K), total NAEs in AC2 (L), 
upon MD and WD. Panels A, D, G and J refer to mean concentrations of the two donors; panels 
B, E, H, K refer to concentrations in donor 1; panels C, F, I, L refer to to concentrations in 
donor 2. 
 
 
 
Figure 5.2. Variation from baseline of LEA (A) in AC, LEA in AC1 (B) and LEA in AC2 
(C), OEA in AC (D), OEA in AC1 (E) and OEA in AC2 (F), PEA in AC (G), PEA in AC1 
(H), PEA in AC2 (I), total NAEs in AC (J), total NAEs in AC1 (K), total NAEs in AC2 (L). 
Panels A, D, G and J refer to mean concentrations of the two donors; panels B, E, H, K refer 
to concentrations in donor 1; panels C, F, I, L refer to to concentrations in donor 2.  The 
statistical tests used for analysis were Mann-Whitney and Wilcoxon tests. Different letters 
indicate significant differences (p<0.05) within the same diet. Asterisks indicate significant 
differences (p<0.05) between MD and WD (number of replicates=3). 
138 
 
 
 
No difference between the diets for LEA bioaccessibility in AC was found. A reduction of 
mean concentration of LEA at 2h, 4h and 6h vs 1h with MD was observed (p=0.028; p=0.028; 
p=0.028) (Figure 5.2A), whereas in WD no difference was found. 
No significant effect of time in individual donors was evidenced (Figure 5.2B-C). However, 
WD determined a higher bioaccessibility of LEA in AC of donor 2 than of donor 1 after 4h 
(p=0.049), whereas with MD no difference between donors was observed. 
Compared to the concentration in SI, the concentration of LEA in AC was reduced by a 
minimum of 79% after 1h to a maximum of 105% after 6h of treatment with MD, whereas the 
reduction ranged between 71% (after 1h) and 88% (after 8h) upon the WD. 
Similarly to LEA, no difference between the diets for OEA bioaccessibility in AC was found 
but reduction over time of OEA at 2 h and 4h vs 1h with MD was observed (p=0.046) (Figure 
5.2D). 
Looking at OEA profile in individual donors (Figure 5.2E-F) it is evident that donor 2 (Figure 
5.2F) showed a higher bioaccessibility of OEA from both diets than donor 1. Specifically, a 
higher bioaccessibility in donor 2 vs donor 1 was found with MD after 1h (p=0.049) and with 
WD after 1h, 4h and 6h (p=0.049) of fermentation. Moreover, at 2h and 4h fermentation OEA 
concentration in AC of donor 2 from WD was higher than from MD (p=0.049). 
Compared to the concentration in SI, the concentration of OEA in AC was reduced by a 
minimum of 34% after 1h to a maximum of 110% after 4h of treatment when the system was 
fed with MD, whereas the reduction ranged between 9% (after 2h) to 72% (after 8h) upon WD. 
PEA was the least bioaccessible NAE. No difference between diets was found but a trend 
towards a reduction over time of PEA at 2h, 4h 6h, 8h vs 1h with MD was observed (p=0.028, 
p=0.046, p=0.028 and p=0.046, respectivey) (Figure 5.2G). 
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That difference was exclusively due to the donor 1 (Figure 5.2H) who also showed a smaller 
reduction of baseline concentration with MD than with WD after 1h and 4h fermentation 
(p=0.049; p=0.049). 
A higher bioaccessibility in donor 2 vs donor 1 was found with WD after 4h (p=0.049) 
Compared to the concentration in SI, the concentration of PEA in AC was reduced by a 
minimum of 44% after 1h to a maximum of 101% after 4h fermentation with MD, whereas the 
reduction ranged between 99% minimum (after 8h) to 137% (after 6h) upon the WD. 
Similarly to OEA (that was the most abundant NAE in AC), no difference was found between 
the two diets for bioaccessibility of total NAEs (Figure 5.2J) which mainly reflected those of 
donor 2.  
Specifically a significantly higher bioaccessibility of total NAEs was recorded from WD than 
from MD after and 4h fermentation (p=0.049) in donor 2 (Figure 5.2L); no difference between 
diets in donor 1 was found. Moreover, a higher bioaccessibility in donor 2 vs donor 1 was found 
with MD after 1h (p=0.049) and with WD after 1h, 4h and 6h (p=0.049) of fermentation. 
Compared to the concentration in SI, the concentration of total NAEs in AC was reduced by a 
minimum of 54% after 1h to a maximum of 102% after 4h fermentation with MD, whereas the 
reduction ranged between 32% (after 2h) to 78% after (8h) upon the WD. 
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Concentration of ECs and NAEs in TC 
Figure 5.3 shows the variation from baseline of ECs in TC (A), ECs in transverse colon of 
donor 1 TC1 (B), ECs in transverse colon of donor 2 TC2 (C). 
 
 
 
Figure 5.3. Variation from baseline of ECs in TC (mean of the two donors) (A), in TC1 
(donor 1) (B) and in TC2 (donor 2) (C). The statistical tests used for analysis were Mann-
Whitney and Wilcoxon tests. Different letters indicate significant differences (p<0.05) within 
the same diet. (number of replicates=3). 
 
 
No difference was found for the variation from baseline of the ECs in TC between diets and 
within diet over time. No difference was found in TC1 and TC2 (Figure 5.3B-C) and between 
donors with the same diet. 
Compared to the concentration in SI, the concentration of ECs in TC was reduced by a 
minimum of 89% after 8h to a maximum of 100% after 1h of treatment with MD, whereas the 
reduction ranged between 92% (after 2h) and 101% (after 4h) upon the WD. 
Figure 5.4 shows the variation from baseline of LEA in TC (A), LEA in TC1 (B), LEA in TC2 
(C), OEA in TC (D), OEA in TC1 (E), OEA in TC2 (F), PEA in TC (G), PEA in TC1 (H), 
PEA in TC2 (I), total NAEs in TC (J), total NAEs in TC1 (K), total NAEs in TC2 (L), upon 
MD and WD. ). Panels A, D, G and J refer to mean concentrations of the two donors; panels 
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B, E, H, K refer to concentrations in donor 1; panels C, F, I, L refer to to concentrations in 
donor 2 
 
 
Figure 5.4.  Variation from baseline of LEA (A) in TC, LEA in TC1 (B) and LEA in TC2 
(C), OEA in TC (D), OEA in TC1 (E) and OEA in TC2 (F), PEA in TC (G), PEA in TC1 
(H), PEA in TC2 (I), total NAEs in TC (J), total NAEs in TC1 (K), total NAEs in TC2 (L). 
Panels A, D, G and J refer to mean concentrations of the two donors; panels B, E, H, K refer 
to concentrations in donor 1; panels C, F, I, L refer to concentrations in donor 2. The 
statistical tests used for analysis were Mann-Whitney and Wilcoxon tests. Different letters 
indicate significant differences (p<0.05) within the same diet. Asterisks indicate significant 
differences (p<0.05) between MD and WD (number of replicates=3). 
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No difference between the diets for LEA bioaccessibility in TC was found. A reduction of 
mean concentration of LEA at 8h vs 1h, 2h and 4h with MD (p=0.027; p=0.026; p=0.027) and 
at 2h, 6h and 8h vs 1h with WD was observed (p=0.028; p=0.028; p=0.028) (Figure 5.4A). 
Looking at LEA profile in individual donors (Figure 5.4B-C) it is evident that donor 2 (Figure 
5.2C) showed a higher bioaccessibility of LEA from both diets than donor 1 with a significant 
difference from WD. Compared to the concentration in SI, the concentration of LEA in TC was 
reduced by a minimum of 93% after 1h to a maximum of 99% after 8h of treatment with MD, 
whereas the reduction ranged between 82% (after 1h) and 97% (after 4h) upon the WD 
The bioaccessibility of OEA in TC was higher from WD than from MD at 1h (p=0.049) and 
2h (p=0.049). When the system was fed with WD a reduction of mean concentration of OEA 
at 2h, 6h and 8h vs 1h (p=0.027;p=0.046; p=0.028),  at 8h vs 2h (0.028) and 8h vs 4h (p=0.046) 
was observed. (Figure 5.4D). 
Considering the OEA profile in individual donors it is evident that donor 2 showed a higher 
bioaccessibility of OEA. 
In particular donor 2 showed a higher bioaccessibility of OEA than in donor 1 from WD after 
1h (p=0.049) and 2h (p=0.049). Furthermore, in donor 2 the bioaccessibility of OEA was higher 
in WD than in MD at 1h (p=0.049), at 2h (p=0.049) (Figure 5.4F). 
Compared to the concentration in SI, the concentration of OEA in TC was reduced by a 
minimum of  98% after 1h to a maximum  of 115% after 4h of treatment when the system was 
fed with MD, whereas the reduction ranged between 41% (after 1h) to 108%  (after 8h) upon 
WD. 
Considering PEA bioaccessibility in TC no difference was found between diets (Figure 5.4G). 
In donor 1 the bioaccessibility was not influenced by diet (Figure 5.4H), while in donor 2 the 
bioaccessibility was higher from MD than from WD after 8h (p=0.049) (Figure 5.4I). 
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The bioaccessibility of this compound with WD it was higher in donor 1 than in donor 2 after 
8h (p=0.046). 
Compared to the concentration in SI, the concentration of PEA in TC was reduced by a 
minimum of 76% after 8h to a maximum of 102% after 4h of fermentation with MD, whereas 
the reduction ranged between 58% (after 1h) to 95% (after 8h) upon WD. 
Considering total NAEs, the bioaccessibility in TC was higher from WD than from MD at 1h 
(p=0.046). Total NAEs bioaccessibility from WD was reduced at 2h, 6h and 8h vs 1h, (p=0.028; 
p=0.046; p=0.028) and at 8h vs 2h (p=0.028) (Figure 5.4J). 
For the total NAEs profile in individual donors (Figure 5.4K-L) it is evident that donor 2 
(Figure 5.4L) showed a higher bioaccessibility than donor 1 particulary with significant effect 
after 1h and 2h (p=0.049; p=0.049) of feeding the system with WD.   
Furthermore, in donor 2 the bioaccessibility of total NAEs was higher from WD than from MD 
at 1h (p=0.049), at 2h (p=0.049). 
Compared to the concentration in SI, the concentration of total NAEs in TC was reduced by a 
minimum of 96% after 1h to a maximum of 105% after 4h using the MD, whereas the reduction 
ranged between 53% (after 1h) to 104% (after 8h) upon WD. 
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Concentration of ECs and NAEs in DC 
Figure 5.5 shows the concentration of the ECs in DC (A), in DC of donor 1 (DC1) (B) and 
donor 2 (DC2) (C) upon MD and WD.  
 
 
Figure 5.5 Variation from baseline of ECs in DC (mean of the two donors) (A), in DC1 
(donor 1) (B) and in DC2 (donor 2) (C). The statistical tests used for analysis were Mann-
Whitney and Wilcoxon tests.Different letters indicate significant differences (p<0.05) within 
the same diet. (number of replicates=3). 
  
No difference was found for the variation from baseline of the ECs in DC between diets and 
within diet over time. No difference was found in donor 1 and donor 2 (Figure 5.5B-C), but  
donor 1 showed a higher bioaccessibility than donor 2 that was significant after 6h (p=0.046), 
of feeding system with WD, whereas no difference with MD was found. 
Compared to the concentration in SI, the concentration of ECs in DC was reduced by a 
minimum of 88% after 8h to a maximum of 102% after 2h of treatment with MD, whereas the 
reduction ranged between 92% (after 2h) and 96% (after 4h) upon the WD. 
Figure 5.6 shows the variation from baseline of LEA in DC (A), LEA in DC1 (B), LEA in 
DC2 (C), OEA in DC (D), OEA in DC1 (E), OEA in DC2 (F), PEA in DC (G), PEA in DC1 
(H), PEA in DC2 (I), total NAEs in DC (J), total NAEs in DC1 (K), total NAEs in DC2 (L), 
upon MD and WD. Panels A, D, G and J refer to mean concentrations of the two donors; panels 
B, E, H, K refer to concentrations in donor 1; panels C, F, I, L refer to to concentrations in 
donor 2 
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Figure 5.6. Variation from baseline of LEA (A) in DC, LEA in DC1 (B) and LEA in DC2 
(C), OEA in DC (D), OEA in DC1 (E) and OEA in DC2 (F), PEA in DC (G), PEA in DC1 
(H), PEA in DC2 (I), total NAEs in DC (J), total NAEs in DC1 (K), total NAEs in DC2 (L). 
Panels A, D, G and J refer to mean concentrations of the two donors; panels B, E, H, K refer 
to concentrations in donor 1; panels C, F, I, L refer to to concentrations in donor 2. The 
statistical tests used for analysis were Mann-Whitney and Wilcoxon tests.Different letters 
indicate significant differences (p<0.05) within the same diet. Asterisks indicate significant 
differences (p<0.05) between MD and WD (number of replicates=3). 
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No difference between the diets for LEA bioaccessibility in DC was found (Figure 5.6A). 
In donor 1 a higher bioaccessibility from WD than from MD at 8h (p=0.046) was observed. 
Furthermore a higher bioaccessibility in donor 1 than in donor 2 when the system was fed with 
MD after 2h (p=0.049) was found. 
Compared to the concentration in SI, the concentration of LEA in DC was reduced by a 
minimum of  97% after 1h to a maximum  of 101% after 8h  of fermentation with MD, whereas 
the reduction ranged between  72% (after 6h) to  96% (after 2h) upon WD. 
No difference between diets for the bioaccessibility of OEA in DC (Figure 5.6D) was found, 
whereas a reduction of mean concentration with MD at 4h vs 1h (p=0.046), at 8h vs 1h 
(p=0.046), at 4h vs 2h (p=0.043) and at 8h vs 1h (p=0.046) was found. 
Donor 1 showed a higher bioaccessibility than donor 2 that was significant after 1h (p=0.049), 
after 4h (p=0.049), after 6h (p=0.049) and after 8h (p=0.049) of feeding system with WD. 
In donor 1 the bioaccessibility was higher from WD than from MD after 1h (p=0.049), 4h 
(p=0.049) and 8h (p=0.049), whereas in donor 2 the bioaccessibility was higher from MD than 
from WD after 8h (p=0.049). 
Compared to the concentration in SI, the concentration of OEA in DC was reduced by a 
minimum of 79% after 2h to a maximum of 101% after 8h using the MD, whereas the reduction 
ranged between 69% (after 6h) to  98% (after 1h) upon WD. 
No difference between the diets for PEA bioaccessibility in DC was found (Figure 5.6G) and  
a reduction after 8h vs 1h (p=0.027) with WD was found. 
The bioaccessibility of PEA in donor 2 was higher from MD than from WD after 8h (p=0.049).  
Compared to the concentration in SI, the concentration of PEA in DC was reduced by a 
minimum of 84% after 2h to a maximum  of  101% after 6h during the fermentation with MD, 
whereas the reduction ranged between  75% (after 1h) to  102% (after 6h) upon WD. 
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The bioaccessibility of total NAEs  was not different  between the two diets (Figure 5.6J), but 
a reduction after 8h vs 1h, 2h and 6h (p=0.028; p=0.046; p=0.046) and after 4h vs 2h (p=0.028) 
from MD was found, while a reduction after 4h vs 1h (p=0.046) from WD was found. 
In donor 1 the bioaccessibility was higher from WD than from MD after 1h (p=0.049), after 4h 
(p=0.049) and after 8h (p=0.049) (Figure 5.6 K).  
A higher bioaccessibility of total NAEs in donor 1 than in donor 2 after 4h (p=0.046) and 8h 
(p=0.049) from MD and after 1h (p=0.049) and 8h (p=.0.049) from WD was found. 
Compared to the concentration in SI, the concentration of total NAEs in DC was reduced by a 
minimum of   84% after 2h to a maximum  106% after 4h using the MD, whereas the reduction 
ranged between 76  (after 6h) to  93%  (after 1h) upon WD. 
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5.3.1 Assay FAAH inhibition 
Figure 5.7 shows the results of the FAAH inhibition assay. No difference between the two 
diets was found. The highest percentage of inhibition was found in small intestine before the 
fermentation of both diets. 
%
S
T S
I
A
C
T
1
h
A
C
T
4
h
A
C
T
8
h
T
C
T
1
h
T
C
T
4
h
T
C
T
8
h
D
C
T
1
h
D
C
T
4
h
D
C
T
8
h
-5 0
0
5 0
1 0 0
M D
W D
a
 a
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
b
 
Figure 5.7. Percentage of inhibiton in supernatants of MD and WD deriving from SHIME®. 
The statistical tests used for analysis were Mann-Whitney test. Different letters indicate 
significant differences (p<0.05) between MD and WD (number of replicates=3). 
 
 
 
 
 
 
 
 
149 
 
5.4 Discussion 
In the present study the bioaccessibility of NAEs and ECs deriving from MD and WD along 
GIT in vitro using SHIME® was assessed. 
Data showed a low bioaccessibility of NAEs and ECs from both the diets. Moreover, 
considering the amount of NAPEs (24 mg with MD and 9 mg with WD) added with the two 
diets and the NAEs retrieved in the system, a weak activity of microbial NAPE-PLD and/or an 
over-activity of FAAH could be hypothesised. 
Previous studies showed the link between diet and ECs system and between ECs system and 
gut microbiota, but the mechanisms of this link is not yet clarified. 
Data showed a lack of influence of diets on the concentrations of NAEs and ECs in the colon 
but an influence of the fecal donors. Indeed, the donor 2 was always associated with higher 
variation from baseline of total NAEs and particularly OEA in AC with MD and with WD.  
In TC the variations from baseline of LEA, OEA and total NAEs was higher in donor 2 than in 
donor 1 upon WD, while the variation from baseline of  PEA was higher in donor 1 than in 
donor 2. No difference was found upon MD. 
This behavior changed in DC where the higher variation from baseline of LEA upon MD, OEA 
and total NAEs upon WD was higher in donor 1 than in donor 2. 
Such differences between donors were likely due to a different microbiota composition. Indeed, 
the ratio of Firmicutes/Bacteroidetes was 1.55 in AC1 and 2.43 in AC2, 0.85 in TC1 and 0.70 
in TC2, as well as 1.12 in DC1and 0.85 in DC2 (data not shown). 
A recent study showed that the treatment with OEA (10 mg/kg) for 11 days changed the 
composition of gut microbiota in mice. OEA treatment shifted the Firmicutes/Bacteroidetes in 
favour of Bacteroidetes and reduced Firmicutes, the ratio was similar to the ratio of TC1 and 
DC2 (Di Paola et al., 2018). 
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In contrast, another study showed that a treatment with PEA (30 mg/kg) for 10 days changed 
the gut microbiota with an increase of Firmicutes and a reduction of Bacteroidetes determining 
a ratio that was similar to AC1 (Cristiano et al.,  2018). 
In humans, an alteration of nutrient load of the diet changed the gut microbiota.  Jumpertz & 
coworkers (2011) observed that in normal weight subjects a 20% increase in Firmicutes and a 
corresponding decrease in  Bacteroidetes were associated with an increased energy harvest of 
150 kcal (Jumpertz et al., 2011). De Filippo et al. (2010) showed that the Firmicutes are most 
abundant in European children compared to Burkina Faso children, and the ratio 
Firmicutes/Bacteroidetes was higher in European children than in Burkina Faso children. In 
humans, the ratio Firmicutes/Bacteroidetes differs in obese and lean humans and this ratio 
decreased with weight loss after a low calories diet (Ley et al., 2006). 
A study conducted in patients with ulcerative colitis (UC) and Crohn’s disease following a MD 
showed that the subjects with UC increased the levels of NAPEs in feces suggesting a 
modification  of the ECs system and demonstrating the link of the ECs system with 
gastrointestinal functions (Santoru et al., 2017). 
Another study showed that the administration of engineered NAPE-expressing E.coli Nissle 
1917 for 8 weeks reduced obesity in mice fed with a high fat diet. Furthermore, it was shown 
an increase of hepatic NAEs after the administration of P-NAPE-ECn suggesting the possibility 
that NAPEs were absorbed by colon and transformed in NAEs to entry in portal circulation 
(Chen et al., 2014). 
Furthermore the synthesis and the degradation of NAEs and ECs in intestine was shown to be 
modulated by gut microbiota, where high-fat diet increased NAPE-PLD activity and reduced 
FAAH in intestine and in adipose tissue of mice, whereas the treatment with prebiotics reduced 
these effects. Anyway, the mechanisms by which the gut microbiota participate in this 
regulation is not yet understood (Cani, 2012). 
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PEA is an anti-inflammatory compound that has beneficial effects on colon inflammation. The 
action of this compound is terminated by hydrolysis of FAAH and NAAA. Alhouayek, et al. 
(2015) showed that in murine model of inflammatory bowel diseases (IBDs) the NAAA 
inhibition increased the levels of PEA in the colon and reduced the colon inflammation similar 
to the action of PEA, while FAAH inhibition did not increase PEA levels in the colon. So 
NAAA is the enzyme responsible for the control of PEA in the colon.  
Regarding the FAAH inhibition, it was highest in SI for both the diets. It was hypothesised that 
the presence of bile salts and pancreatin in the system might increase the release of compounds 
having an inhibitory activity on FAAH. 
Indeed, many in vitro studies showed the presence of natural inhibitor of FAAH present in 
plants (Thors et al., 2007; Thors et al., 2008).  
New compounds such as N-arachidonoyl-amino acids are able to inhibit FAAH in vitro (Cascio 
et al., 2004). Recently, Donvito & coworkers (2018) showed that the N-oleoyl-glycine (O-Gly) 
is able to inhibit FAAH in vitro with a IC50   8.65 µM and the FAAH inhibition produced by 
maximum dose tested (50 µM) was 89.4%. However, after the treatment with the two diets O-
Gly was present at same concentration in the supernatants deriving from AC, TC and DC (data 
not shown), thus its influence in our results could be excluded. 
5.5 Conclusions  
This study showed that both the concentration of NAEs and FAAH inhibition upon a MD and 
a WD were not influenced by diets but mainly by fecal donor. This was associated with the 
different composition of the gut microbiota of the two donors.  
Considering the amount of NAPEs (precursors of NAEs) added to the diet and the amount of 
NAEs retrieved, a weak activity of NAPE-PLD was suggested. 
Further in vivo studies are necessary to confirm the influence of gut microbiota on metabolic 
fate of NAEs and ECs along gastrointestinal tract. 
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5.6 Abbreviations 
NAEs: N-acylethanolamines; ECs: endocannabinoids, NAPEs: N-
acylphosphatidylethanolamine; NAT: N-acytransferase; FFAs: free fatty acids; NAPE-PLD: 
N-acyl phosphatidylethanolamine-specific phospholipase D; FAAH: fatty acid amide 
hydrolase; NAAA: N-acyethanolamine-hydrolyzing acid amidase;  ECs: endocannabinoids; 
AEA: anandamide; 2-AG: 2-arachidonoylglycerol: CB: cannabinoid receptor;  PPAR-α: 
peroxisome proliferator-activated-α; GPR: G- protein-coupled receptors; GIT: gastrointestinal 
tract; GLP-1: glucagone like peptide-1; GIP: glucose dependent insulinotropic peptide;  PYY; 
peptide YY;  LPS: lipopolysaccharide; GIT: gastrointestinal tract; SHIME®: Simulator of the 
Human Intestinal Microbial; AC: ascending colon; TC: transverse colon; DC: descending 
colon; SI: small intestine; MD: Mediterranean diet; WD: Western diet; LEA: 
Linoleoylethanolamide; PEA: Palmitoylethanolamide; OEA: Oleoylethanolamide. SEM: 
standard error of means; O-Gly: N-oleoyl-glycine.  
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Chapter 6. Summary, conclusions and future 
perspectives 
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NAPEs, NAEs and ECs are bioactive molecules that participate to the hedonic and homeostatic 
phenomena underpinning food intake.  
NAEs have a wide range of biochemical effects and derive from hydrolysis of NAPEs. This 
reaction is catalysed by the enzyme NAPE-PLD present in many plant and animal tissues. 
Subsequently, NAEs are hydrolysed in mammal tissues and in plants by FAAH which leads to 
the formation of free fatty acids and ethanolamines (Coulon et al., 2012). 
Animal studies showed that NAEs and ECs are involved in different biological pathways since 
they are agonists of cannabinoid receptor-1 (CB1), transient receptor potential vanilloid 1 
(TRPV1) and the peroxisome proliferator-activated receptor-α (PPAR-α). Moreover, NAEs are 
also able to link GPR119 which is expressed on cells in the small intestine, colon and stomach 
(Hansen & Diep, 2009). 
The receptors are involved in food intake and in blood glucose control due to the regulation 
from the gastrointestinal tract (GIT) of GLP-1 secretion (Izzo & Sharkey, 2010). 
Although NAPEs, NAEs and ECs are compounds widespread in nature, only few studies 
reported the amount of ECs and NAEs in some food products (Di Marzo et al., 1998; Chapman 
et al., 1999; Venables et al., 2005). Anyway, the possibility that some of these food-derived 
compounds act through the receptors present along the GI mucosa depends from their survival 
to the degrading enzymes (Izzo & Sharkey, 2010).  
The gut microbiota is able to control levels of ECs in both the gut and the adipose tissue by 
regulating NAPE-PLD, CB1 and FAAH expression in obese mice (Muccioli et al., 2010). In 
humans, a relationship between the changes in the gut microbiota and in the ECs system tone 
have not yet demonstrated. 
The studies described in this PhD thesis investigated the presence of NAPEs, NAEs and ECs 
in foods and tested their bioaccessibility in the oral cavity during food mastication in vivo and 
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in the GIT in vitro to evaluate their potential availability to activate the receptors present on 
the alimentary canal mucosa. 
In Chapter 1 the mechanisms involved in gut-brain axis and nutrient sensing were described, 
by mainly focusing on the ascertained and potential role of NAPEs, NAEs and ECs in the 
physiological systems underpinning homeostatic and hedonic control of food intake. 
In Chapter 2 the concentration of NAPEs, NAEs and ECs in 43 foods of different origin was 
assessed and the daily intakes upon a Mediterranean (MD), Vegetarian (VD) and Western diet 
(WD) were calculated. Data showed that NAPEs and NAEs were more abundant in vegetal 
than in animal food products. Furthermore, NAPEs daily intake was higher in MD (263 
mg/day) and VD (242 mg/day) compared to WD (163 mg/day); also NAEs daily intake was 
higher in MD (0.25 mg/day) and VD (0.28 mg/day) compared to WD (0.08 mg/day); 
conversely ECs daily intake was higher in WD and MD (0.17 mg/day) than in VD (0.01 
mg/day). These amounts may be enough to activate receptors along GIT. 
In fact, in vitro studies showed that NAEs activate GPR119 with an EC50 between 65 µg/L and 
1.0 mg/L for OEA, 180 µg/L for LEA and 250 µg/L for PEA (Hansen et al., 2011; Overton et 
al., 2006); while Fu et al. (2003) also showed that OEA can activate PPAR-α with an EC50 of 
39 µg/L influencing food intake and lipid metabolism.  
Therefore, data suggested that NAPEs and NAEs travelling in the GIT upon food consumption 
may contribute to nutrient metabolism, to the regulation of food intake and body weight as well 
as to the gut permeability and GIT motility through the nutrient sensing in the gut. Further 
studies are necessary to define the contribution of these compounds on the benefits elicited by 
MD and VD in vivo. 
An overall graphical summary of chapter 2 was shown in Figure 6.1. 
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Figure 6.1. Graphical summary of Chapter 2: extraction of NAPEs, NAEs and ECs from 
foods and estimation of daily intakes of these compounds from different diets. 
 
In the Chapter 3 a sham feeding study was described. It showed the concentration of NAEs in 
stimulated saliva of healthy normal weight subjects. Interestingly, salivary concentration of 
NAEs increased upon food mastication compared to the mastication of a parafilm piece 
(stimulated saliva). The concentration of NAEs in the oral cavity within the first hours after 
food mastication was influenced by the type of dietary fiber (3% of β-glucan or whole-wheat 
bran) used for the preparation of biscuits. 
The post-prandial concentration of salivary oleoylethanolamide (OEA) was associated with the 
sensations of fullness and satiety as well as the liking of the biscuits for sweetness. These links 
could explain the potential role of salivary OEA upon food preference and individual choice. 
In Figure 6.2 the graphical summary of this chapter was shown. 
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Figure 6.2. Graphical summary of Chapter 3: salivary NAEs upon mastication of different 
types of biscuit and in postprandial phase 
 
 
In the Chapter 4 another sham feeding study was described. It aimed at evaluating the 
influence of individual nutritional status on bioaccessibility (release in saliva) of NAPEs and 
NAEs upon mastication of three biscuits differing for amount and type of fat. To this purpose 
three types of biscuits were prepared with 8% of extravirgin olive oil (EVOB), 8% of palm oil 
(PALMB) and without added fat (CONB). Data showed that the obese (OB) subjects had a 
higher release of NAPEs in unstimulated saliva than normal weight (NW) subjects, while the 
concentration of NAEs in both unstimulated saliva and stimulated saliva was higher in OB than 
in NW subjects. 
During the mastication of biscuits a higher concentration of salivary NAPEs and NAEs than a 
no food condition in both NW and OB subjects was found. An overall graphical summary of 
this chapter is shown in Figure 6.3. 
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Figure 6.3. Graphical summary of Chapter 4: salivary NAPEs and NAEs upon mastication of 
biscuits prepared with different fats. 
 
In a Chapter 5 the bioaccesibility of NAEs and ECs along the gastrointestinal tract in vitro 
using Simulator of the Human Intestinal Microbial Ecosystem (SHIME®) simulating both 
physiological conditions and the microbial ecosystem found in the ascending (AC), transverse 
(TC) and descending (DC) colon was assessed. To this purpose we prepared two different diets: 
Mediterranean (MD) and Western diet (WD) and the supernatants deriving from the different 
phase of colon were analysed by HRMS analysis to measure NAEs and ECs. Data showed that 
the diets did not influence the concentration of these compounds, but the microbiota 
composition could influence the release of compounds in the colon phase. In Figure 6.4 the 
graphical summary of this chapter was shown. 
 
Figure 6.4. Graphical summary of Chapter 5: study of the bioaccessibility of NAEs and ECs 
from a Mediterranean (MD) and a Western diet (WD) along the gastrointestinal tract was 
assessed in vitro by using SHIME®. 
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Considering the results obtained from the experiments performed in this PhD thesis it is 
possible to conclude that: 
● NAPEs, NAEs and ECs are present at different concentrations in many food products. 
● In vivo studies showed that these compounds are released from food matrix during the 
mastication and that other food components (fibers and fats) as well as the individual 
nutritional status of individuals may influence both the delivery of these compounds 
from the food (bioaccessibility) as well as their persistence in the oral cavity after 
eating; this might influence liking of food and subsequent food intake. 
● During in vitro digestion with SHIME® the concentration of NAPEs, NAEs and ECs 
was hypothesised to be majorly influenced by the microbiota composition inside the 
system acting on the biosynthesis and degradation of NAEs and ECs arriving into the 
colon, independently from the diet. 
● Specifically designed studies are necessary to elucidate better the influence of 
enzymatic activity of NAPE-PLD and FAAH at different sites of the alimentary canal 
and in the gut microbiota to ascertain the metabolic fate of dietary NAPEs, NAEs and 
ECS in vivo and to possibly find dietary strategy to modulate the concentration of these 
bioactive compounds at intestinal level. 
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